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A B S T R A C T
ORAL TALKS
S1- O1 | Effects of physical exercise during 
pregnancy on the modulation of liver mitochondrial 
function in an animal model of non- alcoholic fatty 
liver disease
Jelena Stevanović1; Jorge Beleza1; Pedro Coxito1; Manoel Rios1; 
Susana Pereira1,2; Carlos Palmeira2; António Moreno2,3; Paulo 
Oliveira2; António Ascensão1; José Magalhães1
1LaMetEx — Laboratory of Metabolism and Exercise, CIAFEL — 
Research Centre in Physical Activity, Health and Leisure, Faculty 
of Sport, University of Porto, Porto, Portugal;  2CNC — Centre for 
Neuroscience and Cell Biology, UC- Biotech, University of Coimbra, 
Coimbra, Portugal;  3Department of Life Sciences, School of Sciences 
and Technology, University of Coimbra, Coimbra, Portugal
Background: Non- alcoholic fatty liver disease (NAFLD) is 
associated with high- caloric intake and physical inactivity. 
Among other pathological alterations, liver mitochondrial- 
related dysfunction characterizes NAFLD development, but 
seems to be attenuated by physical exercise (PE). In addition 
to more prevalent metabolic conditions in which NAFLD is 
present, women with gestational diabetes mellitus (GDM) 
present signs of NAFLD. The aim of this study was to eluci-
date whether PE during pregnancy influences liver mitochon-
drial function in a GDM- associated NAFLD model.
Methods: After 6 weeks under control (C) or high- fat- high- 
sugar (HFHS) diets, female Sprague- Dawley rats were mated 
and distributed into the following experimental groups: C or 
HFHS; pregnant or non- pregnant; sedentary or exercised dur-
ing pregnancy. Oral glucose tolerance test (OGTT) and his-
tological analysis were used to confirm the presence of GDM 
and NAFLD, respectively. Liver mitochondrial function was 
assessed using complex I and II- related substrates.
Results: Although body weight was not altered by HFHS or 
PE, gestational body weight gain was increased in sedentary 
HFHS group compared to C (~1.5- fold) or exercised HFHS 
groups (~1.3- fold). Pre- mating OGTT did not show differ-
ence between C and HFHS groups, while pregnant HFHS- 
fed animals were more glucose intolerant, regardless of PE. 
Histological analysis confirmed the presence of steatosis 
in HFHS sedentary groups. Regarding liver mitochondrial 
function, pregnancy and HFHS per se negatively affected 
mitochondrial function, although the synergistic effect of 
both factors did not additionally deteriorate mitochondrial 
function. PE improved mitochondrial function of HFHS 
groups, regardless of pregnancy.
Conclusion: Pregnancy and HFHS impaired mitochondrial 
function of sedentary rats. However, 3 weeks of PE during 
pregnancy was able to attenuate the effects of HFHS and/
or pregnancy on liver mitochondrial function on this animal 
model of NAFLD.
Funding: EU's Horizon 2020 Research and Innovation 
programme Marie Skłodowska- Curie (No. 722619, 
FOIE GRAS; No. 734719, mtFOIE GRAS); UID/
DTP/00617/2013; POCI- 01- 0145- FEDER- 016690- PTDC/
DTP- DES/7087/2014; POCI- 01- 0145- FEDER- 016657 
- PTDC/DTP- DES/1082/2014; SFRH/BD/129645/2017, 
SFRH/BPD/116061/2016.
S1- O2 | RIP3 deficiency remodels mitochondrial 
bioenergetics and function in experimental NAFLD
Tawhidul Islam1; Marta B. Afonso1; Véronique Lenoir2; Rui E. 
Castro1; Carina Prip-Buus2; Cecília M. P. Rodrigues1
1Imed.ulisboa, Faculty Of Pharmacy, University Of Lisbon, Lisbon, 
Portugal;  2Institut Cochin, INSERM U1016, CNRS UMR8104, Université 
Paris Descartes, Paris, France
Mitochondrial dysfunction, liver cell damage and inflam-
mation constitute key pathogenic mechanisms underlying 
non- alcoholic fatty liver disease (NAFLD) progression to 
non- alcoholic steatohepatitis (NASH) and hepatocellular car-
cinoma. Increased mtFAO without collateral up- regulation 
of the mitochondrial respiratory chain (MRC) activity leads 
to reactive oxygen species (ROS) overabundance. Here, we 
aimed to evaluate the role of RIP3 depletion on restoration 
of the MRC activity in experimental NAFLD progressing 
from steatosis to the development of preneoplastic lesions. 
C57BL/6N wild- type (WT) and RIP3- /- mice were fed either 
a choline- sufficient, amino acid- defined control diet (CSAA; 
n = 38) or a choline- deficient, amino acid- defined diet 
(CDAA; n = 38) for 32 and 66 weeks. Liver samples were 
collected and processed for assessment of biomolecular stud-
ies. Citrate synthase and MRC complex I, II, II+III and IV 
activities were investigated. Mitochondrial biogenesis mark-
ers (PGC1α, NRF1, TFAM),and ROS detoxification markers 
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(SOD1, SOD2) and SIRT3 were also analyzed. Compared to 
CSAA- fed WT mice, citrate synthase activity was slightly 
diminished at both 32 and 66 weeks of CDAA feeding. In 
addition, at 32 weeks, the CDAA diet resulted in signifi-
cantly decreased enzymatic activities of MRC complex I, II, 
II+III and IV in WT mice compared to CSAA- fed animals. 
Strikingly, RIP3- /- mice showed an overall protection against 
CDAA- induced impairment of MCR complex activity, no-
tably at 32 weeks. mRNA expression of PGC1α, NRF1 and 
TFAM was downregulated in CDAA- fed WT mice at both 
32 and 66 weeks, but significantly increased in RIP3- /- mice. 
Similarly, SOD1, SOD2 and SIRT3 mRNA levels were 
downregulated in CDAA- fed WT mice, while RIP3 depletion 
significantly abrogated this effect at 32 weeks. In conclusion, 
impaired MRC complex activity correlates with inflam-
mation, fibrosis and ROS overproduction in experimental 
NAFLD. RIP3 deficiency restores MRC complex activity, 
enhances mitochondrial biogenesis, increases ROS detoxifi-
cation capacity and, collectively, halts NAFLD progression.
Funding: FCT PTDC/BIM- MEC/0895/2014 and 
SAICTPAC/0019/2015grants; EU H2020Marie Sklodowska- 
Curie 722619 grant.
S1- O3 | Contributions of Glutaminolysis to 
CD8+ Metabolism in Rheumatoid Arthritis by 13C 
Isotopomer Analysis of Lactate
Francisco X. Carvalho1; Bárbara G. Carvalho1; Hanns-Martin 
Lorenz2; M.M. Souto-Carneiro2; Rui A. Carvalho1,2
1Department of Life Sciences, Faculty of Sciences and Technology, 
University of Coimbra, Coimbra, Portugal;  2Division of Rheumatology, 
Heidelberg University Hospital, Heidelberg, Germany
Background: In a basal quiescent state, naïve and memory 
CD8 + T cells rely on the breakdown of glucose and fatty 
acids through oxidative phosphorylation (OXPHOS). Upon 
stimulation, CD8 + T cells differentiate into short- term ef-
fector cells, where they increase enormously their metabolic 
requirements, met primarily by glucose consumption through 
aerobic glycolysis. To evaluate the perseverance of such pro-
file under low glucose, typical of the synovial membrane en-
vironment, CD8 + T were incubated in 3 distinct mediums 
with complementary ¹³C labeling profiles.
Material and methods: After density gradient isolation of 
peripheral blood mononuclear cells (PBMC), CD8 + T cells 
from Rheumatoid Arthritis (RA) patients and healthy do-
nors were purified by magnetic negative selection. To fol-
low CD8 + T cell metabolism, cells were cultured for 72 h 
using 3 RPMI mediums supplemented with 2 mM [1,6- ¹³C]
glucose; [U- ¹³C]glutamine and 2 mM [2- ¹³C]acetate; and 
2 mM [U- ¹³C]glucose, 2 mM [U- ¹³C]glutamine and 2 mM 
[2- ¹³C]acetate, respectively, in the absence (negative control) 
or presence of anti- human CD28 and plate- bound anti- human 
CD3 (positive control).
Results: Analysis of the ¹H NMR spectra of cell culture 
media allowed the quantification of lactate ¹³C isotopomers, 
providing glycolytic, Krebs and pyruvate cycling fluxes, and 
the monitoring of glutaminolysis. Upon CD8 + T cells stim-
ulation, a significant increase in [U- ¹³C]lactate production, 
more pronounced in RA, was observed.
Conclusions: CD8 + T cells from RA patients in a low glu-
cose environment still rely in a glycolytic metabolic profile, 
with high lactate production from glutamine.
Funding sources: Grant SO 1402/1- 1 (German Research 
Foundation) to RAC and MMSC.
[Correction added on 28 June 2019, after online publica-
tion: the title of the abstract S1-O3 has been changed to 
“Contributions of Glutaminolysis to CD8+ Metabolism 
in Rheumatoid Arthritis by 13C Isotopomer Analysis of 
Lactate” in the online version.]
S1- O4 | Cardiac mitochondrial function in the 
offspring of sedentary and exercised mothers with 
gestational diabetes
João D. Martins1,4; Susana P. Pereira1,2,4; Óscar M. Rodrigues3; 
Jorge Beleza2; Jelena Stevanovic2; David Rizo-Roca2; Estela 
Santos-Alves2; Pedro Coxito2; Manoel Ríos2; António J. Moreno3; 
José Magalhães2; António Ascensão2; Paulo J. Oliveira1
1CNC — Centre for Neuroscience and Cell Biology, UC- Biotech, 
University of Coimbra, Coimbra, Portugal;  2CIAFEL — Research Centre 
in Physical Activity, Health and Leisure, Faculty of Sport, University of 
Porto, Porto, Portugal;  3Department of Life Sciences, School of Sciences 
and Technology, University of Coimbra, Coimbra, Portugal;  4These 
authors contributed equally to the work
Background: Gestational diabetes mellitus (GDM) is a state 
of glucose intolerance and hyperglycemia with first onset 
during pregnancy. Prevalence of GDM has steadily increased 
and the offspring (F1) of GDM mothers are likely to develop 
metabolic disorders, such as obesity, type 2 diabetes and car-
diovascular diseases. Our objective is to test whether GDM 
mothers subjected to a protocol of physical exercise (E) breed 
F1 with a more robust mitochondrial function compared with 
F1 from sedentary mothers.
Methods: Female Sprague- Dawley rats were fed with control 
diet (C) or high- fat- high- sugar (HFHS) diet to induce GDM. 
Some GDM specimens were subjected to E during preg-
nancy. Body weight and blood glucose were used to assess 
GDM. The F1 cardiac mitochondria oxygen consumption 
and membrane potential were measured with a Clark- type 
and TPP + - electrode.
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Results: The diet- based protocol adequately mimics some 
GDM metabolic disturbances. In comparison to control ani-
mals, HFHS females exhibited alterations in body weight 
gain (~11% more) and glucose tolerance (~20% more) only 
when pregnant. HFHS mothers bred larger litters (~1.3- fold), 
with F1 showing an increased body weight at weaning (~22% 
more in HFHS, ~8% more in HFHS- E). No differences 
were observed in cardiac mitochondrial function between 
6- weeks- old F1 from C and HFHS. However, cardiac mito-
chondria from 6- weeks- old HFHS- E F1 showed increased 
oxygen consumption linked to ATP production, when com-
pared to sedentary groups. In F1 from sedentary HFHS moth-
ers, ADP- induced mitochondrial depolarization significantly 
increased with age (~44% increase from 6 to 16 weeks).
Conclusions: Understanding lifetime mitochondrial cardiac 
metabolism from GDM offspring is critical for appreciating 
the consequences of this condition. The E during pregnancy 
can modulate offspring mitochondrial cardiac function and 
counteract GDM effects.
Support: FEDER through COMPETE and FCT grants PTDC/
DTP- DES/1082/2014(POCI- 01- 0145- FEDER- 016657), 
PTDC/DTP- DES/7087/2014(POCI- 01- 0145- FEDER- 016690); 
SFRH/BPD/116061/2016; SFRH/BD/129645/2017; POCI- 01- 
0145- FEDER- 007440, and EU's Horizon 2020 Research and 
Innovation programme Marie Skłodowska- Curie (No. 722619, 
FOIE GRAS; No. 734719, mtFOIE GRAS).
S1- O5 | Mitochondrial dihydroorotate 
dehydrogenase plays an important role in tumor 
formation
Ana Coelho1; Jaromira Kovarova2; Martina Bajzikova2; Jakub 
Rohlena2; Paulo Oliveira1; Jiri Neuzil2
1CNC, Coimbra, Portugal;  2Institute of Biotechnology, Prague, Czech 
Republic
Mitochondria are vital organelles involved in mitochondrial 
respiration, which is essential for ATP production, metabo-
lite synthesis and regulation of the cellular redox state. In our 
previous work, we showed that mtDNA- devoid cancer cells 
(ρ0 cells) form tumors in mice only after they had acquired 
whole mitochondria from the host animal and restored respi-
ration. In the present work we therefore investigated, using 
time- resolved analysis, why the functional respiration is im-
portant. After grafting, ρ0 cells were recovered at individual 
time points and mtDNA as well as various mitochondrial and 
bioenergetic parameters were evaluated, using qPCR, west-
ern blotting, seahorse analysis and fluorescence microscopy. 
CRISPR/cas9 system was used to prepare ATP5B KO and 
DHODH KO cells, that completely lack mitochondrial ATP 
synthase and DHODH protein, respectively. While respira-
tion was recovered by mitochondrial transfer prior to tumor 
appearance, the ATP levels were stable during the whole- time 
course, indicating that the absence of mitochondrial ATP 
production may not be limiting for tumorigenesis. Albeit the 
delay, ATP synthase- deficient cells formed tumors, confirm-
ing that mitochondrial ATP generation is dispensable for 
tumorigenesis. In contrast, knocking out of dihydroorotate 
dehydrogenase (DHODH), a key respiration- linked enzyme 
of the de novo pyrimidine synthesis pathway, completely 
blocked tumor development. Indeed, DHODH was non- 
functional in ρ0 cells, and was reactivated by the recovery of 
complex III/complex IV respiration by mitochondrial trans-
fer before the ρ0- derived tumors started to appear. DHODH 
activity was suppressed in ρ0 cells due to the absence of oxi-
dized coenzyme Q (CoQ), the electron acceptor for DHODH, 
in respiration- deficient cells where CoQ recycling is stalled. 
In conclusion, DHODH- driven pyrimidine biosynthesis pre-
sents a crucial link between respiration and tumorigenesis.
Funding: FCT PhD- fellowship SFRH/BD/103399/2014 and 
Czech Science Agency.
S1- O6 | Amelioration of hepatic mitochondrial 
dysfunction after sleeve gastrectomy and Roux- en- Y 
gastric bypass in diet- induced obese rats
Silvia Ezquerro1,5; Leire Méndez-Giménez1,5; Sara Becerril1,5; 
Rafael Moncada2,5; Víctor Valentí2,5; Javier Álvarez-Cienfuegos3,5; 
Victoria Catalán1,5; Javier Gómez-Ambrosi1,5; Gema Frühbeck1,4,5; 
Amaia Rodriguez1,5
1Metabolic Research Laboratory, Clínica Universidad de Navarra, 
idiSNA, Pamplona, Spain;  2Department of Anesthesia, Clínica 
Universidad de Navarra, Pamplona, Spain;  3Department of Surgery, 
Clínica Universidad de Navarra, Pamplona, Spain;  4Department of 
Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, 
Spain;  5CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain
Background: Short- term lipid overload in hepatocytes stim-
ulates the mitochondrial activity in order to protect against 
lipotoxicity. However, long- term metabolic adaptations of 
hepatic mitochondria are lost in nonalcoholic fatty liver dis-
ease (NAFLD) and steatohepatitis (NASH) due to structural, 
molecular and functional alterations causing a mitochondrial 
dysfunction. We evaluated the impact of two bariatric sur-
gery procedures, namely sleeve gastrectomy and Roux- en- Y 
gastric bypass (RYGB) in the hepatic mitochondrial dysfunc-
tion of diet- induced obese (DIO) rats.
Material and methods: Four- week- old male Wistar rats 
(n = 129) were fed a normal diet (ND) or a high- fat diet (HFD) 
for 4 months. DIO rats were subjected to surgical [sham sur-
gery, sleeve gastrectomy and RYGB] or dietary interventions 
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[pair- fed to the amount of food eaten by sleeve gastrectomy or 
RYGB group]. OXPHOS protein complexes were determined 
by Western blot and the mtDNA content by real- time PCR in 
order to analyse the hepatic mitochondrial dysfunction.
Results: Obesity was associated with a decrease (P < 0.05) 
in the expression of mitochondrial OXPHOS protein com-
plexes I- V, while mtDNA copy number remained unchanged 
in liver samples of HFD- fed rats compared to animals fed 
a ND. Interestingly, sleeve gastrectomy enhanced the mi-
tochondrial copy number (P < 0.05), as well as the expres-
sion of the OXPHOS complexes I to V (P < 0.05). On the 
other hand, RYGB markedly increased the mtDNA content 
(P < 0.05) and upregulated the OXPHOS complexes I and II 
(P < 0.05) compared to sham- operated and pair- fed groups.
Conclusions: To sum up, our data provide evidence that both 
bariatric techniques ameliorated obesity- associated hepatic 
mitochondrial dysfunction by increasing mtDNA content as 
well as the expression of OXPHOS complexes.
Funding sources: Supported by Fondo de Investigación 
Sanitaria- FEDER (PI16/00221 and PI16/01217) from the 
Instituto de Salud Carlos III. CIBEROBN is an initiative of 
the Instituto de Salud Carlos III, Spain.
S1- O7 | Delving the Bone- buried Osteocytes 
lipid metabolism commitment in post- menopausal 
osteoporosis 
Ana M. P. Silva1,2,3; Romeu A. Videira4; Ana C. Moreira3,5,6; 
Paulo J. Oliveira1; Rui A. Carvalho2; Vilma A. Sardao1
1CNC - Center For Neuroscience And Cell Biology, Coimbra, Portugal;  
2Department of Life Sciences, University of Coimbra, Coimbra, Portugal; 
3Institute for Biomedical Sciences Abel Salazar, University of Porto, 
Porto, Portugal;  4REQUIMTE/LAQV, Laboratory of Pharmacognosy, 
School of Pharmacy, University of Porto, Porto, Portugal;  5i3S - Instituto 
de Investigação e Inovação em Saúde, University of Porto, Porto, 
Portugal;  6IBMC – Instituto de Biologia Molecular e Celular, University 
of Porto, Porto, Portugal
Background: Upon estradiol (E2) withdrawal in the post- 
menopausal period, bone change its efficient capacity for 
self- renewal. Osteocytes (Ocys), a bone remodeling unit cell, 
controls bone microstructure. Thus, changes in metabolic/lipid 
profile in those cells after menopause may play a role during 
osteoporosis development. Our aim was to analyze in vivo the 
metabolic/lipid profile of osteocytes in the absence of estro-
gens and identify the effects on that profile of an intervention 
with estradiol or with the phytoestrogen coumestrol (Coum).
Methods: Sham and ovariectomized (OVX) female rats were 
treated with E2 or Coum (24 h, single injection 30microg/
Kg; or 21 days, implantation of 0.5 mg slow- release pellets) 
to compare bone metabolic/lipid profiles. Femur/tibia were 
used to perform DXA/μCT analysis and extract metabolites/
lipids of Ocys- enriched fraction to perform deuterium- NMR 
spectroscopy and proton- NMR for de novo synthesis anal-
yses. Total lipids were analyzed by LC- MS/MS. ALP and 
TGs/HDL/LDL were evaluated in serum. Statistical com-
parisons were performed by one- way ANOVA, followed by 
Bonferroni post- test test.
Results: Changes in bone cells lipid profile were observed 
in OVX animals, when compared with sham. OVX PE+PC 
content vs total lipids increased 8%, and treatment with E2 
for 24 h reverted that alteration before changes in serum turn-
over markers and bone structure were observed. Coum did 
not reach the same therapeutic performance as E2.
Conclusions: Our results suggest that metabolic alterations 
occur in osteocytes after ovariectomy. Thus, controlling the 
metabolic activity of osteocytes after E2 withdrawal in post 
menopausal women may be a potential therapeutic approach 
to counteract osteoporosis.
Funding sources: Supported by FEDER funds through the 
Operational Programme Competitiveness Factors- COMPETE 
and national funds by FCT under research grant PTDC/
AGR- ALI/108326/2008, PEst- C/SAU/LA0001/2013- 2014, 
IF/01182/2015, POCI- 01- 0145- FEDER- 007440. FCT PhD 
and Post- doc fellowships (SFRH/BD/33892/2009, SFRH/
BD/76086/2011 and SFRH/BPD/31549/2006).
S1- O8 | Altered oligomerization of 
mitochondrial ATP synthase due to glycative 
damage increases the vulnerability of aged 
cardiomyocytes to mitochondrial permeabilization
Diana Bou-Teen1; Marisol Ruiz-Meana1,2; Elisabet Miro-Casas1,2; 
Celia Castans3; Elena Bonzon-Kulichenko3; Ricardo Moure1,2; 
Jesus Vazquez2,3; David García-Dorado1,2
1Vall d´Hebron Institut de Recerca VHIR, Barcelona, Spain;  2Centro 
de Investigación Biomédica en Red Enfermedades Cardiovasculares 
CIBERCV, Madrid, Spain;  3Centro Nacional de Investigaciones 
Cardiovasculares CNIC, Madrid, Spain
Background: During aging, cardiomyocytes become more 
vulnerable to develop mitochondrial permeabilization 
(mPTP), energy exhaustion and death when they are chal-
lenged (i.e. ischemia- reperfusion). Adequate oligomeriza-
tion of mito- ATP synthase determines respiratory efficiency 
through preservation of mitochondrial cristae morphology 
and membrane integrity.
Objectives: To investigate whether aging impairs mito- ATP 
synthase oligomerization and the consequences it may have 
on enzyme activity, mitochondrial respiration and suscepti-
bility to experience mPTP.
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Methods- Results: Blue native- PAGE electrophoresis dis-
closed a significant reduction in the proportion of mito- 
ATP synthase oligomers in IF mitochondria from aged 
mice (>20 months) respect to young ones (4- 6 months), 
without age- associated changes in SS mitochondria. The 
ATPase activity of mito- ATP synthase in the oligom-
ers, as measured by in- gel activity, was decreased in IF 
mitochondria from aged mice. Also, ADP- stimulated O2 
consumption was specifically reduced in IF mitochondrial 
from aged mice, respect to young ones. Cardiomyocytes 
from aged mice exposed to ROS stress (intermittent laser 
irradiation after TMRE- loading) were more susceptible to 
undergo mPTP and energy depletion (rigor shortening). 
Proteomic analysis and proximity ligation assay identified 
increased glycative damage in mito- ATP synthase during 
aging. Pharmacologic induction of mito- ATP synthase gly-
cation in HL- 1 cardiomyocytes recapitulated the increased 
susceptibility of aged cells to undergo mPTP upon ROS 
exposure.
Conclusion: Aging induces mitochondrial ATP synthase 
glycation which might impair the adequate molecule oli-
gomerization. Altered formation of mito- ATP synthase oli-
gomers results in reduced enzymatic activity and increased 
vulnerability of senescent cardiomyocytes to undergo mPTP 
opening and energy exhaustion.
S1- O9 | Targeting mitochondrial dysfunction in 
Parkinson's disease
Ria De Haas1; Lisa Heltzel1; Julien Beyrath2; Jan Smeitink1,2
1Department of Pediatrics, Radboud Center For Mitochondrial Medicine, 
Nijmegen, The Netherlands;  2Khondrion BV, Nijmegen, The Netherlands
Background: Mutations in several genes (e.g. ATP13A2, 
DJ- 1, LRRK2, Parkin, PINK1, SNCA, VSP35) encoding 
proteins that impact mitochondrial function and clearance, 
cellular oxidative stress and redox balance are known to 
underlie monogenic Parkinson's Disease (PD) with unmet 
medical need for treatment development. We evaluated ther-
apeutic potential of KH176, a new molecule currently under 
clinical development for the treatment of mitochondrial dis-
ease, in the PINK1 knockout rat model. These animals pre-
sent marked behavioral motor dysfunction and significant 
loss of dopaminergic neurons in the substantia nigra, both 
major characteristics of PD.
Material and methods: Therapeutic effects of long- term 
KH176 treatment were evaluated by behavioral readouts 
(gait analysis, open field and balance beam) and extracel-
lular striatal dopamine levels were measured by in vivo 
microdialysis. Tyrosine hydroxylase immunohistochemis-
try was performed on brain slides to quantify the number 
of dopamine neurons in the substantia nigra. Furthermore, 
complex activity and ATP production were measured in 
muscle tissue.
Results: Strikingly, no reduction of dopamine neurons was 
detected in the substantia nigra and no differences in extra-
cellular striatal dopamine levels were noted. PINK1 knock-
out male rats though showed impaired performance on the 
balance beam, reduced activity in the open field and abnor-
mal gait. Significant beneficial effects of KH176 treatment 
were noted on different behavioral parameters. Preliminary 
results showed a significant reduction in ATP production and 
mitochondrial content in muscle from PINK1 knockout rats 
compared to wild type, the latter was normalized by KH176 
treatment.
Conclusions: No loss of dopamine neurons was detected, 
however PINK1 knockout male rats did show a behavioral 
disease phenotype and a significant reduction in mitochon-
drial content in muscle which could be normalized by KH176 
treatment. Further investigation is needed to determine the 
validity and robustness of this PD model.
Funding sources: This project was funded by the Michael J. 
Fox Foundation (grant ID 11702).
S1- O10 | Reversal of mitochondrial 
abnormalities by CRISPR/Cas9 editing of the 
mutant HTT allele in vitro in Huntington s´ Disease 
patient- derived pluripotent and neural stem cells 
Carla Lopes1,2; Thorsten Schlaeger2,4; Luis Pereira de Almeida1,5; 
George Daley3,4,6; Cristina Rego1,7
1Center for Neuroscience and Cell Biology, University of Coimbra, 
Coimbra, Portugal;  2Institute for Interdisciplinary Research of the 
University of Coimbra , Coimbra, Portugal;  3Division of Hematology/
Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, 
Boston, Boston, USA;  4Stem Cell Program, Boston Children's Hospital, 
Boston, USA;  5Faculty of Pharmacy, University of Coimbra, Coimbra, 
Portugal;  6Harvard Medical School; Harvard Stem Cell Institute, 
Boston, USA;  7Faculty of Medicine, University of Coimbra, Coimbra, 
Portugal
Huntington's disease (HD) is one of the most common 
inherited neurodegenerative disorders, caused by CAG 
repeat expansion in the HTT gene, coding for hunting-
tin. Selective loss of striatal medium spiny neurons is a 
major hallmark, with symptoms ranging from psychiat-
ric disturbances, involuntary movements and cognitive 
deficits leading to dementia. Multiple mechanisms have 
been implied in HD pathogenesis including mitochondrial 
and energy metabolism defects associated with increased 
oxidative stress. Here we report that the correction of 
HD human induced- Pluripotent Stem Cells (iPSC) using 
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a CRISPR- Cas9 system resulted in a rescue of the mi-
tochondrial and metabolic abnormalities. Heterozygous 
human iPSC (HD- iPSC; 72/18 CAGs), control AMS4- 
iPSC and corrected HD- iPSC were used. Mitochondria 
dynamics, metabolism and function were analyzed. HD- 
iPSC and NSC exhibited lower basal respiration, de-
creased ATP levels and were shown to mainly depend 
on glycolysis. HD- iPSC also presented decreased mRNA 
levels of nuclear- and mitochondrial- encoded complex III 
(CxIII) subunits and activity, as well as impaired mRNA 
levels of PGC- 1alpha and TFAM. An analogous dysfunc-
tion was found in HD- NSC, but the mRNA levels of CxIII 
subunits were similar to AMS4- NSC. Moreover, we found 
increased levels of mitochondrial reactive oxygen species 
(ROS). HD- iPSC and HD- NSC also displayed increased 
phosphorylation of pyruvate dehydrogenase (PDH), re-
flecting reduced enzyme activity. Increased mRNA lev-
els of PDH kinase 1 and reduced mRNA levels of PDP1 
(PDH phosphatase) were observed in HD- iPSC. Using a 
CRISPR/Cas9 based approach, we demonstrated that cor-
recting the HD mutation in the iPSC line resulted in im-
proved basal respiration and spare respiratory capacity. 
In accordance, we found that the mRNA levels of CxIII 
subunits increased significantly and mitochondrial ROS 
levels were largely mitigated. In conclusion, this study 
evidences that the expanded trinucleotide repeat in HTT 
can be efficiently corrected, reducing the mitochondrial 
dysfunction described as an early event in HD pathogenic 
cascade.
S1- O11 | Mitochondrial whole genome 
sequencing of single cholinergic neurons located 
in the pedunculopontine nucleus of Parkinson's 
disease post- mortem brains to characterize the 
spectrum of mitochondrial DNA deletions
Alex Mcloughlin1; Angela Pyle2; Amy Reeve2; Gavin Hudson2; 
Christopher Morris2; Joanna Elson2; Ilse Pienaar2
1University Of Sussex, Brighton, UK;  2Newcastle University, Newcastle, 
UK
Background: Mitochondrial dysfunction associates with 
neuropathogenesis underlying progressive Parkinson's 
Disease (PD). In PD, vulnerable cholinergic neurons in 
the pedunculopontine nucleus (PPN) show evidence of 
increased mitochondrial DNA (mtDNA) copy number 
and mtDNA deletions, resulting in impaired oxidative 
phosphorylation (OXPHOS) (Pienaar et al., 2013, Am 
J Pathol; Bury et al., 2017, Ann. Neurol.). As choliner-
gic neurons are high- energy demanding cells, reduced 
OXPHOS and increased reactive oxygen species deriving 
from dysfunctional mitochondria leave these neurons vul-
nerable to damage and cell death. mtDNA deletions arise 
somatically in post- mitotic neurons and are unique to indi-
vidual cells. This requires sequencing of the mitochondrial 
genome at a single cell level to identify mtDNA deletions. 
In this study we aimed to sequence the mitochondrial ge-
nome in PPN cholinergic neurons from post- mortem PD 
compared to neurological control cases.
Methods and materials: Sections from human post- 
mortem brain tissue (7 PD vs. 6 control cases) were 
serially- cut and PPN cholinergic neurons confirmed im-
munohistochemically. Individual PPN cholinergic neurons 
were isolated by laser- capture microdissection, lysed and 
the mitochondrial genome amplified by PCR prior to Next 
Generation Sequencing.
Results and Conclusions: Low starting concentrations of 
mtDNA in single neurons make PCR amplification of mtDNA 
challenging. In order to amplify and sequence the entire mi-
tochondrial genome we have optimised PCR for covering the 
entire mitochondrial genome and amplifying sufficient levels 
of mtDNA for sequencing and bioinformatic analyses.
Findings: By characterizing the spectrum of mtDNA de-
letions within individual PPN cholinergic neurons of PD 
patients compared to aged- controls, we expect to make infer-
ences regarding mechanisms that generate mtDNA deletions 
in such disease- affected neurons, to thereby consider novel 
therapeutic angles for treating PD patients.
Funding Sources: This study was funded by a PhD student-
ship funded by the University of Sussex, awarded to ISP 
and AM, alongside a project grant awarded to ISP by the 
Rosetrees Trust.
S1- O12 | Measuring mitochondrial DNA content 
in human blood: Observations from studies of two 
diabetic nephropathy cohorts from the UK and 
USA
Hannah Rosa1; Luigi Gnudi2; Saima Ajaz1; Helen Looker3; Robert 
Nelson2; Afshan Malik1
1Diabetes Research Group, School of Life Course Sciences, King's 
College London, London, UK;  2Cardiovascular Division, King's College 
London, London, UK;  3Phoenix Epidemiology and Clinical Research 
Branch, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health, Phoenix, USA
Background: Despite emerging evidence of mitochondrial 
dysfunction in diabetic nephropathy (DN), the mechanis-
tic cause/effect relationships are, as yet, poorly understood. 
We previously showed that circulating mitochondrial DNA 
(mtDNA) levels were increased in diabetes but decreased in 
DN patients from the KingsDiab cohort, and these changes 
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correlated with altered mitochondrial function. However, cir-
culating cell- free (cf) mtDNA, which is increasingly reported 
for its prognostic value in several diseases, has not been sys-
tematically evaluated in this cohort. Therefore, this study 
aimed to establish the proportion of cellular and cf mtDNA 
in human blood, and to evaluate the impact of diabetes and 
DN on these proportions.
Materials and methods: Participants enrolled to the 
KingsDiab cohort were grouped as healthy controls (no 
history of diabetes, n = 23), DC (>10 years diabetes, no 
nephropathy, n = 43) and DN (diabetes with clinically con-
firmed nephropathy, n = 85). Whole blood samples were 
collected and processed to isolate cellular (PBMC) and cf 
(plasma, serum) fractions. Longitudinal serum samples were 
available from diabetes patients of the Pima Indian cohort 
(n = 50). mtDNA content was determined using quantitative 
PCR and analysed as mtDNA copies per nuclear genome 
(Mt/N) for cellular, and mtDNA copy number per µl for cf 
fractions.
Results: Cellular mtDNA content of HC whole blood and 
PBMCs was 84 ± 29 and 312 ± 138, respectively, and did 
not show any disease- associated changes. HC cf mtDNA 
content was 695 ± 1595 copies/μl plasma and 914 ± 680 
copies/μl serum and was significantly increased in DC 
versus HC (P = 0.0423/plasma; P = 0.0144/serum) and 
DN (P = 0.006/serum). Although serum mtDNA con-
tent was significantly higher in the Pima Indian cohort 
(P < 0.0001), we saw no correlation with DN progression 
in these patients.
Conclusions: mtDNA content can be measured in cel-
lular and cf fractions of human blood using our assay. 
Furthermore, levels of cf mtDNA are altered in diabetes 
and DN, supporting the hypothesis that mitochondrial dys-
function is present.
Funding sources: EFSD.
S1- O13 | The insecticide diazinon induces 
mitochondrial permeability transition in rat liver 
mitochondria
Fábio Erminio Mingatto; Camila Araújo Miranda; Anilda Rufino 
de Jesus Santos Guimarães
Unesp - Fcat, Dracena, Brazil
Diazinon (DZN) is an organophosphate insecticide widely used 
in agriculture, in veterinary medicine as antiparasitic, mainly in 
farm animals, and in the control of domestic pests. There are sev-
eral reports in the literature about poisoning caused by the sub-
stance and the liver is one of the affected organs. Mitochondria 
provide most of the ATP required to drive all of the mechanical, 
transport, and biosynthetic work done by the cell. They are also 
the main intracellular sources and important targets of reactive 
oxygen species, which, in association with calcium, can induce 
the mitochondrial membrane permeability transition (MPT), 
which can lead to cell death. Therefore, xenobiotics that interfere 
with the mitochondrial functions can be acutely or chronically 
toxic. In a previous study, we demonstrated DZN's inhibition 
of mitochondrial oxygen consumption and membrane poten-
tial, which were associated with a significant reduction in ATP 
synthesis. In the present study, we have evaluated the ability of 
DZN to induce MPT and its associated processes in isolated rat 
liver mitochondria. Mitochondrial swelling, hydrogen peroxide 
production, Ca2 + efflux, cytochrome c release and the oxida-
tive status of glutathione, NAD(P)H and protein thiol groups 
were evaluated in the presence of different concentrations of 
DZ (50 to 150 μM). Statistical significance was determined by 
analysis of variance, followed by Dunnett's multiple compari-
son test. In the presence of 10 μM Ca2 + , DZN (50 to 150 μM) 
elicited MPT in a concentration- dependent manner as assessed 
by mitochondrial swelling, which was associated with mito-
chondrial Ca2 + efflux and cytochrome c release. Swelling 
was prevented by N- ethylmaleimide and cyclosporin A. DZN 
did not cause hydrogen peroxide accumulation or glutathione 
oxidation but did deplete endogenous NAD(P)H and oxidized 
protein thiol groups. These results potentially indicate the in-
volvement of mitochondria, probably via apoptosis, in the well- 
documented cytotoxicity of the insecticide diazinon to the liver.
S1- O14 | Effects of H2S synthesis modulators at 
I/R induced MPTP opening in rat heart
Raisa Fedichkina; Yulia Goshovska; Vadim Sagach
Bogomoletz Institute of Physiology NASU, Kyiv, Ukraine
Effects of hydrogen sulfide are intensively studied under 
ischemia- reperfusion (IR). Renewal of blood flow in the is-
chemic area of the myocardium is accompanied by a reperfu-
sion syndrome - tissue damage and deterioration of the heart 
function. The mechanism of damage is that oxygenated blood 
induces oxidative stress and the formation of reactive oxy-
gen species (ROS) by the respiratory chain of mitochondria. 
ROS increasing can promote opening of mitochondrial per-
meability transition pores (MPTP) - the non- selective mega 
channels that allow the mixture of substances release out of 
mitochondria including cytochrome c, ATP etc. This release 
might be detected in situ as increased UV- optical density 
(OD) of outflow solutions from the isolated heart. Previously, 
we showed that inhibition of MPTP with cyclosporine A or 
ischemic preconditioning greatly reduced reperfusion distur-
bances of heart function and prevented the increase of OD 
of effluents. Based on this knowledge, we studied the effect 
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of modulation of H2S synthesis at IR induced MPTP open-
ing. The solutions outflowing from the Langendorff- isolated 
rat heart were collected before and after ischemia, and tested 
in UV. IR caused a significant increase in OD of solutions 
collected at the 1st minute of reperfusion. Pretreatment with 
L- cysteine (121mg/kg), precursor of H2S synthesis, had no 
significant effect on heart function and OD. Propargyl gly-
cine (PAG, 11.3mg/kg), inhibitor of H2S synthesis, improved 
myocardium relaxation at reperfusion and decreased OD of 
effluents (0.408±0.059rel.un. vs 0.578±0.089 in I/R group, 
p<0.05). Combination of PAG and L- cysteine impoved re-
covery of heart function up to 90% after reperfusion and 
decreased OD of coronary solutes (0.382±0.024 rel.un., 
p<0.01). Both cardioprotective and MPTP inhibitory effect 
of PAG+L- cysteine were abolished by glutathione depletor 
butionine- SL- sulfoximine (0.528±0.026 rel.un. vs control, 
p<0.01). Thus, PAG+L- cysteine exert cardioprotective ef-
fect via glutatione induction and inhibiting MPTP opening.
S1- O15 | Mitochondrial function and hunting-
tin proteostasis predict striatal vulnerability in 
Huntington's Disease
Tânia R. Soares1,2; Brígida R. Pinho1; Michael R. Duchen2,3; Jorge 
M. A. Oliveira1,3
1REQUIMTE/LAQV, Faculty of Pharmacy, University of Porto, Porto, 
Portugal;  2Department of Cell and Developmental Biology, University 
College London, London, UK;  3Consortium for Mitochondrial Research, 
University College London, London, UK
Background: Striatal medium spiny neurons are highly 
vulnerable to Huntington's Disease. Differences in mutant 
huntingtin (mHtt) proteostasis and mitochondrial function 
between striatal neurons and other less vulnerable neurons, 
such as cortical neurons, have been pinpointed as underlying 
causes for striatal vulnerability. However, it remains unclear 
whether and how these differences interact to condition neu-
ronal survival.
Methods: The risk of death, mitochondrial membrane po-
tential (MMP) loss, IB formation and mHtt diffuse levels 
were longitudinally assessed in rat striatal (STR) and cortical 
(CTX) neurons expressing mHtt. MHtt mobility and NAD(P)
H levels were estimated using fluorescence lifetime micros-
copy (FLIM), neuronal mitochondrial respiration was meas-
ured with a Seahorse respirometer.
Results: In the absence of mHtt expression, CTX and STR 
neurons presented no differences in oxygen consumption or 
in NAD(P)H levels. However, when expressing mHtt, STR 
neurons presented lower NAD(P)H levels in comparison to 
their cortical counterparts. Striatal and cortical neurons ex-
pressing mHtt also presented differences in the risks of death 
and MMP loss, which were higher in STR vs CTX, and in 
the risk of IB formation, which was lower in STR vs. CTX 
neurons. The lower risk of IB formation in STR neurons cor-
related with their lower levels of diffuse mHtt. Differential 
vulnerability may stem from differences in IB formation, 
since neurons with IBs survived longer than those only with 
diffuse mHtt. Independently of brain region, mHtt in IBs pre-
sented lower mobility than diffuse mHtt, suggesting that the 
IBs formed are more compact structures than diffuse forms.
Conclusion: Striatal neurons are less able to cope with mHtt, 
possibly due to their lower ability to form compact structures 
that sequester mHtt (IBs) and their lower redox capacity, 
potentiating an earlier collapse of MPP and an accelerated 
death.
Funding: Fundação para a Ciência e a Tecnologia 
P2020- PTDC/NEU- NMC/0412/2014, POCI- 01- 0145- 
FEDER- 016577, 3599- PPCDT; SFRH/BD/108733/2015; 
SFRH/BPD/102259/2014, UID/QUI/50006/2013.
S1- O16 | Novel avenues of ischemia/reperfusion 
injury prevention: Lessons from a soluble adenylyl 
cyclase inhibitor and a SirT3 activator
João Teodoro1,2; Anabela Rolo1,2; Rui Silva1,2,4; Ivo Machado1,2; 
Joan Rosello-Catafau4; Clemens Steegborn3; Carlos Palmeira1,2
1Department of Life Sciences of the University of Coimbra, Coimbra, 
Portugal;  2Center for Neurosciences and Cell Biology of the University 
of Coimbra, Coimbra, Portugal;  3Department of Biochemistry, 
University of Bayreuth, Bayreuth, Germany;  4Ischemia- Reperfusion 
Unit, Experimental Pathology Department, Institut d'Insvestigacions 
Biomèdiques de Barcelona , Barcelona, Spain
Background: Ischemia/reperfusion injury (IR) is a common 
deleterious process that occurs after an ablation and resto-
ration of circulation to an organ, and typically hinges on a 
surge of reactive oxygen species (ROS) generation, leading 
to cellular injury and tissue failure. Given the ubiquitous 
role of mitochondria as a key organelle to the survival to IR, 
strategies that directly target mitochondria and prime them 
towards stress handling might prove clinically invaluable. In 
fact, mitochondrial pre- conditioning has shown promising 
results, only marred by the need of surgical intervention. As 
such, a pharmacological intervention that could mimic surgi-
cal mitochondria precondition could improve mitochondrial 
function in a setting of rodent model of hepatic IR. Therefore, 
to this aim, we tested if two compounds, LRE1 (a sAC inhibi-
tor) and S1 (a novel SirT3 activator) could achieve similar 
results.
Materials and methods: Male Wistar rats were subjected 
to a portal vein injection with either LRE1 or S1 previous 
to surgical IR. After 24 h, liver mitochondria were isolated 
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and several metabolic parameter assessment tests were 
conducted.
Results: Both LRE1 and S1 were able to revert several evalu-
ated parameters, including calcium tolerance, ROS genera-
tion and OXPHOS activity. It is clear that, by acting through 
different mechanisms, both compounds were able to acclima-
tize mitochondria to the insult.
Conclusions: It is apparent from our data that, by ma-
nipulating either the generation of cAMP or by elevating 
mitochondrial deacetylation, we could prime mitochon-
dria for IR injury, leading to prospective clinical inves-
tigation of the feasibility of these compounds for human 
utilization.
Funding sources: This work was financed by the 
European Regional Development Fund (ERDF), through 
the Centro 2020 Regional Operational Programme project 
CENTRO- 01- 0145- FEDER- 000012- HealthyAging2020, 
the Portugal 2020; POCI- 01- 0145- FEDER- 016770; UID/
NEU/04539/2013. JST is a recipient of a FCT grant (SFRH/
BPD/94036/2013).
S1- O17 | A mathematical model of expansion of 
disadvantaged but altruistic mitochondrial mutants 
in skeletal muscle fibres
Ferdinando Insalata; Hanne Hoitzing; Nick Jones
Imperial College London, London, UK
Mitochondria are cytoplasmic organelles present in most 
of eukaryotic cells. Their main – but not sole – function is 
to supply the cells with energy. Mitochondria are unique in 
that they have their own mitochondrial DNA. This can ac-
quire mutations, that can lead to mitochondrial dysfunctions. 
Mitochondria are also involved in aging. For instance, mus-
cle fibre damage occurring with age has been connected to 
the expansion of mitochondrial mutants. A satisfactory ac-
count of this phenomenon has defied scientists for decades. 
The main challenge is that these dysfunctional mitochondrial 
mutants are actively eliminated, but nonetheless invade the 
muscle fibres. 
We have devised and tested a stochastic population dynamics 
model which can reconcile this apparent contradiction. Our 
model is, in essence, a stochastic reaction- diffusion system, 
in which the reaction term stems from demographic noise and 
produces a wave- like expansion of the disadvantaged species. 
My work is also linked to the evolution of altruism and, in 
fact, offers an alternative to conventional natural selection.
S1- O18 | Anti- tumor activity of 
triphenylphosphonium conjugates of betulinic acid 
and their effect on ROS level in mitochondria
Igor Antipin1,2; Denis Ponomaryov1; Leisan Grigor'eva1; Taliya 
Salikhova1; Ruba Ali1; Thin Dang1; Olga Tsepaeva2; Andrey 
Nemtarev1,2; Timur Abdullin1; Vladimir Mironov1,2
1Kazan Federal University, Kazan, Russia;  2Arbuzov Institute of Organic 
& Physical Chemistry, Kazan, Russia
Background: Betulinic acid is pentacyclic triterpenoids ex-
tracted from different plant sources. This acid induce cancer 
cell apoptosis by intrinsic mitochondrial pathway accompa-
nied by an increase in mitochondrial membrane permeability, 
swelling and release of pro- apoptotic molecules from the in-
termembrane space of mitochondria into the cytoplasm.
Material and Methods: New triphenylphospho-
nium (TPP) derivatives of the betulinic acid (C- 28- 
triphenylphosphonioalkyl(C5,C6)- (compounds 1a,b); C- 28 
- tri(3,4- dimethoxyphenyl)phosphonioalkyl(C5,C6)- 
(compounds 2a,b); C- 28- tri(4- methylphenyl)phosphonioalkyl 
(C5,C6)- (compounds 3a,b); C- 28- tri(3- methylphenyl)
phosphonioalkyl(C5,C6)- (compounds 4a,b)) have been eval-
uated for their cytotoxic effect against human breast cancer 
(MCF- 7), prostate adenocarcinoma (PC- 3) and human skin 
fibroblast (HSF) cells. Cytotoxicity of tested compounds was 
evaluated using MTT assay. Changes in transmembrane po-
tential of mitochondria and ROS level were assessed by flow 
cytometry technique using TMRE and MitoSOX fluorescent 
probes, respectively.
Results: Betulinic acid inhibited growth of MCF- 7 and PC- 3 
cells (IC50 3.32- 4.94 µM), while it does not alter HSF viabil-
ity (IC50 > 12.5 µM). The TPP conjugates (1- 4) exhibited 
increased antiproliferative effect against MCF- 7 and PC- 3 
cells with IC50 values from 0.12 to 0.36 µM. In comparison 
with (1a,b), the conjugates (2- 5), containing modified aryl 
moiety, showed less difference in IC50 values between can-
cer cells and HSF. Betulinic acid not considerably lowered 
the TMRE signal. The compounds (1- 5) had depolarizing ef-
fect on mitochondria (MFI values were 1.5 times lower than 
those for the untreated cells) and effectively increase the pro-
duction of O2∙- in mitochondria.
Conclusion: The conjugation of betulinic acid with the TPP 
group at C- 28 position provides compounds with enhanced 
anticancer effect in vitro which retained selectivity towards 
cancer cells vs. normal cells. The triterpenoid derivatives 
at micromolar concentrations induce both considerable de-
crease in transmembrane potential and increase in superoxide 
radical level in mitochondria of viable cells.
Funding Sources: This work was funded by subsidy al-
located to KFU (4.1493.2017/4.6 and 4.5151.2017/6.7). 
Authors are grateful to CSF- SAC FRC KSC RAS for techni-
cal assistance in research.
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S2- O1 | Layers of NETs inside Neutrophil 
Swarms Contain Candida albicans 
Daniel Irimia; Alex Hopke
Massachusetts General Hospital, Harvard Medical School, Boston, USA
Background: Classical phagocytosis mechanisms do not ad-
equately explain how neutrophils contain microbes that are 
larger than the neutrophils.
Materials and methods: We designed and employed mi-
crofabricated ‘swarming arrays’ to study the interactions be-
tween human neutrophils and clusters of Candida albicans in 
thousands of repeats and in precisely controlled conditions.
Results: We determined that within 4 hours after the start 
of the interaction, healthy human neutrophils stop Candida 
growth. First, neutrophils coordinate their activity and swarm 
against the microbial target. Then, 100% of the swarms re-
lease NETs at their core. This core is separated from the sur-
roundings by layers of intact, motile neutrophils. Interfering 
with the ability of neutrophils to communicate during swarm-
ing reduces their ability to contain Candida. Moreover, the 
addition of DNase degrades the NETs and resumes Candida 
growth, the formation of hyphae, and the escape of Candida 
from the neutrophil swarm.
Conclusion: Neutrophils swarming and the release of NETs 
are highly choreographed processes that are key to the natural 
protection against Candida.
Funding sources: National Institutes of Health GM092804.
S2- O2 | Externalized histone H4 orchestrates 
chronic inflammation by inducing lytic cell death
Quinte Braster1,2,3; Carlos Silvestre-Roig1,2,3; Kanin Wichapong4; 
Ernest Y. Lee5; Jean M. Teulon6; José M. Adrover7; Julia 
von Blume8; Viacheslav O. Nikolaev9,10; Jean-Luc Pellequer 
Pellequer6; Andrés Hidalgo1,7; Gerry A. F. Nicolaes4; Gerard C. L. 
Wong5; Oliver Soehnlein1,2,3,10
1Institute for Cardiovascular Prevention IPEK, Munich, Germany;  
2Department of Pathology, AMC, Amsterdam, the Netherlands;  3German 
Center for Cardiovascular Research DZHK, Munich, Germany;  
4Department of Biochemistry, CARIM, Maastricht, the Netherlands;  
5Department of Bioengineering, University of California, Los Angeles, 
USA;  6University of Grenoble Alpes, Grenoble, France;  7Area of 
Developmental and Cell Biology, Fundación Centro Nacional de 
Investigaciones Cardiovasculares Carlos III CNIC, Madrid, Spain;  8Max 
Planck Institute of Biochemistry, Martinsried, Germany;  9Institute of 
Experimental Cardiovascular Research, University Medical Center 
Hamburg- Eppendorf, Hamburg, Germany;  10Department of Physiology 
and Pharmacology  (FyFa), Karolinska Institutet, Stockholm, Sweden
Background: Impaired smooth muscle cell (SMC) integrity 
is a hallmark of atherosclerotic plaque destabilization that 
precedes rupture- associated thrombotic events and subse-
quent acute coronary syndrome. Neutrophils and neutrophil- 
derived extracellular traps (NETs) foster inflammation and 
promote initiation of atherosclerosis, however their role in 
promoting plaque destabilization prior to rupture remains to 
be defined.
Material and methods: Here we studied the role of neu-
trophils in a mouse model of atherosclerotic plaque desta-
bilization. Using several mouse lines and applying different 
antibody- and peptide- treatments we changed neutrophil 
numbers and functions. Furthermore, by using imaging and 
biophysical techniques like live cell imaging, high resolution 
confocal microscopy, atomic force microscopy, live scan-
ning ion conductance microscopy, and small angle X- ray 
scattering (SAXS) we identified an underlying mechanism.
Results: Increasing or decreasing neutrophil numbers re-
spectively destabilized or stabilized atherosclerotic plaques. 
Mechanistically, NET derived histone- H4 showed cytotoxic 
effects on SMCs, reducing membrane integrity, and enhanc-
ing SMC cell death, consequently favoring plaque instability. 
This loss of membrane integrity was not only observed in 
advanced atherosclerotic plaques but also in cell culture set-
tings with SMCs and reconstituted membrane lipid bilayers 
treated with recombinant histone- H4 or N- terminal histone-
 H4 peptides.
Conclusions: Neutrophils orchestrate smooth muscle cell 
death in advanced atherosclerotic plaques. They exert direct 
cytotoxic effects by presenting nuclear histone H4 within ex-
tracellular DNA traps to target cells and thereby permeabiliz-
ing plasma membranes and mediating cell death. Therapeutic 
neutralization of histone H4 rescues smooth muscle cells 
and stabilizes atherosclerotic lesions. Our data, introduces 
a novel form of cell death which might be applicable in a 
broader context than atherosclerosis.
Funding sources: The study was supported by the DFG, the 
NWO, and the EKFS.
S2- O3 | Gasdermin D is a key executioner in the 
formation of neutrophil extracellular traps
Gabriel Sollberger1; Axel Choidas2; Garth Burn1; Peter 
Habenberger2; Raffaella Di Lucrezia2; Susanne Kordes2; Sascha 
Menninger2; Jan Eickhoff2; Peter Nussbaumer2; Bert Klebl2; 
Renate Krüger3; Alf Herzig1; Arturo Zychlinsky1
1Max Planck Institute For Infection Biology, Berlin, Germany;  
2Lead Discovery Center GmbH, Dortmund, Germany;  3Charité- 
Universitätsmedizin Berlin, Department of Pediatric Pneumonology, 
Immunology and Intensive Care, Berlin, Germany
Background: Activation of innate immune cells often 
induces lytic forms of cell death. One such form, the 
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formation of neutrophil extracellular traps (NETs), results 
from activation of neutrophils by various sterile or micro-
bial insults. NETs are chromatin structures decorated with 
antimicrobial proteins that are able to capture extracellular 
pathogens. Despite the importance of NETs in various pa-
thologies, it is still unclear, which molecular pathways lead 
to their release.
Materials and methods: We used human primary neutro-
phils and screened a library consisting of 182´710 small mol-
ecules to identify inhibitors of NET formation.
Results: We determined the pore- forming protein gasdermin 
D (GSDMD) as the target of one of the NET formation inhib-
itors identified in our screen. GSDMD is a key executioner of 
pyroptosis, a pro- inflammatory cell death that occurs in mac-
rophages upon inflammasome activation. During pyroptosis, 
caspases proteolytically activate GSDMD in order to allow 
it to execute its pore- forming activity. We show that during 
NET formation, however, GSDMD is activated by neutrophil 
proteases. GSDMD plays a dual role during NET formation; 
it acts in a feed- forward loop with neutrophil proteases to 
allow their full activation, and it enables cell lysis by form-
ing plasma membrane pores during the final steps of NET 
formation.
Conclusions: We identified GSDMD as a key component 
of NET formation and we propose that different forms 
of proinflammatory cell death, such as pyroptosis and 
NET formation, converge on the use of GSDMD as an 
executioner.
Funding sources: This project was funded by the Max 
Planck Society.
S2- O4 | Proteomic analysis of neutrophil 
extracellular traps in rheumatoid arthritis and 
systemic lupus erythematosus
Elinor Chapman; Max Lyon; Deborah Simpson; David Mason; 
Robert Beynon; Robert Moots; Helen Wright
University Of Liverpool, Liverpool, UK
Background: Neutrophil Extracellular Traps (NETs) 
are implicated in the development of auto- immunity in 
rheumatoid arthritis (RA) and systemic lupus erythema-
tosus (SLE) through the externalisation of intracellular 
neoepitopes (dsDNA and nuclear proteins in SLE, citrul-
linated peptides in RA). Our aim was to use quantitative 
proteomics to measure NET proteins produced by neutro-
phils from healthy controls, and from patients with RA and 
SLE to determine if NETs can be differentially generated 
to expose different neoepitopes.
Materials and methods: Ultra- pure neutrophils (>99%) 
from healthy individuals (n = 3) and patients with RA 
or SLE (n = 6 each) were incubated ±PMA (50 nM, 
PKC super- activator) or A23187 (3.8 μM, calcium iono-
phore) for 4 h. NETs were digested and concentrated onto 
Strataclean beads prior to on- bead digestion with trypsin. 
Data- dependent LC- MS/MS analyses were conducted on 
a Q Exactive HF quadrupole- Orbitrap mass spectrometer, 
and label- free protein quantification was carried out using 
Progenesis QI.
Results: PMA- induced NETs were decorated with annex-
ins, azurocidin and histone H3, whereas A23187- induced 
NETs were decorated with granule proteins (CAMP/LL37, 
CRISP3, MMP8), histones (H1.0, H1.4, H1.5), PADI4 
and α- enolase. Four proteins were significantly differ-
ent between PMA- NETs from RA and SLE neutrophils 
(P < 0.05) RNASE2 was higher in RA; MPO, leukocyte 
elastase inhibitor and thymidine phosphorylase were 
higher in SLE. For A23187- NETs, six NET proteins were 
higher in RA (P < 0.05), including CAMP/LL37, CRISP3 
and MMP8; thirteen proteins were higher in SLE, includ-
ing histones H1.0, H2B and H4.
Conclusions: This work provides the first, direct compari-
son of NOX2- dependent (PMA) and NOX2- independent 
(A23187) NETs, and the first comparison of RA and SLE 
NETs using quantitative proteomics. We show that it is the 
nature of the stimulant rather than neutrophil physiology that 
determines NET proteins in disease, since stimulation of 
NETosis in either a NOX2- dependent or NOX2- independent 
manner generates broadly similar NET proteins irrespective 
of the disease background.
Funding: Wellcome Trust Seed Award in Science.
S2- O5 | Proteolytic modification of NET 
components affects their recognition by 
autoantibodies
Cynthia De Bont; Nienke Eerden; Wilbert Boelens; Ger Pruijn
Biomolecular Chemistry, Institute of Molecules and Materials, Radboud 
University Nijmegen, the Netherlands, Nijmegen, Netherlands
Background: Neutrophils are able to eject their nuclear 
material into the extracellular space to form a Neutrophil 
Extracellular Trap (NET) in a process called NETosis. 
NETs contribute to capturing and eliminating pathogens, 
but when not properly cleared autoimmune responses 
might be elicited to NET components. Neutrophil proteases 
play an essential role in NET formation, but they also af-
fect the protein content of the NETs. The conversion of 
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NET- associated proteins by the neutrophil proteases might 
generate neoepitopes of autoantibodies or alternatively re-
sult in the loss of autoepitopes.
Material and methods: NETs were formed and harvested 
either in presence or absence of the non- specific serine 
protease inhibitor phenylmethylsulfonyl fluoride (PMSF). 
Protein content of the harvested NETs were analysed via 
western blotting using a large panel of monoclonal antibod-
ies and RA and SLE patient sera.
Results: As soon as NETs are formed in vitro, (NET- 
associated) neutrophil proteases degrade the protein con-
tent of NETs. Interestingly, antibacterial NET proteins 
such as myeloperoxidase and proteinase 3 are less prone 
to degradation than other proteins such as actin and TNF- 
α. Proteolysis also leads to the disappearance of post- 
translational modifications, such as citrullination of histone 
3, a molecular hallmark of NETs. The degradation of the 
protein content of NETs can be inhibited by the addition 
of PMSF. Furthermore, SLE or RA patient sera, which fre-
quently contain autoantibodies to NETs, show more reac-
tivity with NETs produced in the presence of PMSF than 
with non- treated NETs.
Conclusions: Proteases are responsible for the degradation 
of NET- associated proteins in vitro, which alters their im-
munogenicity. These proteases are most likely serine pro-
teases, because degradation can be inhibited by PMSF. Our 
data are consistent with an important role for neutrophil 
protease activities in the recognition of NET components by 
autoantibodies.
Funding sources: This work was supported in part by the 
Dutch Technology Foundation STW.
S2- O6 | Neutrophil extracellular traps 
accumulate in Cystic Fibrosis sputum and are 
associated with inflammation and lung function 
decline.
Sheonagh Law; Gareth Hardisty; Essor Ian Dransfield; Robert 
Gray
University of Edinburgh, Edinburgh, UK
Background: Neutrophil extracellular traps (NETs) have 
been shown to accumulate in the airways of Cystic Fibrosis 
(CF) patients. There is uncertainty around whether NETs’ 
beneficial antimicrobial actions outweigh the threat they 
pose through triggering inflammation, which may worsen 
lung disease. This study aimed to elucidate the mechanisms 
through which NETs contribute to non- resolving airway in-
flammation in CF.
Materials and methods: This was a prospective study 
on 45 patients with CF and 15 healthy controls (HC) in 
south east Scotland. Sputum and blood samples were 
collected and lung function measured between April 
2017- August 2018. Clinical data were collected from elec-
tronic medical records. We quantified sputum NETs using 
a novel in- house double- sandwich ELISA, which measures 
histone- bound calprotectin. Differential cell counts, free 
DNA, proinflammatory cytokines, calprotectin, and my-
eloperoxidase (MPO) and neutrophil elastase (NE) activi-
ties were also quantified from sputum and correlated with 
clinical parameters.
Results: CF sputum contained significantly more NETs than 
HC sputum. CF patients taking DNase had significantly 
decreased sputum NETs. CF sputum also contained higher 
concentrations of IL- 8, TNF- α, calprotectin and free DNA 
relative to HC sputum, as well as increased MPO and NE ac-
tivity. There was a strong positive correlation between NETs 
and other markers of inflammation such as calprotectin and 
IL- 8, as well as MPO activity, suggesting a central role in 
inflammation. Forced expiratory volume in one second was 
negatively correlated with neutrophils/g sputum, free DNA, 
MPO activity, and calprotectin.
Conclusions: Taken together, our results suggest NETs 
are highly associated with non- resolving neutrophilic 
airways inflammation and lung function decline in CF. 
Furthermore, daily DNase therapy reduces the abundance 
of NETs in patients’ airways, revealing a novel anti- 
inflammatory pathway.
Funding sources: SML is funded by a Wellcome Trust 
Clinical Research Training Fellowship (grant number 
201246/Z/16/Z). RDG is funded by an NRS Senior Clinical 
Fellowship (SCAF/16/02).
S2- O7 | Targeting the neutrophil- clock for 
cardiovascular protection
Alejandra Aroca-Crevillén; José María Adrover; Sandra Martín-
Salamanca; Georgiana Crainiciuc; Andrés Hidalgo
Spanish National Center for Cardiovascular Research, Madrid, Spain
Background: Neutrophils are critical mediators of tissue 
death after ischemia- reperfusion (I/R), which major conse-
quences in global health¹. However, targeting neutrophils has 
not been an option given their essential anti- microbial roles. 
Our recent discovery of a neutrophil- intrinsic clockwork that 
controls the circadian properties of neutrophils, or aging², re-
vealed that CXCR4 is a key negative regulator of this process 
that could be potentially targeted to interfere with neutrophil 
aging and its deleterious consequences. Here we aimed to 
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manipulate the neutrophil clock to protect infarcted hearts 
from I/R injury.
Material and methods: To study the therapeutic effect of 
CXCR4 agonists (ATI2341 and NUCC54121), we per-
formed flow cytometry, in vivo migration assays, intravital 
microscopy and acute myocardial infarction (AMI) induced 
by ischemia- reperfusion of the left anterior descending coro-
nary artery in wild- type, as well as in aging- defective mice at 
different diurnal times and after the treatment with CXCR4 
agonists.
Results: CXCR4 agonists impaired neutrophil aging in 
vivo. Cardiac damage upon AMI displayed diurnal varia-
tions in wild- type mice and became arrhythmic in mice with 
disrupted neutrophil aging (Bmal1ΔN and WHIM mice). 
Genetic- impairment of aging protected from AMI and, no-
tably, infarct sizes were markedly reduced by the CXCR4 
agonists. Agonist- induced protection was lost in CXCR4ΔN 
mice, indicating that neutrophils were the relevant population 
targeted by the agonists.
Conclusions: Manipulation of the neutrophil clock by 
CXCR4 agonists has a protective effect on I/R damage. This 
postulates the neutrophil clock as an efficient therapeutic 
target for cardiovascular disease. We are currently exploring 
whether manipulation of this circadian clock has detrimental 
effects in anti- microbial immunity.
Funding sources: “La Caixa” Banking Foundation.
References: 1. Phillipson and Kubes, 2011. Nat. Medicine.
2. Adrover et al., 2019. Immunity.
S2- O8 | Neutrophil activation by 
immunoglobulin A exacerbates pathogenesis of 
inflammatory bowel disease
Amelie Bos; Marjolein van Egmond
Vumc Amsterdam, Amsterdam, Netherlands
Immunoglobulin A (IgA) is the most prevalent antibody at 
mucosal surfaces and plays a crucial role in defense. It op-
sonizes invading pathogens, which results in phagocytosis 
by neutrophils. As a result, these IgA- activated neutrophils 
trigger recruitment of novel neutrophils, which helps to clear 
a looming infection. In contrast to the resolving functions in 
infections, we propose that neutrophils have harmful proper-
ties and contribute to colon damage and inflammatory bowel 
disease (IBD) pathology. 
We generated a transgenic mouse model containing human- 
IgA and its human- Fcα receptor. FcαRIxhIgA mice were 
challenged with dextran sulfate sodium (DSS) to induce co-
litis and had decreased survival, reduced bodyweight, shorter 
intestines and severe tissue damage compared to control 
mice. In addition, FcαRIxhIgA mice had high infiltration of 
neutrophils within the gut. 
In line, we observed in human IBD biopsies en enhanced 
amount of neutrophils infiltrating the colon and epithelial 
barrier. The amount of neutrophil infiltration positively 
correlated with scoring for tissue damage, indicating that 
neutrophils contribute to pathology. We confirmed human 
neutrophil- epithelial cell interaction in- vitro using a co- 
culture, and found neutrophils capture epithelial cells with 
their neutrophil extracellular traps. 
Finally, we investigated the presence of anti- epithelial auto- 
antibodies in plasma of patients with IBD. We coated human 
epithelial cells with plasma from either flared/remission 
Crohn's- or Colitis- diseased patients and compared this to 
healthy control plasma. We observed an enhanced amount of 
anti- epithelial IgA antibodies within active patients. In addi-
tion, we confirmed the existence of IgA autoantibodies using 
human colon organoids. 
Overall, we propose that IgA contributes to IBD pathology 
by binding to the human epithelial lining, which will acti-
vate neutrophils and initiate a neutrophil migration loop. 
Consequently, recruited neutrophils are also activates by 
IgA, which will ultimately lead to massive tissue destruction.
S2- O9 | Characterisation of neutrophils 
generated in vitro from immortalized HoxB8- 
transduced myeloid progenitor cells
Anita Orosz; Attila Mócsai
Semmelweis University, Budapest, Hungary
Background: Neutrophil granulocytes play a critical role in 
the innate immunity. However, deeply understanding their 
biology has been challenging, as they are short- lived, ter-
minally differentiated cells unfitted to be kept in culture or 
genetically manipulated. Our aim is to overcome these obsta-
cles using the HoxB8- driven, immortalized myeloid progeni-
tor cell line. This allows us to generate unlimited amounts of 
neutrophils, followed by a detailed analysis of various cell 
functions.
Material and methods: HoxB8 progenitors were cultured in 
medium containing β- estradiol. Neutrophils were grown in β- 
estrogen free medium supplemented with G- CSF. Functional 
experimental assays (ROS production, phagocytosis, etc.) 
were performed in vitro and in vivo using various stimulat-
ing agents. HoxB8 chimeras were generated with adoptive 
transfer of HoxB8 progenitors. KBxN serum transfer arthri-
tis model was used to monitor HoxB8 neutrophils’ role in 
autoantibody- induced inflammation.
Results: Ly6G+ HoxB8 neutrophils showed adhesion 
and ROS production upon PMA and immune complex 
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stimulation. They could carry out phagocytosis of op-
sonized bacteria in vitro. Upon adoptive transfer of progen-
itors, HoxB8 neutrophils soon appeared in the circulation 
of the recipients. These neutrophils were able to migrate 
into the inflamed peripheral tissues, where they carried out 
phagocytosis. However, progenitors were unable to colo-
nize the bone marrow permanently, so neutrophils died in 
2 days, without reappearing in the circulation. Upon arthri-
togenic serum treatment, chimeras containing only Hoxb8 
neutrophils developed a systemic joint inflammation, com-
parable to the WT animals.
Conclusions: This unique HoxB8 progenitor cell line is 
a robust tool to generate neutrophils in vitro. These neu-
trophils seem to be functionally active in all the classical 
experimental assays both in vitro, and in vivo. Their role 
in acute inflammation further proves the cell line's util-
ity in wide- ranging studies of neutrophil granulocytes. 
Moreover, the in vitro cultured HoxB8 progenitors also 
provide an easy target for genetic modifications, manifest-
ing on the neutrophil level.
S2- O10 | The Development of a Novel, Targeted 
and Less Toxic Anti- Inflammatory Drug for the 
Treatment of Gout 
Maria Fernandes1; Guillaume Paré1; Julien Vitry1; Myriam 
Vaillancourt1; François Marceau1; Paul Naccache1; Jack 
Tuszynski2
1Université Laval, Québec, Canada;  2University of Alberta, Edmonton, 
Canada
Background: Gout is one of the most painful types of ar-
thritis and its prevalence is increasing worldwide. It is 
characterized by acute inflammatory episodes initiated 
by monosodium urate crystals (MSU). The use of anti- 
inflammatory drugs to treat gout is challenging since most 
patients suffer from co- morbidities. Colchicine effectively 
dampens MSU- induced inflammation but is associated with 
undesirable side effects. Since colchicine exhibits specificity 
towards the molecular pathways involved in gout we modi-
fied its structure to render it less toxic. Colchicine binds to 
beta- tubulin isoforms with different affinities. Using a ra-
tional drug design approach, we increased the affinity of 
colchicine for a beta- tubulin isotype whose expression is en-
riched in leukocytes including neutrophils. Neutrophils play 
a key role in gout attacks.
Methods: We generated colchicine derivatives that preferen-
tially bind the beta- tubulin isotype expressed in leukocytes 
and tested them in in vitro assays on human neutrophils, in-
cluding the MSU- induced secretion of IL- 8, the synthesis 
of IL- 1, the production of reactive oxygen species and the 
increase in cytoplasmic calcium. Their anti- inflammatory ac-
tivity was assessed in the air- pouch model of MSU- induced 
inflammation.
Results: One of the colchicine derivatives tested inhibits 
MSU- induced, neutrophil activation at a 100- fold lower dose 
than colchicine in all the in vitro assays except IL- 1 produc-
tion. The observed decrease in IL- 1 production did not reach 
significance. This compound also significantly inhibited leu-
kocyte recruitment at a 100- fold lower dose than colchicine 
in the air pouch model. Similar observations were made for 
the second compound at doses 10- to 100- fold lower than 
colchicine.
Conclusions: We have developed anti- inflammatory com-
pounds that may offer gout patients a safer drug as well as 
patients with other diseases treated with colchicine. To our 
knowledge, this is the first demonstration that beta- tubulin 
isotypes are a potential therapeutic target to treat neutrophil- 
driven inflammation in gout.
Funding: Highbury Foundation, The Arthritis Society.
S2- O11 | Annexin A1 induces a pro- angiogenic 
macrophage phenotype to promote myocardial 
repair
Bartolo Ferraro1,2; Giovanna Leoni1,2; Rabea Hinkel2,4; Christian 
Kupatt2,4; Oliver Soehnlein1,3,5
1Institute for Cardiovascular Prevention IPEK, Ludwig- Maximilians- 
University, Munich, Germany;  2DZHK, partner site Munich Heart 
Alliance, Munich, Germany;  3Department of Pathology, AMC, 
Amsterdam, the Netherlands;  4Medizinische Klinik I, TUM, Munich, 
Germany;  5Department of Physiology and Pharmacology, Karolinska 
Institutet, Stockholm, Sweden
Background: Heart failure following myocardial infarction 
(MI) remains one of the major causes of death worldwide 
and its treatment is a crucial challenge of cardiovascular 
medicine. An attractive therapeutic strategy is to stimulate 
endogenous mechanisms of myocardial regeneration. This 
study evaluates the potential therapeutic treatment with the 
anti- inflammatory and pro- resolving endogenous protein 
Annexin A1 (AnxA1) to induce cardiac repair after MI.
Material and methods: AnxA1 knockout (AnxA1KO) and 
wild type mice, underwent MI, induced by ligation of the left 
anterior descending coronary artery. Cardiac functionality 
was assessed by longitudinal echocardiographic measure-
ments. Histological, FACS, dot blot analysis and in- vitro/
ex- vivo studies were used to assess the myocardial neovas-
cularization, macrophage content and activity in response to 
AnxA1.
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Results: AnxA1KO mice showed a reduced cardiac func-
tionality and an expansion of pro- inflammatory macrophages 
in the ischemic area. Cardiac macrophages from AnxA1KO 
mice exhibited dramatically reduced ability to release the pro- 
angiogenic mediator VEGF- A. Vice versa, AnxA1 treatment 
enhanced VEGF- A release from cardiac macrophages and its 
delivery in vivo markedly improved cardiac performance. The 
positive effect of AnxA1 treatment on cardiac performance 
was abolished in wild type mice transplanted with bone mar-
row derived from Cx3cr1creERT2Vegfflox/flox or in mice 
depleted of macrophages. Similar, cardioprotective effects 
of AnxA1 were obtained in pigs in which full length AnxA1 
was overexpressed by use of a cardiotropic adeno- associated 
virus (AAV). Annexin A1 content was also explored in 
human myocardial tissue with histologically confirmed acute 
myocardial infarction, finding a positive correlation between 
Annexin A1 expression and parameters of neoangiogenesis.
Conclusions: AnxA1 has a direct action on cardiac mac-
rophage polarization towards a pro- angiogenic, reparative 
phenotype. AnxA1 stimulated cardiac macrophages to re-
lease high amounts of VEGF- A, thus inducing neovasculari-
zation and cardiac repair.
Funding: This study is funded by the DFG and the Fritz 
Thyssen Stiftung.
S2- O12 | Tissue hypoxia induces mobilisation of 
pro- angiogenic neutrophils from the spleen through 
sympathetic nerve signalling
Cédric Seignez; Mia Phillipson
Department Medical Cell Biology, Biomedical Centre, Uppsala 
University, Uppsala, Sweden
Background: We recently described that hypoxic tissues 
induce the recruitment of a distinct population of neutro-
phils (CD49d+ VEGFR1high CXCR4high and MMP9high), 
called pro- angiogenic neutrophils, crucial for restoring tissue 
oxygen supply by inducing development of new and func-
tional blood vessels (1,2). This study aims to delineate the 
origin of the pro- angiogenic neutrophils and the signals driv-
ing their recruitment into the hypoxic tissue.
Materials and methods: Ischemia is induced in the mouse 
hind limb following ligation of femoral artery. Different or-
gans (muscles, spleen and blood) are dissociated and cell 
populations are analysed by flow cytometry 3 hours follow-
ing ischemia induction. Different pharmacological inhibitors 
and surgical protocols are used to identify the molecular sig-
nals inducing the mobilisation of pro- angiogenic neutrophils 
visualised by histological stainings and intravital confocal 
microscopy.
Results: We demonstrated a substantial enrichment of pro- 
angiogenic neutrophils in the splenic population of neutro-
phils during homeostasis. Three hours following induction 
of ischemia in the hind limb, splenic pro- angiogenic but not 
ordinary neutrophils are promptly mobilised into the circu-
lation and subsequently recruited into the hypoxic muscle 
where they peak at two days. Intra- muscular recruitment of 
pro- angiogenic neutrophils is specifically blocked by the in-
hibition of the integrin CD49d and the receptors VEGFR1 
and CXCR4. Furthermore, chemical and surgical suppres-
sion of the sympathetic signalling impaired the mobilisation 
of splenic pro- angiogenic neutrophils and delayed blood flow 
recovery of the ischemic hind limb.
Conclusions: The spleen houses a peripheral pool of the 
newly described pro- angiogenic neutrophils, which are 
quickly mobilised into the circulation by the sympathetic 
nerves activation and recruited into VEGF- A- and CXCL12- 
producing hypoxic tissues through the engagement of the in-
tegrin CD49d.
Funding: Swedish Research Foundation; Knut and Alice 
Wallenberg Foundation; Ragnar Söderberg Foundation; 
O.E.och Edla Johanssons Foundation; Johansson, Gustaf 
Adolf Foundation.
References: 1. Massena S. et al. Blood 126(17), 2015
2. Christoffersson G. et al. Blood 120(23), 2012
S2- O13 | Neutrophils activated with Hif- 1α are 
protective in zebrafish tuberculosis in vivo models
Piotr Szkuta; Amy Lewis; Stephen Renshaw; Alison Condliffe; 
Philip Elks
University Of Sheffield, Sheffield, UK
Background: Tuberculosis is on the rise due to the in-
creasing prevalence of multi- drug resistant strains. 
Understanding the neutrophil response to the causative 
pathogen, Mycobacteria tuberculosis, is crucial to under-
stand the pathogenesis of disease and to identify host- 
derived factors as potential therapeutic targets, a strategy 
that will circumvent bacterial resistance. We have identi-
fied hypoxic signalling, (via hypoxia inducible factor 1 
alpha, Hif- 1α), as a host- derived signalling pathway that is 
host protective via the neutrophil response to mycobacte-
rial infection.
Materials and methods: There is a lack of whole organ-
ism, in vivo, models in which to study host- mycobacterial 
interactions. Zebrafish embryos are transparent and fluores-
cent transgenic lines allow detailed imaging of phagocytes. 
Hif- 1α was modulated in embryos by expression of dominant 
active and negative constructs. Mycobacterium marinum 
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(Mm), a close relative of Mycobacterium tuberculosis, was 
microinjected into Hif modulated embryos and the host re-
sponse to infection was investigated in both single models 
and dual models of infection and inflammation.
Results and Conclusion: Stabilization of Hif- 1α at early 
infection stages led to decreased bacterial burden. Hif- 1α 
stabilization upregulated early pro- inflammatory Il- 1β and 
Tnf- α signalling. When macrophages were depleted, wild- 
type neutrophils were not protective against Mm, however 
when Hif- 1α is stabilized then neutrophils alone are able 
to control infection. Hif- 1α's protective effect was dem-
onstrated to be dependent on neutrophil inducible nitric 
oxide synthase (iNOS), a bacterial killing mechanism of 
phagocytes. Although Hif- 1α stabilization also caused a 
delayed resolution of neutrophil inflammation at a sterile 
wound, the overall protective effect against infection was 
maintained in larvae with both infection and inflammation 
processes occurring concurrently. Elevating neutrophil 
Hif- 1α/iNOS levels may be a novel therapeutic strategy 
that circumvents the problem of multi- drug resistance in 
tuberculosis.
Funding: This work was supported by a Sir Henry Dale 
Fellowship jointly funded by the Wellcome Trust and the 
Royal Society (Grant number 105570/Z/14/Z).
S2- O14 | Aspirin- triggered lipoxin A4 enhances 
phagocytosis- induced neutrophil apoptosis and 
resolution of acute lung inflammation 
Janos Filep1,2; Driss El Kebir1,2; Meriem Sekheri2
1University Of Montreal, Montreal, Canada;  2Research Center, 
Maisonneuve- Rosemont Hospital, Montreal, Canada
Background: Timely resolution of bacterial infections criti-
cally depends on phagocytosis of invading pathogens by 
neutrophil granulocytes, followed by neutrophil apoptosis 
and efferocytosis. Inefficient clearance of invading bacteria 
and delayed neutrophil apoptosis are characteristic features 
of variety pathologies, including sepsis and cystic fibrosis. 
The identification of endogenously generated molecules, in-
cluding aspirin- triggered 15- epi- lipoxin A4 (15- epi- LXA4), 
which promote resolution of inflammation suggest that these 
actions may have therapeutic potential. We investigated the 
impact of 15- epi- LXA4 on bacterial clearance, phagocytosis- 
induced neutrophil apoptosis and resolution of acute lung 
inflammation.
Materials and methods: We studied the effects of 
15- epi- LXA4 on phagocytosis and killing of E. coli 
and phagocytosis- induced apoptosis in isolated human 
neutrophils and in a mouse model of acute lung injury evoked 
by intratracheal instillation of live E. coli and bacterial DNA.
Results: Culture of human neutrophils with 15- epi- LXA4 
restored impaired phagocytosis and killing of opsonized E. 
coli, and promoted phagocytosis- induced neutrophil apopto-
sis through enhancing NADPH oxidase- mediated activation 
of caspase- 8 and caspase- 3. These actions of 15- epi- LXA4 
were prevented by pharmacological blockade of the formyl- 
peptide receptor 2 (FPR2). In wild type mice, 15- epi- LXA4, 
administered at the near peak of inflammation, enhanced pul-
monary clearance of E. coli, redirected alveolar neutrophils 
to apoptosis, enhanced efferocytosis and consequently accel-
erated resolution of acute lung injury.
Conclusions: Our results identify a novel mechanism, restor-
ing impaired bacterial clearance and phagocytosis- induced 
neutrophil apoptosis, by which 15- epi- LXA4 could counter 
neutrophil dysfunction and facilitate resolution of acute lung 
inflammation. These findings also identify FPR2 as a poten-
tial therapeutic target for combating bacterial infections.
Funding: Grant support CIHR MOP- 97742.
S2- O15 | Re- programming atherosclerotic 
plaque macrophages towards an anti- atherogenic 
phenotype 
Jan Nagenborg1; Han Jin1; Eoin Brennan2; Pieter Goossens1; 
Marjo Donners1; Erik Biessen1
1CARIM - Cardiovascular Research Institute Maastricht, Maastricht, 
Netherlands;  2UCD Conway Institute of Biomolecular and Biomedical 
Research, Dublin, Ireland
Background and aim: Atherosclerosis is a chronic inflam-
matory disease with severe clinical outcome such as stroke 
or myocardial infarct. Macrophages are one of the critical 
drivers of atherosclerotic plaque inflammation, which may 
be beneficial in early disease stages, at later stages, rather 
act detrimental. The latter effects could potentially be halted 
by re- instructing plaque macrophages towards an anti- 
inflammatory, inflammation- resolving phenotype. Therefore, 
we aim to identify key genes in atherosclerosis that skew mac-
rophages from pro- towards an anti- atherogenic phenotypes.
Material and methods: Microarray data from stable plaque 
segments obtained from carotid endarterectomy were ana-
lyzed using weighted gene co- expression analysis (WGCNA) 
and modules were correlated to plaque characteristics; par-
ticularly anti- inflammatory Arg1 + CD68 + macrophage 
content. To consolidate genes of interest, module members 
were ranked based on 1. correlation to Arg1 + CD68 + stain-
ing, 2. module centrality and 3. macrophage relevance. The 
top 20 genes were analyzed for specific expression in major 
plaque cell types.
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Results: WGCNA generated a network encompass-
ing 58 gene modules. Two modules strongly corre-
lated with Arg1 + CD68 + macrophage (P value = 0.05; 
0.003) presence, and inversely with pro- inflammatory 
iNOS+CD68 + macrophages. Gene ontology analysis 
showed module enrichment in fatty acid and glucose me-
tabolism genes. The majority of candidates were selectively 
expressed by macrophages over endothelial and smooth 
muscle cells. Silencing of STAT5B and to a lesser extent 
SNTB2, HNMT, RABGGTB and ARHGEF7 expression in 
primary human macrophages caused significant changes in 
the expression of the other candidates, indicating a central 
role of STAT5B in the co- expression network. Finally, the 
presence of phosphorylated STAT5 in GM- CSF- stimulated 
macrophages underpinned the candidate's relevancy for mac-
rophage phenotype.
Conclusion: Our data suggest that STAT5 might act as 
a hitherto unknown key regulator of plaque macrophage 
phenotype.
Funding sources: This project has received funding from 
the European Union's Horizon2020 research and innovation 
program under the Marie Sklodowska- Curie grant agreement 
No. 675111.
S2- O16 | Anti- EMMPRIN immunization with 
161- pAb promotes necroptosis and immunogenic 
cell death 
Michel Rahat1,3; Nizar Hijaze2; Max Ledersnaider1; Elina 
Simanovich1; Sameer Kassem2,3
1Immunotherapy Lab, Carmel Medical Center, Haifa, Israel;  2Internal 
Medicine A, Carmel Medical Center, Haifa, Israel;  3Ruth and Bruce 
Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, 
Haifa, Israel
Background: Immunogenic cell death (ICD) is a regulated 
death that activates an adaptive immune response against an 
antigen expressed by the dying cell in immunocompetent 
hosts. Cancer therapy aims to trigger ICD with an anti- tumoral 
agent to elicit a gradual adaptive anti- tumoral immune re-
sponse, as seen in chemotherapy (e.g., doxorubicin). While 
the tumor microenvironment imposes immune suppression, 
ICD alleviates it and allows cytotoxic T cells to eradicate 
tumor cells. However, antigen- targeted immunotherapy that 
induces ICD has not been described so far. EMMPRIN is a 
multifunctional protein best known as a pro- angiogenic pro-
tein due to its ability to induce VEGF and matrix metallo-
proteinases (MMPs). EMMPRIN is overexpressed in more 
than 77% of human tumors, and its expression is increased 
with tumor stage and grade and in tumor metastases, suggest-
ing its importance in tumor progression and attractiveness for 
targeting.
Methods and results: We have previously developed a 
polyclonal antibody (161- pAb) against a novel epitope of 
EMMPRIN, which reduced tumor growth and the number 
of metastatic foci in three different mouse models. Now we 
show that 161- pAb and complement induce cell death in 
vitro in the mouse cell lines CT26 (colon carcinoma) and 
RENCA (renal carcinoma). Dying cells exhibited both ne-
crotic (LDH release) and apoptotic (cleaved caspase- 3) char-
acteristics, indicating necroptosis. Moreover, relative to other 
inducers of death (e.g., apoptosis- inducing doxorubicin and 
etoposide, necrosis- inducing hydrogen peroxide) 161- pAb 
and complement enhanced the release of dsRNA (by 2- 6 
fold, P < 0.001). When supernatants from dying cells were 
added to RAW 264.7 macrophages, secretion of IL- 1, TNF, 
and of IL- 10, that stimulates CD8 + T cell cytotoxicity, were 
increased.
Conclusions: 161- pAb can trigger ICD and adaptive anti- 
tumoral immune response, explaining its efficacy in reduc-
ing tumor growth. Secretion of alarmins such as dsRNA 
can shift macrophages towards a pro- inflammatory activa-
tion and stimulate CD8 + T cells cytotoxicity and IFN- ɣ 
secretion.
S2- O17 | Single- live- cell assessment of the role 
of calcium bursts in chemotaxis and phagocytosis 
of human neutrophils
Emmet Francis; Volkmar Heinrich
University of California, Davis, Davis, USA
Background: Global bursts in intracellular calcium concen-
tration are among the most conspicuous signals in immune 
cells. It has long been recognized that receptor engagement 
during migration and phagocytosis can trigger such bursts, 
but their direct causes and effects remain unclear. Here, we 
examine the role of calcium bursts in mechanoregulation of 
neutrophil motility.
Materials and Methods: Dual- micropipette manipulation of 
individual human neutrophils and pathogenic targets allows 
us to quantify the chemotactic and phagocytic behavior of 
these cells in terms of their morphology, surface area, corti-
cal tension, etc. (examples at https://www.youtube.com/user/
HeinrichLab). Additionally, we use fluorescence imaging of 
cytosolic calcium to interrelate the timing of calcium bursts 
with cell behavior. We test hypotheses about cause- effect re-
lationships by performing experiments in the absence of ex-
tracellular calcium or after depletion of intracellular calcium 
stores.
Results: At physiological calcium concentrations, neutro-
phils maintained a baseline calcium concentration during 
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chemotaxis and exhibited a calcium burst early during 
phagocytosis. In a calcium- free medium, calcium bursts 
with a similar magnitude still occurred during phagocyto-
sis, but we observed a markedly different cell morphology 
characterized by an initial outward push of the target parti-
cle followed by its engulfment. When intracellular calcium 
stores were pre- emptied by treatment with thapsigargin (in 
a calcium- free medium), no calcium bursts were observed, 
but phagocytosis still proceeded with a similar push- out. 
Overall, this suggests that calcium influx through plasma 
membrane channels (triggered by store release) normally 
acts to strengthen linkages between the actin cytoskeleton 
and the cell membrane.
Conclusions: Phagocyte motility is significantly altered 
in the absence of extracellular calcium and/or after deple-
tion of intracellular calcium stores, indicating that calcium 
plays an important role in regulating actin dynamics and 
cytoskeleton- membrane connections. Bursts of calcium 
appear to modulate adhesion- dependent cell protrusion by 
regulating the lock and release of cytoskeleton- membrane 
anchors.
Funding: NSF Graduate Research Fellowship, ARCS 
Foundation Award.
S2- O18 | The kidney specific glycoprotein 
Uromodulin induces leukocyte recruitment in vivo
Monika Prünster1; Tobias Steffen1; Roland Immler1; Georg Hupel1; 
Ursula Keller2; Jürgen Scherberich3; Bernd Uhl1; Hanna Mannell1; 
Heike Beck1; Christoph Reichel1; Bärbel Lange-Sperandio2; 
Markus Sperandio1
1Walter Brendel Centre of Experimental Medicine, Biomedical Center, 
Planegg, Martinsried, Germany;  2von Haunersches Kinderspital, 
Department of Pediatric Nephrology Ludwig- Maximilians Universität 
München, Munich, Germany;  3Klinikum Harlaching, Lehrkrankenhaus 
der Ludwig- Maximilians Universität München, Munich, Germany
Background: Uromodulin (UMOD), a kidney specific gly-
coprotein, is produced by tubular epithelial cells of the thick 
ascending limb of Henle's loop. It is secreted primarily into 
the tubular lumen, where it exerts its role as a defense mol-
ecule against bacterial infections and kidney stone formation. 
Interestingly, a minor fraction of UMOD is also physi-
ologically secreted into the interstitium and blood. Under 
pathological conditions, e.g. inflammatory kidney diseases, 
obstructive nephropathies and recurrent urinary tract infec-
tions, UMOD may generate pathological interstitial deposit, 
thus acting as a proinflammatory molecule.
Material and methods: We used the mouse model of neo-
natal unilateral ureteral obstruction (UUO) to investigate 
UMOD levels and its localization in a model of obstructed 
kidney. To investigate the putative role of UMOD as a pro-
inflammatory molecule we used intravital microscopy and 
visualized leukocyte recruitment in C57Bl/6 wild type mice 
after intrascrotal injection of UMOD or control buffer.
Results and conclusion: Intrascrotal injection of UMOD 
reduced leukocyte rolling and rolling velocities on post-
capillary venules of the mouse cremaster. Number of ad-
herent and extravasated leukocytes was increased in this in 
vivo model. Interestingly, UMOD was unable to directly 
activate beta2 integrins on neutrophils and to directly in-
duce upregulation of adhesion relevant molecules, such 
as E- selectin, ICAM- 1 and VCAM- 1 on endothelial cells. 
Rather, UMOD stimulated tissue resident macrophages to 
produce TNF- alpha, which then may activate the proximate 
endothelium and, subsequently, affect leukocyte rolling 
and adhesion on postcapillary venules. However, UMOD 
also directly contributes to a proinflammatory microen-
vironment as it modulates the permeability of endothelial 
cells and increases the transmigration of neutrophils across 
an endothelial monolayer. Taken together, we present in-
terstitial UMOD as a proinflammatory molecule, leading 
to increased leukocyte recruitment to sites of high UMOD 
expression.
Funding sources: Supported by the FöFoLe- program 
of the Medical Faculty, LMU Munich and the Deutsche 
Forschungsgemeinschaft (PR 1864/1- 1).
S2- O19 | s100A9 regulates neutrophil migration 
during experimental lung inflammation and is a 
novel therapeutic target in respiratory disease
Gareth Hardisty; Sheonagh Law; Jonathan Gillan; Emily Gwyer 
Findlay; Sonja Vermeren; Donald Davidson; Robert Gray
University of Edinburgh, Edinburgh, UK
s100A9 expression correlates with severe neutrophilic in-
flammation in the lung. For example, levels in serum and 
sputum are reliable biomarkers of exacerbation severity 
in Cystic Fibrosis (CF) disease. In spite of a clear correla-
tion with respiratory disease, the direct contribution of s100 
proteins to the neutrophilic lung inflammation remains un-
clear. We hypothesised that s100A9 in neutrophils directly 
contributes to pathology during lung inflammation. WT and 
s100A9- /- mice were challenged with LPS induced inflam-
mation in the lung and neutrophils from the bone marrow, 
peripheral blood and bronchoalveolar lavage were analysed. 
s100A9- /- bone marrow chimera mice were created and chal-
lenged in a similar fashion. Neutrophils were isolated from 
WT and KO mice and in vitro analysis of chemotaxis and 
actin mobilisation by video- microscopy were performed. 
Neutrophil recruitment to the lung is significantly impaired 
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in s100A9- /- mice and associated with increased neutrophil 
retention in the bone marrow and significantly reduced num-
bers of neutrophils in peripheral circulation. In bone marrow 
chimera mice we demonstrate that the failure of s100A9- 
/- neutrophils to migrate to the lung is independent of any 
chemotactic properties of s100A9 and is therefore depend-
ent on the role of intracellular s100A9. s100A9- /- neutrophils 
have significantly impaired migration in terms of distance, 
directness and velocity. Furthermore s100A9- /- neutrophils 
have altered F- actin mobilisation upon stimulation with 
chemotactic peptide fMLP. Finally we demonstrate that neu-
trophil migration into the lung can be significantly reduced 
with the s100A9 binding drug Paquinimod. s100A9 regulates 
neutrophil migration to the lung and can be targeted to reduce 
inflammation. Modulation of s100A9 offers a novel approach 
to reduce immune mediated damage in respiratory diseases.
S2- O20 | ARAP3- mediated integrin inactivation 
promotes neutrophil recruitment to inflammatory 
sites
Barry Mccormick1; Julia Chu1; Leo Carlin2; Sonja Vermeren1
1Centre for Inflammation Research, University of Edinburgh, Edinburgh, 
UK;  2Cancer Research UK, Beatson Institute, Glasgow, UK
Neutrophils are the most abundant circulating leuko-
cytes, and are key players in host defense and inflamma-
tion. Underpinning this role is the ability of neutrophils to 
be rapidly recruited to sites of inflammation or injury in an 
integrin- dependent manner. Whilst mechanisms of integrin 
activation are well characterised, mechanisms mediating in-
tegrin inactivation remain less clear. We investigated the role 
of the GTPase- activating protein ARAP3 on neutrophil in-
tegrin activity, chemotaxis, and adhesion- dependent activa-
tion. We generated ARAP3 knock- down and ARAP3 rescue 
clones of CHO cells expressing the human platelet integrin, 
and investigated effects of ARAP3 on integrin activity, and 
cell spreading. We examined the effect of genetic ARAP3 
deletion on neutrophil recruitment in vivo using models of 
sterile peritonitis, acute lung injury and anti- collagen induced 
arthritis. We found that ARAP3 promotes inactivation of β1 
integrins in mouse neutrophils. ARAP3- deficient neutrophils 
were also characterised by impaired chemotaxis, increased 
adhesion, and adhesion- dependent ROS production and de-
granulation. Similar results were observed with CHO cells, 
where ARAP3- knock- down cells showed greater integ-
rin activity and spreading than control, or ARAP3- rescued 
clones. In mouse models of sterile peritonitis and acute lung 
injury we found a neutrophil recruitment defect in ARAP3- 
deficient mice compared to controls. Further analysis of neu-
trophils within the lung suggested that ARAP3- deficient cells 
accumulated in the vasculature of the lung, whilst control 
cells moved through the interstitium and into the bronchoal-
veolar space. Anti- collagen induced arthritis was studied as 
a prolonged model of neutrophilic inflammation. We found 
that ARAP3- deficient mice were characterised with con-
sistently less severe disease progression compared to con-
trols. These studies suggest ARAP3 is a negative regulator 
of integrin activation, and as such plays an important role 
in efficient extravasation and recruitment of neutrophils by 
allowing neutrophils to detach from endothelial integrin li-
gands and continue migration towards a site of inflammation.
Funding: Funded by the Medical Research Council UK.
S2- O21 | The neutrophil attractant CXCL5 
targets monocytes and proteolytic modification and 
citrullination alter CXCL5 receptor signaling and 
specificity 
Mieke Metzemaekers1; Anneleen Mortier1; Alessandro Vacchini2; 
Karen Yu1; Daiane Boff1,3; Rik Janssens1,3; Nele Berghmans1; 
Noëmie Pörtner1; Samantha Milanesi2; Flavio Almeida Amaral3; 
Massimo Locati2; Elena Monica Borroni2; Paul Proost1
1Ku Leuven, Leuven, Belgium;  2Humanitas Clinical and Research 
Center, Milan, Italy;  3Universidade Federal de Minas Gerais, Belo 
Horizonte, Brazil
Background: The chemokine CXCL5 interacts with CXCR2 
to induce chemotaxis and activation of neutrophils. Former 
research efforts showed that the activity of CXCL5 is reg-
ulated by posttranslational proteolysis and citrullination. 
However, the underlying mechanisms are only partially 
understood.
Materials and methods: CXCL5(1- 78), [Cit9]CXCL5(1- 78), 
CXCL5(9- 78) and [Cit9]CXCL5(9- 78) were chemically syn-
thesized. CXCL5 forms were compared in G protein signal-
ing and β- arrestin recruitment assays based on Alphascreen 
and BRET technology using CXCR2- transfected HEK293 
cells. Also the capacity of CXCL5 forms to induce CXCR2 
internalization and their glycosaminoglycan- binding proper-
ties were evaluated. Ca2 + signaling assays with transfected 
HEK293 cells were performed to analyze the effects of NH2- 
terminal modifications of CXCL5 on its potency on CXCR1. 
The target cell repertoire of CXCL5 forms was explored 
using in vitro chemotaxis and Ca2 + signaling assays, and 
after local chemokine injection into the tibiofemoral joints of 
C57Bl/6 mice.
Results: Truncation significantly enhanced G protein sign-
aling and β- arrestin recruitment through CXCR2, promoted 
CXCL5- induced CXCR2 internalization and chondroitin 
sulfate binding. Moreover, CXCL5 becomes a more relevant 
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agonist for CXCR1 upon NH2- terminal cleavage. Analysis of 
the murine synovial cell content after local administration of 
CXCL5 forms revealed that the neutrophil attractant CXCL5 
also recruits monocytes. These findings were confirmed in 
in vitro chemotaxis and Ca2 + signaling assays. The effect 
of in vivo CXCR1/2 blockage and results from in vitro de-
sensitization experiments suggest that CXCL5 targets mono-
cytes via CXCR1/2. No induction of the monocyte attractants 
CCL2 and CCL3 was observed upon in vivo administration 
of CXCL5. All isoforms also failed to induce release of these 
monocyte attractants by human fibroblasts, endothelial cells 
and mononuclear leukocytes.
Conclusion: Our results support the notion that posttrans-
lational modifications control the activity of CXCL5. NH2- 
terminal truncation potentiated, whereas citrullination rather 
ameliorated its biological effects. Moreover, we propose that 
CXCL5 targets monocytes directly via CXCR1/2.
Funding: FWO- Vlaanderen, L'Oréal Belgilux.
S2- O22 | MKL1 deficiency results in a 
severe neutrophil defect with impaired actin 
polymerization and excessive degranulation
Evelien Sprenkeler1,2; Stefanie Henriet3; Anton Tool1; Iris Kreft4; 
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Background: Megakaryoblastic leukemia 1 (MKL1) pro-
motes the regulation of essential cell processes, including 
actin cytoskeletal dynamics and apoptosis by co- activating 
serum response factor. Recently, we identified by whole- 
exome sequencing a patient with a homozygous frameshift 
mutation in the MKL1 gene, the second case reported to date. 
The infant died from Pseudomonas infection at two months 
of age, suggesting a severe phagocyte defect.
Methods: Heparinized venous blood was drawn from the patient 
to extensively test neutrophil functions. Primary fibroblasts were 
isolated upon skin biopsy and cultured to similarly assess several 
functions of a representative non- hematopoietic cell type.
Results: In vitro, MKL1- deficient neutrophils demonstrated 
a pronounced actin polymerization defect and a strongly re-
duced chemotactic response. As we will discuss, mass spec-
trometry analysis and RNA sequencing revealed numerous 
actin- related proteins and genes to be downregulated com-
pared to control neutrophils. Degranulation was enhanced 
upon sub- optimal neutrophil activation, while no apparent 
difference was noted in the production of extracellular reac-
tive oxygen species. Although our patient suffered from se-
vere Pseudomonas pneumonia, no apparent phagocytosis or 
killing defect in response to bacterial pathogens was found. 
In contrast to neutrophils, patient fibroblasts expressed the 
MKL2 protein. Although these primary cells demonstrated 
defective differentiation into myofibroblasts, migratory be-
havior and filamentous actin (F- actin) content was normal.
Conclusion: Our findings confirm and extend the findings 
on a non- redundant role of MKL1 in human neutrophils with 
cytoskeletal dysfunction and reduced F- actin levels as key 
features. Primary MKL1- deficient fibroblasts demonstrated 
no defects in migratory behavior and F- actin content possi-
bly due to compensatory mechanisms of non- hematopoietic 
MKL2 expression.
S3- O1 | Decreased life expectancy of 
descendants induced by intrauterine environmental 
alteration in gestational obesity
Diana-Elena Comandasu1,2; Maria Mohora3; Bogdana Virgolici3; 
Claudia Mehedintu1,4; Costin Berceanu5; Elvira Bratila1,2
1Carol Davila University Of Medicine And Pharmacy, Department 
of Obstetrics and Gynecology, Bucharest, Romania; 2Prof Dr Panait 
Sarbu Clinical Obstetrics and Gynecology Hospital, Bucharest, Romania; 
3Department of Biochemistry, Carol Davila University of Medicine and 
Pharmacy, Bucharest, Romania; 4Nicolae Malaxa Clinical emergency 
Hospital, Bucharest, Romania; 5Craiova University of Medicine and 
Pharmacy, Craiova, Romania
Background: Obesity is a gestational comorbidity which 
causes obstetrical, neonatal and long- term complica-
tions. The aim of our study is to present the consequences 
of obesity on the prognosis of descendants, showing that 
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longevity is closely correlated with the quality of the intrau-
terine environment.
Material and method: We studied the effects of maternal 
obesity on adult offspring using 30 Wistar rat obese females. 
We have induced obesity through the hyperlipidemic hyper-
caloric diet administered by gavage. The pregnant females 
were then divided into a normal diet group and another who 
continued eating fat during gestation.
Results: Obese female rats were followed during pregnancy 
and sacrificed on term together with some of their off-
spring, while another part was followed up to natural death. 
We analyzed adipokine secretion in maternal blood (leptin 
and adiponectin), lipid peroxidation state through malonyl- 
dialdehyde (MDA) and glutathione level (GSH) as an anti-
oxidant factor in maternal blood and placental homogenates. 
Low adiponectin and high leptin levels were positively cor-
related with increased placental lipid peroxidation, as meas-
ured by high MDA and low GSH levels. Placental histology 
has shown dysplastic epithelial and mesodermal cells in the 
Yolk sack, a higher density of inflammatory cells and con-
gested vessels with thrombotic areas and glycogen stores 
when analyzing the trophoblast in the fat group. Following 
the pups from obese mothers during maturity, we found that 
the average life of those in the fat group was significantly 
reduced compared to normal (up to 30%). These rats were 
more likely to develop accelerate aging and chronic diseases.
Conclusions: Our study suggests the important correlation 
between the biochemical and histopathological changes of 
the intrauterine environment demonstrated by placental dys-
function and reduced life of the descendants. This suggests 
that altering the quality of the intrauterine environment has a 
major impact on longevity.
S3- O2 | Endothelial monocyte- activating 
polypeptide- II improved heart function in focal 
cerebral ischemia- reperfusion
Natalya Dorofeyeva; Roman Sharipov; Vadym Sagach
A.A. Bogomoletz Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine
Background: Stroke is one of the most severe forms of cer-
ebrovascular disease with a high level of mortality. The focal 
cerebral ischemia is accompanied by cardiac dysfunction and 
cerebrocardiac syndrome. The aim of work is to investigate 
the effect of Endothelial monocyte- activating polypeptide-
 II (EMAP- II) on cardiac function during focal cerebral 
ischemia- reperfusion.
Material and methods: The study was conducted on adult 
(6 months) male Wistar rats. The model of focal cerebral is-
chemia was as result from middle cerebral artery occlusion 
during 60 minutes, after it was 30 minutes reperfusion. The 
recombinant endothelial monocyte- activating polypeptide 
II—EMAP II (28 μg/kg) was administered intravenously on 
the end of 50 minutes of focal cerebral ischemia before the 
reperfusion. The functional cardiohemodynamic indicators 
registered via microcatheter and Pressure- Volume System.
Results: It was found that the parameters of the pumping 
function of the heart were decreased during focal cerebral 
ischemia and reperfusion. The stroke volume decreased by 
48.4% after 60 minutes of focal cerebral ischemia and—by 
65.1% after 30 minutes of reperfusion. In a group of treat-
ment with EMAP II, the stroke volume decreased by 27.1% 
and 15.3% respectively. The cardiac output decreased by 
40.9% after 60 minutes of focal cerebral ischemia and by 63% 
after 30 minutes of reperfusion (P < 0.01). After the EMAP 
II administration, the cardiac output decreased only by 19.9% 
after focal cerebral ischemia- reperfusion. We demonstrated 
that EMAP II improved the diastolic heart function after focal 
cerebral ischemia- reperfusion. The enddiastolic myocardial 
stiffness decreased by 7.3 times and partly improved the ac-
tive isovolumic relaxation of the left ventricle: dP/dt min and 
the time constant of isovolumic relaxation (tau).
Conclusions: The treatment with EMAP II improved di-
astolic heart function and increased the parameters of 
the pumping function of the heart during focal cerebral 
ischemia- reperfusion.
S3- O3 | The visceral adiposity index predicts 
cardiovascular events both in cardiovascular 
disease patients with and in those without diabetes
Arthur Mader1,2,3; Christoph Saely1,2,3; Doz. Alexander 
Vonbank1,2,3; Christine Heinzle1; Daniela Zanolin-Purin1; Barbara 
Larcher1,2,3; Andreas Leiherer1,3,4; Doz Axel Muendlein1,3; Heinz 
Drexel1,3,5,6
1Vorarlberg Institute for Vascular Investigation and Treatment VIVIT, 
Feldkirch, Austria;  2Academic Teaching Hospital Feldkirch, Feldkirch, 
Austria;  3Private University of the Principality of Liechtenstein, Triesen, 
Liechtenstein;  4Medical Central Laboratories, Feldkirch, Austria;  
5Division of Angiology, Swiss Cardiovascular Center, University Hospital 
Bern, Bern, Switzerland;  6Drexel University, College of Medicine, 
Philadelphia, USA
Background: The visceral adiposity index (VAI) is a val-
idated tool for the evaluation of visceral adiposity, using 
waist circumference, serum triglycerides, age and gender to 
diagnose this metabolic abnormality. It has recently been 
associated with cardiovascular risk in primary care patients. 
No data are available on the association of the VAI with 
mortality in patients with cardiovascular disease (CVD).
Material and methods: We therefore prospectively re-
corded the incidence of cardiovascular events over a mean 
follow- up period of 7.9 ± 3.1 years in a large cohort of 1858 
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consecutive patients with established cardiovascular disease 
(1599 patients with angiographically proven coronary artery 
disease and 259 patients with sonographically proven periph-
eral artery disease). The VAI was calculated according to the 
Amato formula; type 2 diabetes (T2DM) was defined accord-
ing to the ADA definition.
Results: At baseline, the VAI was significantly higher in 
CVD patients with T2DM than in those who did not have di-
abetes (347 ± 331 vs. 228 ± 200; P < 0.001). Prospectively, 
585 vascular events occurred; the event rate was significantly 
higher in patients with T2DM than in those who did not have 
diabetes (46.8% vs. 31.3%; P < 0.001). After multivariate 
adjustment, the VAI significantly predicted cardiovascular 
events in CVD patients with T2DM (standardized adjusted 
hazard ratio (HR) 1.24 [1.09- 1.42]; P = 0.007) as well as 
in those who did not have T2DM (HR 1.18 [1.06- 1.31]; 
P = 0.014).
Conclusion: We conclude that the VAI predicts cardiovas-
cular events both in CVD patients with and in those without 
diabetes.
S3- O4 | The effects of repeatedly applied cold 
water immersion on subclinical atherosclerosis, fat 
accumulation and lipid profile parameters
Stefan Toth1; David Kasko2; Zdenka Hertelyova3; Alina Putrya1; 
Timea Toth4; Marianna Dvoroznakova1; Daniel Pella1
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Background and aims: Short time cold water immersion 
(CVI) is associated with significant acute cardiovascular and 
endocrinological responses. There is however no available 
study following the effect of repeated CVI on atherogenesis, 
lipid parameters and fat distribution. This study was aimed to 
explore the suggested protective effect of CVI.
Methods: 35 healthy patients, without CV diseases, DM, 
lipid- lowering therapy were exposed to CVI under standard 
conditions 3 times per week between 11/2018 and 3/2018. 
Neoprene equipment was not allowed; patients with weight 
or muscle mass changes over 5% were excluded. In the begin-
ning and in the end of the study blood collection and clinical 
examinations were made. Lipid and non- lipid parameters in-
cluding PCSK9 and hsCRP levels were quantified. Vascular 
changes were detected by carotid ultrasound (cIMT) and by 
echo- tracking for detection of arterial stiffness parameters 
(PWV; AI; Beta). Liver steatosis quantification was based on 
calculation of hepatorenal index (HRI), fat distribution was 
measured by the quantification of subcutaneous and visceral 
fat thickness changes by standardised ultrasound techniques.
Results: From all participants, 28 volunteers have success-
fully completed the given protocol. Significant decrease of 
cIMT (P < 0.001); Beta (P < 0.01) and PWV (P < 0.01) was 
detected after the long term repeated CVI in comparison to 
entry values. Significant decrease of hsCRP (P < 0.05) and 
PCSK9 (P < 0.01) was observed as well. Liver fat accumu-
lation has decreased by an average of 12% in comparison 
with the entry values. Significant decrease in the visceral fat 
thickness was observed, as well as moderate increase of the 
thickness of subcutaneous fat. Plasma lipid levels showed de-
crease of LDL;TC;TG, as well as increase of HDL.
Conclusions: According to this pilot study, we suggest pos-
sible beneficial effect of repeated- CVI on atherogenesis, 
liver fat accumulation, lipid and non lipid parameters (de-
crease of inflammation and PCSK9 levels).
This project was supported by VVGS 2017- 683 grant.
S3- O5 | GlycA, a novel pro- inflammatory 
glycoprotein biomarker predicts mortality: Results 
from The PREVEND study and meta- analysis
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Chronic diseases are associated with an inflammatory 
response. We determined the association of two inflam-
matory markers, GlycA and high sensitivity C- reactive 
protein (hsCRP), with overall and cause- specific mortality 
in a cohort of men and women. Cox regression analyses 
were used to examine associations of GlycA and hsCRP 
with all- cause- , cancer- and cardiovascular mortality in 
5,526 subjects (PREVEND cohort). The average follow-
 up was 12.6 years. GlycA was associated with all- cause 
mortality (n = 838), independent of clinical risk factors 
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and hsCRP. For hsCRP, the association with all- cause 
mortality was non- significant after adjustment for GlycA. 
GlycA and hsCRP were associated with cancer mortality 
(n = 380) in men (n = 248), but not in women (n = 132). 
Neither GlycA nor hsCRP was independently associated 
with cardiovascular mortality (n = 201). In a meta- analysis 
of seven population- based studies, including 8,153 deaths, 
the pooled multivariable- adjusted relative risk (95% confi-
dence interval, CI) of GlycA for all- cause mortality, when 
comparing the top versus bottom quartiles, was 1.74 (95% 
CI 1.40- 2.17). The association of GlycA with all- cause 
mortality was somewhat stronger than that of hsCRP. 
GlycA and hsCRP were not independently associated with 
cardiovascular mortality. The associations of GlycA and 
hsCRP with cancer mortality were present in men, but not 
in women.
S3- O6 | Hypercholesterolemic HDL particles 
lose their atheroprotective potential and become 
deleterious further enhancing atherosclerotic 
plaque burden studies in an animal model by 
MRI 
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Background: High- density lipoprotein(HDL) can protect 
against atherosclerotic plaque development. In fact, many 
studies have supported the ability of HDL infusions to re-
gress atherosclerosis. Yet, in recent years it has become evi-
dent that HDL particles from cardiovascular disease patients 
become dysfunctional losing their protective functions and 
even becoming deleterious. We evaluated by nuclear mag-
netic resonance imaging(MRI) whether infusion of HDL iso-
lated from hypercholesterolemic rabbits retain their ability to 
regress atherosclerotic plaques.
Material and methods: Atherosclerosis was induced in 18 
New Zealand White rabbits by cholesterol feeding(3 months) 
and mechanical injury (double balloon aortic denudation). 
Then, animals underwent MRI to measure aortic athero-
sclerosis (baseline measurements) and were subsequently 
randomized to receive during 1 month a weekly intravenous 
infusion of 1) HDL isolated from normocholesterolemic 
rabbits(NC- HDL, 75 mg/kg, n = 6); 2) HDL isolated from 
hypercholesterolemic rabbits(HC- HDL, 75 mg/Kg n = 6); 
or 3) vehicle (n = 6). Thereafter, animals were subjected to 
another MRI and sacrificed. The aorta and the liver were col-
lected for molecular analyses.
Results: Baseline MRI showed comparable atherosclerotic 
plaque burden among all three groups before initiating HDL 
treatment. As expected, NC- HDL administration resulted in 
a significant plaque regression (6%) vs. baseline (P < 0.05) 
whereas no changes were detected in vehicle- administered 
animals(P=ns vs. baseline). Interestingly, administration of 
HC- HDL particles enhanced plaque progression by 2.8% 
vs. baseline(P < 0.05). At the aortic level, HC- HDLs ad-
ministered animals displayed lower protein levels of the 
vasculoprotective prostacyclin- 2 vs. both NC- HDL- and 
vehicle- treated animals(P < 0.05).In addition, liver expres-
sion of the HDL- cholesterol receptor SRB- 1 was markedly 
reduced in HC- HDLs- administered animals vs.NC- HDL and 
vehicle- administered(P < 0.05) suggesting impaired HDL- 
metabolism(i.e., cholesterol removal).
Conclusions: In contrast to native HDL, HC- HDL particles 
promote atherosclerotic plaque progression. HDL micelles 
formed in a hypercholesterolemic niche have a loss of pro-
tective function and a composition that exert pro- atherogenic 
effects. An unmet clinical need is the recovery of HDL func-
tionality by the identification and restoration of the loss of 
function components.
S3- O7 | Erythropoietin, fibroblast growth factor 
23, and mortality after renal transplantation
Michele F. Eisenga1; Maarten A. De Jong1; David E. Leaf2; Ilja 
M. Nolte1; Martin H. De Borst1; Stephan J. Bakker1; Carlo A. 
Gaillard3
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Background: Elevated circulating levels of erythropoietin 
(EPO) are associated with an increased risk of cardiovascular 
and all- cause mortality in renal transplant recipients (RTRs), 
but the underlying mechanisms remain unclear. Emerging 
data suggest that EPO stimulates production of the phospha-
turic hormone fibroblast growth factor 23 (FGF23), another 
strong risk factor for mortality in RTRs. In the current study, 
we aimed to investigate whether FGF23 mediates EPO- 
associated mortality risk in RTRs.
Material and methods: In a large prospectively followed 
cohort of 592 stable RTRs with a functional graft for more 
than 1 year post transplant, we measured fasting circulating 
EPO and FGF23 levels. Co- primary outcomes were all- cause 
mortality and cardiovascular mortality.
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Results: During a median follow- up of 7.0 years, 126 RTRs 
died, of which 64 due to cardiovascular cause. In univari-
ate analysis, EPO was significantly associated with all- cause 
mortality (HR, 1.87; 95% CI 1.41- 2.48; P < 0.001) and cardi-
ovascular mortality (HR, 1.91; 95% CI 1.29- 2.83; P = 0.001). 
After adjustment for potential confounders, EPO remained 
associated with all- cause (HR, 1.65; 95% CI, 1.18- 2.31; 
P = 0.003) and cardiovascular mortality (HR, 1.89; 95% CI, 
1.18- 3.04; P = 0.008). However, the associations of EPO 
with all- cause and cardiovascular mortality were abrogated 
following adjustment for FGF23 (HR, 1.29; 95% CI, 0.90- 
1.84; P = 0.17, and HR, 1.49; 95% CI 0.90- 2.48; P = 0.12, 
respectively). In mediation analysis, FGF23 mediated 56% 
of the association between EPO and all- cause mortality, and 
35% of the association between EPO and cardiovascular mor-
tality in this patient setting.
Conclusion: EPO- associated increased mortality risk in 
RTRs appears largely related to increased FGF23 levels.
S4- O1 | Targeting adipose tissue glyoxalase 
system with GLP- 1 to improve capillarization and 
insulin sensitivity
Paulo Matafome1,2; Tiago Rodrigues1; Patricia Borges1; Catarina 
Carrêlo3; Laura Mar1; Hans Eickhoff1,4; Bruno Almeida5; Daniela 
Marques1; Salomé Pires6; Margarida Abrantes6; Beatriz Martins3; 
Cristina Uriarte7; Pedro Gomes7; Sónia Silva2,8; Raquel Seiça1
1Institute of Physiology and Institute of Clinical and Biomedical Research 
(iCBR), Faculty of Medicine, University of Coimbra FMUC, Coimbra, 
Portugal;  2Instituto Politécnico de Coimbra, Coimbra Health School 
ESTeSC, Coimbra, Portugal;  3iCBR, FMUC, Coimbra, Portugal;  
4Obesity Center, Hospital de Santiago, Setúbal, Portugal;  5Association 
for the Protection of Portuguese Diabetic Patients APDP, Lisbon, 
Portugal;  6Institute of Biophysics and iCBR, FMUC, Coimbra, Portugal; 
7Department of Surgery, Universitary Hospital Center of Coimbra, 
Coimbra, Portugal;  8Faculty of Pharmacy, University of Coimbra, 
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Background: Methylglyoxal was shown to impair adipose 
tissue (AT) capillarization leading to insulin resistance and 
metabolically unhealthy obesity. We hypothesized that de-
creased AT glyoxalase- 1 (GLO- 1) activity may be correlated 
with insulin resistance in obese patients, being a promising 
therapeutic target in obesity and type 2 diabetes. Given that 
bariatric surgery was observed to increase AT angiogenesis 
and GLP- 1 is known to promote angiogenesis, we hypoth-
esized that GLO- 1 could be a target of GLP- 1 favoring AT 
angiogenesis.
Methods: In a cohort of obese patients (diabetic and non- 
diabetic), GLO- 1 activity was determined in visceral AT, 
as well as insulin resistance indexes. The role of GLP- 1 
in AT angiogenesis and GLO- 1 modulation was assessed 
using the AT angiogenic assay. In vivo, the role of GLP- 1 
in activating GLO- 1 was evaluated in the epididymal AT 
of type 2 diabetic GK rats submitted to sleeve gastrectomy 
(surgical model) or Liraglutide administration (pharmaco-
logical model).
Results: AT GLO- 1 activity was lower in diabetic and pre-
diabetic patients than in normoglycemic ones, along with 
serum adiponectin levels. GLO- 1 activity was correlated 
with the compensatory increase of beta cell function in in-
sulin resistant patients and progressive decline in predia-
betic and diabetic patients (. de Pearson = 0.18; P = 0.043). 
GLP- 1 increased AT capillarization in the AT angiogenic 
assay in a GLO- 1- dependent manner. Moreover, GLO- 1 
expression in AT was increased in both rats submitted to 
sleeve gastrectomy and treated with Liraglutide, surgical 
and pharmacological models of increased GLP- 1 levels. 
Such increase was associated with increased insulin re-
ceptor phosphorylation (Tyr1163) and expression of an-
giogenic and vasoactive factors (VEGF, HIF- 2alpha and 
eNOS).
Conclusions: Lower AT GLO- 1 is correlated with insulin re-
sistance and may be a target of GLP- 1 in order to improve AT 
capillarization and insulin sensitivity, which may be a prom-
ising therapeutic approach to prevent metabolic dysregula-
tion in obesity and type 2 diabetes.
S4- O2 | Steatosis in hepatocytes impairs 
endothelial cell function by promoting lipid 
accumulation and oxidative stress in a manner 
depending on the grade of hepatic steatosis
Francesca Baldini1; Mohamad Khalil1; Nadia Serale1; Adriana 
Voci1; Piero Portincasa2; Laura Vergani1
1Department of Earth, Environment and Life Sciences, University of 
Genoa, Genova, Italy;  2Departmetn of Biomedical Sciences and Human 
Oncology, Medical School, University of Bari, Bari, Italy
Background: Non- alcoholic fatty liver disease (NAFLD) 
is correlated with endothelium dysfunction, the first step 
in atherosclerosis. Although the hepato- vascular crosstalk 
with ongoing steatosis is a distinct feature of atherogenesis, 
the underlying mechanisms are still unclear. Besides cell- 
cell physical contact, intercellular cross- talk occurs through 
soluble factors. Here, we investigated this kind of commu-
nication in vitro using conditioned medium from steatotic 
hepatocytes (HCM) to trigger cell dysfunction in endothelial 
cells.
Materials and methods: FaO hepatoma cells exposed to 
different steatogenic agents alone or combined (3 h oleate/
palmitate- OP, 72 h fructose- Fru, 24 h TNF- α) mimic the 
progression towards more or less severe steatosis in vitro. 
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After treatments, the different HCM were collected and 
used to treat HECV cells for 24 h. Intracellular TG accu-
mulation, cell viability, apoptosis, H2O2 production, oxi-
dative stress markers, and nitric oxide (NO) release were 
assessed by spectrophotometric/fluorimetric assays and/or 
real- time PCR.
Results: Different combinations of OP, TNF- α, and Fru led 
to distinct grade and features of steatosis in FaO cells. HCM 
from all steatotic hepatocytes caused lipid accumulation in 
HECV cells, with endothelial steatogenesis depending on the 
steatosis grade of hepatocytes. Lipid accumulation in HECV 
cells was modest with Fru- HCM, but greatly increased with 
OP–HCM (+182%), OP/TNF- HCM (+166%), and Fru/OP- 
HCM (+210%), compared to controls. A similar trend was 
observed for H2O2 production, lipid peroxidation and NO 
release, with a worsening of HECV cell viability, apoptosis 
and oxidative stress.
Conclusions: Lipid accumulation in FaO cells results in ex-
tracellular release of soluble factors which promote endothe-
lial cell dysfunction in vitro by altering lipid metabolism and 
oxidative stress pathways of HECV cells. The extent of en-
dothelial dysfunction depends on the grade and features of 
steatosis.
S4- O3 | Deficiency of paraoxonase- 1 exacerbates 
high- fat diet- induced glucose intolerance in mice
Maria João Meneses1,2; Inês Sousa-Lima1; Diego O. Borges1,3; Rita 
S. Patarrão1,2; João F. Raposo1,4; M. Paula Macedo1,4,5
1CEDOC, Chronic Diseases Research Centre, NOVA Medical 
School|Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 
Lisboa, Portugal;  2ProRegeM PhD Programme, NOVA Medical School/
Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, 
Portugal;  3Instituto Gulbenkian de Ciência, Oeiras, Portugal;  4APDP 
Diabetes Portugal, Education and Research Center (APDP-ERC), Lisboa, 
Portugal;  5Department of Medical Sciences, Universidade de Aveiro, 
Aveiro, Portugal
Background: The prevalence of metabolic disorders such as 
obesity, type 2 diabetes mellitus (T2DM) and non- alcoholic 
fatty liver disease is increasing exponentially. This increase 
strongly correlates with the consumption of saturated fat and 
carbohydrates, which are known to promote a proinflamma-
tory and prooxidant milieu. Paraoxonase- 1 (PON- 1), a liver- 
expressed protein, may counteract these pathophysiological 
states due to its antioxidant properties. In this work, we hy-
pothesize that PON- 1 deletion has a negative impact in diet- 
induced obesity and T2DM.
Material and methods: C57BL6/J, Pon1 heterozygous mice 
were purchased from the Jackson Labs. Heterozygous breed-
ing generated whole- body Pon1 knockout (KO), heterozy-
gous (Het) and wild- type (CTR) littermates, which were 
given ad libitum access to a hypercaloric diet for 12 weeks. 
Mice were monitored for body weight and blood glucose lev-
els. At 18 weeks of age, whole- body homeostasis was deter-
mined through an insulin sensitivity test (ITT) and a glucose 
tolerance test (GTT). Liver sections were stained with hema-
toxylin & eosin and their lipid content was determined.
Results: Body weight gain was unchanged in KO and Het 
mice, when compared with CTR. After 12 weeks of HFat 
feeding, although fasting blood glucose levels and insulin 
sensitivity were unchanged between the groups, KO and 
HET mice were markedly glucose intolerant, as seen by the 
failure of blood glucose levels to decrease after a glucose 
bolus, when compared with their CTR littermates. Western 
blot analysis showed a decrease in hepatic PON- 1 protein 
levels of about 40% in HET mice and a complete deletion 
in KO mice. Liver sections of both KO and HET showed an 
increase in lipid droplets compared to CTR.
Conclusions: The data obtained demonstrates that PON- 1 
deletion selectively affects glucose homeostasis and ectopic 
lipid accumulation in the liver, in a setting of high- fat and 
high- sucrose feeding.
Funding sources: FEDER/COMPETE/FCT- National 
Funds–Portugal (POCI- 01- 0145- FEDER- 007491; PD/
BD/114256/2016; PTDC/BIM- MET/4265/2014; UID/
Multi/04462/2013; LISBOA- 01- 0145- FEDER- 022170).
S4- O4 | Application of LC- MS- based 
metabolomics to identify and validate nutritional 
biomarkers in a cohort of Northern Irish older 
adults
Gonçalo Rosas Da Silva1; Stewart Graham2; Zafer Ugur2; Ali 
Yilmaz2; Frank Kee3; Ian Young3; Jayne Woodside3; Brian Green1
1School of Biological Sciences, Queen's University Belfast, Belfast, UK;  
2Department of Obstetrics and Gynecology, Beaumont Hospital - Royal 
Oak, Royal Oak, USA;  3School of Medicine, Dentistry and Biomedical 
Sciences, Queen's University Belfast, Belfast, UK
Background: Current tools for the assessment of dietary 
intake, such as food frequency questionnaires and food dia-
ries, can be inaccurate. Metabolomics, an “omics” tool which 
measures the levels of exogenous and endogenous metabo-
lites, is being increasingly used in nutrition research to eluci-
date the physiological responses to food consumption.
Material and methods: Serum samples were collected, 
alongside food diaries and detailed lifestyle information, 
from 96 older adults at two separate time points 6 months 
apart. All subjects were enrolled within NIDAS, a dietary 
validation cohort within the NICOLA study. Targeted LC- 
MS metabolomic data were acquired using a Waters TQ- S 
coupled with an Acquity I- Class UPLC, in conjunction with 
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Biocrates Absolute IDQ p180 metabolomic kits. Data was 
processed using METIDQ software, and the integrity of the 
metabolite peaks was verified using MassLynx v4.1. Data 
distribution, correlation analysis (Spearman's rho), and k- 
means clustering were performed using SPSS Statistics 25. 
Multivariate statistical plots (PCA and PLS- DA) and receiver 
operating characteristic (ROC) curves were produced using 
MetaboAnalyst 4.0.
Results: A total of 72 food- metabolite correlations were 
initially found to be statistically significant. After adjusting 
for potential confounding, including age and sex, a total of 
9 significant correlations remained. The strongest correla-
tions were found between the consumption of dairy products 
and specific glycerophospholipids, namely LysoPC aa C20:3 
and C16:1. An established biomarker for dairy intake, PC aa 
C28:1, was validated, but only in male subjects.
Conclusion: LysoPC aa C20:3 and LysoPC aa C16:1 are po-
tential candidates for blood- based biomarkers of dairy con-
sumption, warranting further validation. These metabolites 
should prove to be valuable auxiliary tools for measuring 
consumption of dairy products in nutrition studies.
Funding sources: This project is supported by the European 
Union's Horizon 2020 Framework Programme, under the 
Marie Skłodowska- Curie Grant Agreement n.754507. 
Additional funding was provided by Queen's University 
Belfast and The Atlantic Philanthropies.
S4- O5 | Application of 1H- NMR Metabolomics 
for the discovery of blood plasma biomarkers 
associated with adherence to a Mediterranean 
dietary pattern in a Northern European population
Shirin Macias1; Brian Green1; Jayne Woodside1; Stewart Graham2; 
Ali Yilmaz2
1Queen's University Belfast, Belfast, UK;  2Beaumont Health, Oakland, 
USA
Background: Adherence to healthy dietary patterns is key to 
improve public health. Current methods for assessing adher-
ence to dietary patterns present weaknesses such as lack of 
accuracy and potential for bias. The Mediterranean diet is a 
dietary pattern well known for its benefits in disease preven-
tion. Monitoring adherence to the Mediterranean diet (MD) 
could be improved by discovery of novel dietary biomark-
ers. The goal of the present study was to analyse the plasma 
metabolomic profile of 58 participants from the MEDDINI 
study, an intervention study which monitored adherence to 
MD for up to 12 months.
Methods: Food diaries from 58 participants were scored 
following a 14- point scale MD score and plasma samples 
collected. Participants were classified into two groups 
low and high Mediterranean diet score and plasma sam-
ples were analysed with 1H- Nuclear Magnetic Resonance 
(1H- NMR).
Results: 59 metabolites were identified. Five metabolites 
significantly differed (P < 0.05; q < 0.5) between ‘low’ 
and ‘high’ citric acid, mannose, pyruvic acid, myo- inositol, 
and betaine. Citric acid was the best performing biomarker, 
which was also enhanced by the paired ratio with pyru-
vic acid. Metabolites correlated with the intake of certain 
food types as was the case of citric acid which positively 
correlated fruit, fruit juice and vegetable constituents of 
the diet, and negatively correlated with sweet foods alone. 
Following multivariate analysis, PLS- DA models showed 
these metabolites corresponded to the top five most influ-
ential metabolites.
Conclusion: The present study reports, for the first time, a 
potential association between blood plasma levels of pyruvic 
acid, mannose and myo- inositol with MD and it confirms pre-
vious associations with citric acid and betaine. Furthermore it 
demonstrates the potential of 1H- NMR based metabolomics 
to be an effective tool in measuring adherence to MD and 
in the discovery of novel dietary biomarkers associated to 
healthy dietary patterns.
S4- O6 | The scope of liver mitochondrial 
hydrogen sulfide oxidation: From nutritional 
physiology to Non- Alcoholic Fatty Liver pathology
Inês Mateus; Véronique Lenoir; Frédéric Bouillaud; Carina 
Prip-Buus
Institut Cochin, INSERM U1016, CNRS UMR8104, Université Paris 
Descartes, 75014 Paris, France
Background and aims: Non- alcoholic fatty liver disease 
(NAFLD) encompasses all liver lesions from isolated stea-
tosis to non- alcoholic steatohepatitis (NASH) - the events 
behind this progression being poorly understood. Recently, 
the hepatic content and biosynthesis of the third mammalian 
gasotransmitter hydrogen sulfide (H2S) were found dimin-
ished in animal models of NAFLD, with the in vivo supple-
mentation of H2S donors preventing the further escalation 
into NASH. A strong inhibitor of mitochondrial complex IV 
when highly concentrated, H2S is oxidized by a mitochon-
drial sulfide quinone reductase, serving as electron donor to 
the mitochondrial electron transport chain. This study as-
sessed whether liver mitochondrial H2S oxidation, which 
modulates H2S content, is regulated i) under different nutri-
tional situations and ii) during NAFLD development, issues 
that presently remain unknown.
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Methods: Liver mitochondria were isolated from fed, 24 h- 
fasted and refed C57Bl6/J mice, and from mice fed a high fat- 
high sucrose (HFHS) diet to induce NAFLD. Mitochondrial 
respiration and H2S oxidation were measured using oxygra-
phy methods (OROBOROS Instruments).
Results: Liver mitochondria from 24- fasted animals pre-
sented a decrease in H2S oxidation (25.64 ± 2.43 pmolO2/s.
mL) when compared to fed mice (62.48 ± 7.23 pmolO2/s.
mL). Overnight refeeding after fasting restored mitochon-
dria's ability to oxidize H2S. Regarding NAFLD develop-
ment, mice 10 weeks- fed a HFHS diet, which led to increased 
body weight and adiposity, glucose intolerance but normal in-
sulin sensitivity, exhibited unchanged liver mitochondrial ca-
pacity for H2S oxidation. However, after 20 weeks of HFHS 
diet, with an insulin resistant phenotype, liver mitochondrial 
H2S oxidation was decreased (54.79 ± 5.35 pmolO2/s.mL) 
when compared to controls (72.46 ± 7.02 pmolO2/s.mL). 
Importantly, the decrease observed both in fasted and HFHS- 
fed mice occurred without any impairment of mitochondrial 
respiration.
Conclusions: In murine liver, mitochondrial capacity to 
oxidize H2S is under nutritional regulation and is impaired 
during NAFLD development. Whether these changes can 
also affect H2S function as a gasotransmitter is still to be 
investigated.
Funding: Early Stage Researcher at ETN “FOIE GRAS” 
Project funded by H2020- MSCA grant N°722619.
S4- O7 | A pilot- study on lifestyle modifications 
in patients with fatty liver disease living in 
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Background: The Mediterranean Diet has beneficial ef-
fects on several metabolic disorders, including non- alcoholic 
fatty liver disease (NAFLD), while improving the overall 
cardiovascular profile. We aimed to assess lifestyle habits 
in NAFLD adults and young healthy subjects in a real- life 
Apulian scenario.
Materials and methods: NAFLD patients (n = 50, 
M:F = 32:18; age 46 ± 1.7 yrs; BMI 31.5 ± 0.9 kg/m²) 
were gender- matched young with healthy controls (n = 50, 
M:F = 25:25; age 28 ± 1.3 yrs; BMI 22.4 ± 0.5 kg/m²). By 
ultrasonography (Noblus Hitachi, Japan), we assessed liver 
steatosis (grade 0- 3) and visceral fat (VF, mm). Mediterranean 
Diet adherence (MDA) and physical activity (PA) were re-
ported by validated questionnaires. Controls and 18 NAFLD 
patients were re- assessed after 3 months of follow- up.
Results: Patients had more VAT and liver steatosis 
(+20.6 mm and + 1.6, P < 0.0001 for both) and were less 
active (- 311METs/week, P < 0.001) than controls. MDA did 
not differ between groups and after three months (score 9/18 
and 10/18; score 11/18 and 10/18, respectively for patients 
and controls). Patients were grouped according to weight loss 
(WL, n = 7) or unchanged/gained weight (UGW, n = 11) 
on follow- up. Weight change was - 5.0 ± 1.6 kg (WL) 
and + 1.3 ± 0.4 kg (UGW); BMI change was - 5.1 ± 1.6% 
(WL) and + 5.5 ± 4.1% (UGW) (P = 0.0005, P = 0.001, re-
spectively). By contrast, median PA change was + 450METs/
week (WL) and - 180METs/week (UGW), P = 0.06. Patients 
reaching recommended PA levels (≤900METs/week) 
were 57.1% and 1.0% in WL and UGW (P = 0.047). VAT 
change was - 16.3 ± 5.3% (WL) and + 2.7 ± 0.8% (UGW), 
P = 0.00041. Patients achieving a sufficient MDA (score 
10/18) were 57% (WL) and 54% (UGW), P=NS.
Conclusions : This exploratory study reveals that overweight- 
obese NAFLD patients exhibit poor compliance towards 
healthy lifestyle education. Even in a typical Mediterranean 
area, MDA remains low in both healthy and metabolically 
ill subjects, irrespective of recommended lifestyle changes 
(Molina- Molina et al. 2018).
Funding source: EMM, HS and GDB are recipients of 
FOIE GRAS Training Grant, a MSCA- H2020 ETN, number 
722619.
S4- O8 | Ghrelin is a protective factor against 
TNF- alpha- induced human hepatocyte cell death 
by apoptosis, pyroptosis and autophagy: Role in 
obesity–associated NAFLD
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Background: Circulating concentrations of TNF- α, a pro-
inflammatory cytokine that promotes hepatocyte cell death, 
are increased in human obesity. Our aim was to evaluate the 
potential beneficial effects of ghrelin isoforms in the progres-
sion of nonalcoholic fatty liver disease (NAFLD) to nonalco-
holic steatohepatitis in obesity by inhibiting TNF- α- induced 
hepatocyte cell death.
Material and methods: Plasma acylated and desacyl ghrelin 
as well as TNF- α were measured in 158 patients, and hepato-
cyte cell death was determined in liver biopsies from 76 pa-
tients with morbid obesity undergoing bariatric surgery with 
available liver echography and pathology analysis. The effect 
of ghrelin isoforms on basal and TNF- α- induced apoptosis, 
autophagic cell death, and pyroptosis was analysed in vitro in 
human HepG2 hepatocytes.
Results: Obese patients with NAFLD exhibited high plasma 
TNF- α and the acylated/desacyl ghrelin ratio, whereas desa-
cyl ghrelin levels were diminished. Six months after bariatric 
surgery, decreased acylated/desacyl ghrelin ratio and improved 
hepatic function were observed. Obese patients with type 2 dia-
betes showed higher hepatic ghrelin O- acyltransferase mRNA 
as well as exacerbated hepatic apoptosis, pyroptosis, and de-
fective autophagy. The stimulation with acylated and desacyl 
ghrelin in HepG2 cells inhibited TNF- α- induced apoptosis, 
evidenced by lower cleaved caspase- 8 and - 3 and TUNEL- 
positive cells, as well as pyroptosis, evidenced by a diminished 
caspase- 1 activation and high- mobility group box 1 (HGMB1) 
expression. Moreover, acylated ghrelin suppressed TNF- 
α- activated hepatocyte autophagy, revealed by a decreased 
LC3B- II/I ratio and higher p62 protein via AMPK/mTOR.
Conclusions: Ghrelin is a protective factor against hepato-
cyte cell death. The increased acylated/desacyl ghrelin levels 
in obese patients with NAFLD might represent a compen-
satory mechanism to overcome TNF- α- induced hepatocyte 
apoptosis, autophagy, and pyroptosis.
Funding sources: This work was supported by FIS- FEDER 
(PI16/00221 and PI16/01217) from the Instituto de Salud 
Carlos III and MINECO- FEDER (BFU- 2015- 70454- REDT 
and BFU2016- 76711- R). CIBEROBN is an initiative of the 
Instituto de Salud Carlos III, Spain.
S4- O9 | Ultrasound evaluation in early 
atherosclerosis: How and when?
Bogdan Augustin Chis1; Ana Florica Chis2; Michael Pelea1; 
Daniela Fodor1; Dan Dumitrascu1
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Background: Metabolic syndrome is one of the lead-
ing causes of morbidity worldwide. Early evaluation of 
its complications is mandatory in treatment management. 
Atherosclerosis is the first cause of ischemic vascular dis-
ease. The aim of the study was to determine the best method 
for ultrasound evaluation of carotid intima thickness in elders 
vs young people.
Material and methods: 27 patients (60.5 ± 12.8 years 
old) with early stages of metabolic syndrome hyperten-
sion or obesity, or metabolic parameters disorders were in-
cluded. Ultrasound evaluations of intima media thickness 
for common carotid artery (CCA), internal (ICA) and ex-
ternal carotid arteries (ECA) were performed using a linear 
7- 12 MHz transducer (G.E. Logiq S7 ultrasound equip-
ment). A cut point of 60 years old was used. Pearson corre-
lation and Fisher r to z transformation tests were computed.
Results: On admittance, mean systolic blood pressure was 
138,3 ± 23,8 mmHg, body mass index 28,5 ± 4,6 kg/sqm, 
abdominal circumference 94,3 ± 12,4 cm, basal glycemia 
108,8 ± 36,4 mg/dL, total cholesterol 195,1 ± 50,8 mg/dL. 
Age was correlated with IMT for CCA, with stronger correla-
tion coefficients in patients over 60 y.o (P = 0.01 and < 0.01 
for right and left CCA, respectively). In patients under 60 
y.o., ICA and ECA IMT was better correlated with age and 
blood pressure, while cholesterol levels positively correlated 
with age (P < 0.01). Basal glycemia correlated with mean 
blood pressure (P = 0.045) in younger group and with left 
CCA (P = 0.022) and ECA IMT (P = 0.045)
Conclusions: Early stages of atherosclerosis in young patients 
are better correlated with age and metabolic syndrome param-
eters in smaller arteries, as ICA and ECA, while CCA is suit-
able in elders (with stronger correlations with basal glycemia).
S4- O10 | The serum metabolic profile and 
lung function in a cohort of chronic obstructive 
pulmonary disease patients 
Ana Florica Chiş; Carmen Monica Pop
Department Of Pneumology, “Iuliu Haţieganu” University Of Medicine 
And Pharmacy Cluj- Napoca, Cluj- Napoca, România
Background: Chronic obstructive pulmonary disease 
(COPD) represents a subject of great interest, already plac-
ing itself in top 3 causes of death worldwide. Frequently, in 
COPD patients, metabolic processes suffer alteration, but 
the exact nature of this link remains unclear. The aim of our 
study was to investigate the serum metabolic profile and the 
possible relation with lung function in a group of COPD pa-
tients without major comorbidities.
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Material and methods: The research included 60 COPD pa-
tients (66,3 ± 9,3 years old), with 47 (78,33%) active or ex- 
smokers and 13 (21,66%) never smokers, with exposure to 
biomass smoke. The diagnosis of COPD was based on 2017 
Global Initiative for Obstructive Lung Disease (GOLD) 
guideline. The Body Mass Index (BMI) was calculated. 
Basal serum glucose, triglyceride and cholesterol levels were 
determined. According to post- bronchodilation spiromet-
ric parameters (Forced Expiratory Volume in 1st second – 
FEV1s), the patients were divided into 3 groups mild (Group 
I), moderate (Group II), severe COPD (Group III).
Results: Group I included 19 patients(31,6%), Group II - 
28(46,6%), Group III - 13(21,6%). A number of 45 patients 
(75%) were defined as overweight and obese, with differ-
ences between COPD stage (mild versus moderate and 
severe, 52.6% versus 39.02%). In Group I, the glucose, tri-
glycerides and cholesterol levels were 134.8 ± 73.7 mg/dl, 
174.8 ± 81.8 mg/dl, and 201,5 ± 51,5 mg/dl respectively. 
Group II had a mean level of glucose of 102.7 ± 17 mg/
dl, triglycerides = 123.7 ± 83.8 mg/dl, and choles-
terol = 190.1 ± 41 mg/dl. In group III, the mean levels of 
glucose, triglycerides and cholesterol were 111.9 ± 16,4 mg/
dl, 103.3 ± 39.5 mg/dl and 178.6 ± 40.7 mg/dl. There was 
a significant difference between groups in terms of triglyc-
erides and glucose level (P = 0.023 and 0.054), but not for 
cholesterol levels (P = 0.3).
Conclusions: Our findings suggest that in COPD patients 
without major comorbidities, the serum levels of triglycerides 
and glucose decrease with the severity of airway obstruction.
S4- O11 | The beneficial effects of a novel 
formulation of Bifidobacterium longum BB536 and 
Lactobacillus rhamnosus HN001 with B6 vitamin 
on gut microbiota and intestinal permeability in 
IBS patients
Leonilde Bonfrate1; Domenica Maria Di Palo2; Giuseppe Celano2; 
Adelin Albert3; Maria De Angelis2; Marco Gobbetti4; Emilio 
Molina-Molina1; Piero Portincasa1
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Background: Irritable bowel syndrome (IBS) is a common 
gastrointestinal disorder, which still lacks effective therapy. 
We aimed to investigate the effects of a novel formulation 
of B. longum BB536 and L. rhamnosus HN001 with vitamin 
B6 on symptoms, intestinal permeability, and microbiota in 
IBS subjects.
Material and methods: Twenty- five IBS patients (Rome IV 
criteria) (M:F = 8:17; age 48 yrs ± 11 SD) were enrolled and 
randomized to treatment (LBB) or placebo in a crossover ran-
domized double- blind controlled trial. Symptoms, intestinal 
habits, severity of disease, intestinal permeability, intestinal 
microbiota were performed at the different time points.
Results: LBB significantly decreased abdominal pain, bloat-
ing and severity of disease more than placebo (30 mm ± 23 vs. 
58 ± 23; 36 mm ± 25 vs. 65 mm ± 22; 181 ± 53 vs. 259 ± 54, 
P < 0.0001). Bristol score in IBS- C patients and in IBS- D 
patients differed significantly between Placebo and LBB 
(2.1 ± 0.3 vs. 3.2 ± 0.5, 5.3 ± 1.1 vs. 4.3 ± 1, P < 0.001). 
LBB significantly improved the percentage of sucralose re-
covery (colonic permeability) (1.86 ± 0.1 vs. 1.1 ± 0.2, 
P = 0.01). Treatment drove the increases of presumptive lactic 
acid bacteria and Bifidobacteria. After treatment the relative 
abundance of propanoic, butanoic, and pentanoic acids and 
hydrocarbons increased, while phenol decreased.
Conclusions: The novel formulation of Bifidobacterium 
Longum BB536 and Lactobacillus Rhamnosus HN001 with 
B6 vitamin improves symptoms and severity of disease, re-
stores intestinal permeability, and gut microbiota in IBS pa-
tients. ClinicalTrials.gov n° NCT03815617
S4- O12 | 16p11.2 microdeletion: The most 
common chromosomal anomaly associated with 
obesity
Joana Rosmaninho-salgado1; Luis Miguel Pires3; Isabel M. 
Carreira2,3,4; Joana Barbosa Melo2,3,4; Pedro Louro7; Joaquim Sá1; 
Maria Margarida Venâncio1; Pedro Almeida1; Sara Ribeiro1; Jorge 
M Saraiva1,5; Sérgio B. Sousa1,6
1Serviço de Genética Médica, Hospital Pediátrico, CHUC, Coimbra, 
Portugal;  2iCBR- CIMAGO - Centro de Investigação em Meio 
Ambiente, Genética e Oncobiologia, Faculdade de Medicina da 
Universidade de Coimbra, coimbra, Portugal;  3Laboratório de 
Citogenética e Genómica, Faculdade de Medicina da Universidade de 
Coimbra, Coimbra, Portugal;  4CNC- IBILI, Universidade de Coimbra, 
Coimbra, Portugal;  5Clinica Universitária de Pediatria, Faculdade de 
Medicina da Universidade de Coimbra, Coimbra, Portugal;  6Instituto 
de Genética Médica, Faculdade de Medicina da Universidade de 
Coimbra, Coimbra, Portugal;  7Instituto Português Oncologia Lisboa, 
Lisboa, Portugal
Background: The presence of a large number of flank-
ing segmental duplications/low- copy repeat sequences 
with a high degree of sequence identity in the short arm 
of chromosome 16 (16p) leads to recurrent deletions and 
duplications as a consequence of non- allelic homolo-
gous recombination. A recurrent 600 kb microdeletion is 
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one of the most frequent genomic imbalances in 16p11.2 
(~600 kb) associated with abnormal phenotypes including 
neurodevelopmental disorders, autism spectrum disorder 
(ASD) and obesity. The 16p11.2 microdeletion (OMIM 
ID:611913; ORPHA:261211) is one of the major causes of 
syndromic obesity.
Material and methods: it was performed a retrospective 
analysis of patient medical records of 33 patients with 16p11.2 
rearrangements (deletion/duplication) obtained by Agilent 
180K oligonucleotide array- comparative genomic hybridiza-
tion (array- CGC) and/or multiplex ligation- dependent probe 
amplification (MLPA). The study was performed at Pediatrics 
Hospital of Coimbra during the period of 2010- 2017
Results: From a total of 33 patients, 26 (78.7 %) showed 
a deletion in the classical region of 16p11.2 (29,562- 
30,192 bp). Although the phenotype of individuals with 
the deletion can be variable, all patients showed at least 
one clinical finding typical of 16p11.2 deletion cognitive 
impairment, language delay, autism or obesity. Other fea-
tures less frequent include neurological issues (epilepsy, 
neuroimaging findings), behavioral problems, cardiac mal-
formations, cardiac malformations, vertebral anomalies, 
macrocephaly, hearing loss.
Conclusion: Although the phenotype of 16p11.2 microde-
letion syndrome shows a high variability, it represents the 
second most frequent genetic cause of obesity. The obesity ob-
served in this population may be explained by the haploinsuf-
ficiency of one or more of the 30 genes present in this region. 
On the other hand, it is known that individuals with intellectual 
disability or autism have a higher predisposition for obesity, 
possibly due to the involvement of one or more pathways.
S4- O13 | NAFLD Awareness amongst T2DM 
patients – A qualitative case study at the Portuguese 
Diabetic Association (APDP)
Mireia Alemany-Pagès1; Sara Araújo3; Mariana Moura-Ramos4,5; 
Francisco Freitas3; Rogério T Ribeiro6; Dulce do Ó6; Maria Paula 
Macedo6; João Ramalho-Santos1,2; Anabela Marisa Azul1,7
1CNC, Center For Neuroscience And Cell Biology, Coimbra, Portugal;  
2Department of Life Sciences, University of Coimbra, Coimbra, 
Portugal;  3CES, Centre for Social Studies, University of Coimbra, 
Coimbra, Portugal;  4Centro Hospitalar e Universitário de Coimbra, 
Reproductive Medicine Unit, Coimbra, Portugal;  5Center for Research 
in Neuropsychology and Cognitive Behavioral Intervention University of 
Coimbra, Coimbra, Portugal;  6APDP, Portuguese Diabetic Association, 
Lisbon, Portugal;  7IIIUC, Institute for Interdisciplinary Research, 
University of Coimbra, Coimbra, Portugal
The metabolic form of Non- Alcoholic Fatty Liver Disease 
(NAFLD) stems from a state of hepatic and peripheral insulin 
resistance resulting from a disruption of energy homeostasis 
brought about by an excessive energy intake not paired by 
energy expenditure. Hypercaloric diets and sedentary life-
styles drive this and other metabolic diseases and constitute 
a major threat to public health. Indeed, NAFLD is consid-
ered the hepatic manifestation of Metabolic Syndrome and 
affecting 1 in 4 adults worldwide is of particular concern in 
cases of obesity and Type 2 Diabetes Mellitus (T2DM), were 
the prevalence reaches 90 and 70% respectively. Research on 
NAFLD awareness is scarce but clear not only the general 
population, but also high- metabolic risk patients and even 
primary care practitioners have low NAFLD awareness. To 
our knowledge, this is the first qualitative study on NAFLD 
awareness amongst T2DM patients. The data was collected 
via face- to- face semi- structured interviews on a purposive 
sample of T2DM patients receiving care at the Portuguese 
Diabetes Association (APDP) in Lisbon between October 
and December 2018. Interviews were audiotaped, transcribed 
verbatim and analyzed with MAXQDA2018 software pack-
age. Four main emerging themes were identified (N = 30). 
Fatty liver awareness, Fatty liver and T2DM, Cirrhosis, and 
Valorization and engagement in NAFLD treatment and pre-
vention. 50% of the sample was NAFLD aware and a 30% had 
a prior or current history of NAFLD. Some patients relate the 
liver to T2DM pathophysiology, but metabolic knowledge is 
lacking. Alcoholic cirrhosis, but also non- alcoholic cirrhosis 
awareness was prevalent, but knowledge on the progressive 
nature of fatty liver into cirrhosis was less spread. A higher 
awareness on mechanisms and progression of NAFLD could 
result in engagement on primary and secondary prevention 
strategies.
Funding: Foie Gras Project (European Union's Framework 
Program for Research and Innovation Horizon 2020 
under the Marie- Sklodowska Curie Grant Agreement No. 
722619).
S4- O14 | MC4R deficiency in a Portuguese 
pediatric cohort study
Joana Rosmaninho-salgado1; Janet Pereira2; Alice Mirante3; Ana 
Raquel Soares4; Sérgio B. Sousa1
1Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e 
Universitário de Coimbra, Coimbra, Coimbra, Portugal;  2Department 
of Hematology, Centro Hospitalar e Universitário de Coimbra CHUC, 
coimbra, Portugal;  3Department of Paediatric Endocrinology, Diabetes 
and Growth, Hospital Pediátrico de Coimbra, Coimbra, Portugal;  
4Pediatric outpatient clinic, Hospital Pediátrico, Centro Hospitalar e 
Universitário de Coimbra, Coimbra, Portugal
Background: Melanocortin 4 receptor (MC4R) deficiency is 
the commonest monogenic form of non- syndromic obesity. 
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MC4R is a seven transmembrane G- protein coupled receptor 
implicated in central regulation of body weight. The loss- of- 
function mutations in MC4R gene will contribute to early- 
onset obesity associated with hyperinsulinemia, hyperphagia 
and “binge eating”. We aim to determine the prevalence of 
MC4R variants in a Pediatrics Portuguese cohort with obe-
sity. We present our preliminary results and the clinical de-
scription of the first identified case.
Material and methods: Patients with obesity onset before 
10 years and BMI > 95th centile observed at Pediatrics 
Hospital of Coimbra, were screened for MC4R variants by 
Sanger sequencing after PCR amplification. Molecular and 
clinical characterization was performed in cases with identi-
fied MC4R variants.
Results: A total of 55 patients (mean age was 11 years, 
32 boys) were included in the study. Mean age of obe-
sity onset was 2Y4mo. It was identified 2 benign variants 
and in one boy (1/55, 1.8%) a pathogenic heterozygous 
MC4R variant inherited from the mother c.631_634del (P.
Leu211Metfs*6). This patient is a 12 years- old boy with 
a BMI z- score of 2.1 (98th centile), height was on 75- 
90th centile, with onset obesity at 20 months and a binge- 
eating behavior. No specific dysmorphisms are reported. 
Mother with a BMI of 23.2 Kg/m2 had 2 previous bariatric 
surgeries.
Conclusions: Our results point out that MC4R deficiency is 
underdiagnosed in the Portuguese population. The absence of 
distinctive phenotypic features reinforce the need of screen-
ing large cohorts with broad inclusion criteria. This diagnosis 
will contribute to the follow- up of identified cases, an early 
diagnosis in other family members and the prospective of 
using the specific therapies that are under development, par-
tial agonists of the MC4R.
S5- O1 | Evolving meaning: Using genetic 
Programming to learn similarity perspectives for 
mining biomedical data
Rita Sousa; Sara Silva; Catia Pesquita
LASIGE, Faculdade de Ciências da Universidade de Lisboa, Lisboa, 
Portugal
Background: In recent years, biomedical ontologies have 
become important for describing the existing biological 
knowledge. Approaches that combine ontologies with data 
mining have been proposed, but they are based on vector rep-
resentations that do not capture the full underlying semantics. 
To overcome this, semantic similarity (SS) can be used by 
learning algorithms to compare ontology annotated biologi-
cal entities. However, since ontologies can model multiple 
perspectives, SS computations for a given learning task need 
to be fine- tuned to account for this. This task is usually man-
ual, since obtaining the best combination of SS aspects for 
each learning task is not trivial.
Material and methods: We use Genetic Programming (GP) 
over a set of SS kernels, each describing a semantic aspect 
of the data, to obtain the best kernel combination for a given 
classification task. The methodology includes three sequen-
tial steps compute the SS for each semantic aspect; learn the 
best combination of those aspects using GP; integrate the best 
combination with a classification algorithm. We have evalu-
ated the proposed methodology on several benchmark data-
sets for instance classification and protein- protein interaction 
prediction.
Results: The quality of the classifications is evaluated using 
the weighted average F- measure for each dataset. As a base-
line, we employed a variation of the proposed methodology 
that disregards the different semantic aspects. The results 
show that the quality of the classifications is improved when 
considering the best combination learnt by GP instead of sin-
gle semantic aspects. The results improve over state- of- the- 
art structural semantic representations.
Conclusions: This work proposes a novel methodology to 
improve the exploration of SS by machine learning algo-
rithms that uses GP to learn a suitable combination of seman-
tic perspectives for a specific learning task. The methodology 
is particularly important for biomedical applications where 
data is often complex and multi- domain.
Funding sources: FCT, PTDC/EEI- ESS/4633/2014, PTDC/
CCI- INF/29168/2017, UID/CEC/00408/2019.
S5- O2 | Automatic instance- edge detection 
network (AID- Net) - vertebral edge detection by 
deep learning
Richard Yan Chak Li1; Nick Jing Wei Chin1; Yi Xiang Wang2,3; 
Richard; Hau Yue So1
1The Hong Kong University Of Science And Technology, Clear Water 
Bay, Hong Kong;  2The Chinese University of Hong Kong, Shatin, Hong 
Kong;  3Prince of Wales Hospital, Shatin, Hong Kong
Background: Osteoporosis is the most prevalent metabolic 
bone disease and vertebral fracture is the most typical sign of 
osteoporosis. Most of the clinical diagnosis were carried out 
manually on X- ray images. Under- diagnosis has been reported 
due to heavy workload and arbitration in subjective assessments 
of anterior, middle and posterior vertebrae heights, similarity of 
adjacent vertebrae, and end- plate disruption, etc. Consequently, 
an automatic and objective shape measurement of vertebrae is 
needed to improve clinical diagnosis of vertebral fracture.
Material and methods: We propose a novel framework, 
Automatic Instance- edge Detection Network (AID- Net) to 
84 |   ABSTRACTS
perform instance edge detection of vertebral bodies on X- ray 
images automatically using Mask R- CNN. With a training to 
validating ratio of 3:1, 120 thoracic + 120 lumber vertebral 
X- ray images with edge annotation provided by medical pro-
fessionals were processed. Differ from the typical regional- 
of- interest based segmentation task, Holistically- nested Edge 
Detection and state- of- the- art supervised edge detection were 
employed.
Results: The accuracy of the edge detection network is 
evaluated to have a dice coefficient of more than 0.7, which 
is as accurate as state- of- the- art of edge detection network 
on other anatomy. Also, our framework can perform verte-
bral edge detection fully automatically, without any human 
interaction.
Conclusion: Our proposed algorithm is the first instance 
edge detection method of vertebrae on X- ray images achiev-
ing more than 0.7 dice coefficient. How to integrate the al-
gorithms to the current vertebral disease diagnosis procedure 
will be discussed.
Funding sources: Hong Kong Research Grants Council via 
GRF16200915
S5- O3 | Data mining applied to the varicocele 
condition
Judith Santos Pereira1; Ana Paula Sousa2; João Ramalho-Santos3; 
Jorge Bernardino4
1ISEC, Polytechnic Institute of Coimbra, Coimbra, Portugal;  2Biology 
of Reproduction & Stem Cell Group, Center for Neuroscience and Cell 
Biology, University of Coimbra, Reproductive Medicine Unit, Centro 
Hospitalar e Universitário de Coimbra, Coimbra, Portugal;  3Biology 
of Reproduction & Stem Cell Group, Center for Neuroscience and 
Cell Biology, University of Coimbra, Department of Life Sciences, 
University of Coimbra, Coimbra, Portugal;  4ISEC, Polytechnic 
Institute of Coimbra, CISUC, University of Coimbra, Coimbra, 
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Background: Varicocele is manifested by an abnormal 
dilation of the veins within the scrotum. Its prevalence is 
related to 40% of the males treated for infertility where 
male factors encompass 50% of infertility causes. Its cor-
rection can be achieved with the radiological embolization 
technique that introduces substances into the circulation to 
devitalize the enlarged veins. The aim of this study was to 
identify data patterns on patient's data that have undergone 
varicocele embolization with Data Mining since, to the 
best of our knowledge, this advanced data analysis tech-
nique has not been yet applied upon this highly prevalent 
condition.
Materials and methods: Data analysis was carried out upon 
a preprocessed data set of 293 men from infertile couples 
described using 64 features that have undergone varicocele 
embolization between January 2007 and April 2016. Data 
mining was achieved by following the CRISP- DM methodol-
ogy with the application of the most commonly applied Data 
Mining algorithms (i.e. C4.5, K- Means and FP- Growth).
Results: The K- Means algorithm was the most effective with 
the following features, where statistical significance between 
the computed centroid values were with the ANOVA test cal-
culated male patient´s age (P = 0.778); normality of the sperm 
concentration 3 months after the treatment (P < 0.001); nor-
mality of the sperm progressive motility before (P < 0.001) 
and 3 months after the treatment (P = 0.011); varicocele se-
verity grade (P < 0.001); presumed occupational exposure 
(P = 0.007) and pregnancy outcome (P = 0.030). The result-
ant data set was of 85 couples partitioned into 4 clusters with 
the Manhattan distance.
Conclusions: This clinical investigation enlightened the pos-
sibility that infertile male patients with a high varicocele se-
verity grade rarely conceive and that the frequency of patients 
with normal sperm concentrations 3 months after the vari-
cocele embolization is much higher in clusters where fewer 
male patients work in putative hazardous environments.
S5- O4 | Rational design of enzymes for 
biopolymer synthesis 
Alexandra Teresa Pires Carvalho; Beatriz Columbano Almeida; 
Pedro Figueiredo
CNC – Center for Neuroscience and Cell Biology, Institute for 
Interdisciplinary Research IIIUC University of Coimbra 3004- 504, 
Coimbra, Portugal, Cantanhede, Portugal
Biodegradable polymers are currently employed in a wide 
range of biomedical applications. There are usually obtained 
via chemical synthesis, however enzymatic polymerization 
is an attractive alternative because it is more sustainable 
and safer since enzymes operate under mild conditions, 
are non- toxic and can display high selectivity. In this work 
we tested esterase enzymes and different monomers for 
tailored chemical synthesis to obtain polyesters with the 
desired properties for biomedical applications. These en-
zymes are usually only active on aliphatic polyesters, but a 
few have shown catalytic activity for semi- aromatic poly-
esters. We have conducted Molecular dynamics (MD) and 
Quantum Mechanics/Molecular Mechanics (QM/MM) MD 
simulations of all the possible reactions in the synthesis 
and in the hydrolysis of models of polycaprolactone (PCL) 
and PCL copolymers, using a thermophilic esterase and the 
commonly used lipase from Candida antarctica B (CALB). 
Our results comprise the detailed profiles for the synthe-
sis and hydrolysis of the polymers. Our insights about 
the reaction mechanisms are important for the design of 
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customized enzymes able to synthesize or degrade differ-
ent polyesters.
Funding sources: Fundação para a Ciência e a Tecnologia ex-
ploratory project MIT- Portugal (MIT- EXPL/ISF/0021/2017) 
and grant IF/01272/2015.
S5- O5 | Uncovering hidden patterns in 
biological datasets to identify metabolic alterations 
caused by acute and sub- chronic DOX treatments
Rute Pino1; Teresa Cunha-Oliveira2; Filipa Carvalho2; Rita 
Garcia2; Ana Burgeiro2; Rui A. Carvalho2; Paulo J. Oliveira2; 
Nuno Lourenço1
1CISUC, University Of Coimbra, Coimbra, Portugal;  2CNC, Center for 
Neuroscience and Cell Biology, UC Biotech, Biocant Park, Cantanhede, 
Portugal
Background: Medical breakthroughs nowadays depend al-
most entirely scientific research which relies in elaborating 
numerous hypothesis and running them through a continu-
ous process of trial and error experiments. These processes 
usually generate a large amount of data which is normally 
processed and treated with statistical methods that are consid-
ered out of date and do not live up to the demands imposed by 
the technological advances that demark our era. Doxorubicin 
(DOX) is an anthracycline quinone antibiotics, used for treat-
ing several types of cancer, such as breast cancer, Hodgkin's 
disease and leukemia. Although mitochondrial disruption is 
an early and sensitive marker of DOX cardiotoxicity, how 
metabolic stress contributes to the development of cardio-
myopathy remains unknown.
Methods: To address this problem, an experimental dataset 
was built at the MitoXT laboratory using a model of meta-
bolic inhibition of perfused hearts from saline and DOX- 
treated Wistar rats to identify metabolic alterations caused 
by an acute and sub- chronic DOX treatment. The hearts 
were removed and perfused with three different cardiac 
substrates such as glucose, galactose plus glutamine and 
octanoate plus malate. Separately, glycolytic (iodoacetate) 
and oxidative phosphorylation (rotenone or cyanide) in-
hibitors were added to the distinctive metabolic perfusion 
buffers, aiming to detect undercover mitochondrial defects 
in DOX- treated group. Data from non- perfused hearts and 
perfused time- control hearts, in which no inhibitors or sub-
strate were added, are also available. In this study we ap-
plied techniques and computational tools in order to expose 
hidden patterns in this data, to structure and analyze the 
dataset, including Machine Learning Algorithms, focusing 
on unsupervised methods.
Conclusions: Data from both acute and sub- chronical 
models appears to suggest that the hearts of DOX treated 
animals have improved function in the presence of meta-
bolic inhibitors, indicating that DOX triggers adaptations 
that allow the hearts to be less susceptible to mitochondrial 
inhibition.
Funding: PTDC/BTM- SAL/29297/2017, POCI- 01- 0145- 
FEDER- 029297.
S5- O6 | Modelling the metabolic heterogeneity 
over the cell division cycle towards metabolic flux 
rate quantification – a 13c- Metabolic Flux Analysis 
approach
Ines Miranda-Santos1; Elmar Heinzle2; Armindo Salvador1
1Center for Neurosciences and Cell Biology/University of Coimbra, 
Coimbra, Portugal;  2Biochemical Engineering/University of Saarland, 
Saarbrücken, Germany
Background: There is increasing evidence of extensive 
metabolic changes over the cell division cycle (CDC), which 
might underlie the metabolic differences between proliferat-
ing and quiescent cells. Metabolism in S- phase, the longest 
in some proliferating cells, is particularly relevant for can-
cer. Seeking to characterize the metabolic flux distribution 
(MFD) of S- phase, we developed a new 13C- tracer methodol-
ogy that avoids the pitfalls of CDC synchronization and cell- 
sorting. It is based on the analysis of the isotopic distribution 
of building- blocks of DNA and RNA. Its application to non- 
synchronous Saccharomyces cerevisiae cultures as a proof- 
of- principle revealed, qualitatively, that the MFD of S phase 
differs from that of the other phases. Towards a quantitative 
analysis, we developed a 13C- MFA model of the intermedi-
ary metabolism of a proliferating cell culture allowing for 
metabolic heterogeneity over the CDC.
Material and methods: We made a customized genome- 
wide intermediary- metabolic network reconstruction, 
tailored and simplified it according to experimental and 
literature data. Namely, nucleosides’ 13C- isotopic distri-
bution, balance rates and biomass composition. We con-
strained and parametrized the cell model according to 
thermodynamics and the collected data. We implemented 
it in 13CFlux2 to perform forward simulations and flux 
estimations.
Results: The model accounts for two sub- populations of 
cells, S- phase and non- S- phase, and includes glucose input, 
pentose- phosphate- pathway, TCA- cycle, glyoxylate- cycle, 
purine and pyrimidine biosynthesis, carbohydrate storage/
recruitment, ethanol and acetate secretion/uptake, recruit-
ment of biosynthetic precursors. In S- phase- cell, purine and 
pyrimidine biosynthesis are parametrized according to the 
fractional biomass content of DNA and all other biosynthetic 
reactions are constrained to zero; in non- S- phase- cell purine 
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and pyrimidine biosynthesis are parametrized according to 
the biomass fractional content of RNA and all other biosyn-
thetic reactions are constrained to their respective fractional 
biomass content.
Conclusions: We successfully performed forward simula-
tions and sensitivity analysis. However, further work is re-
quired to obtain best- fit flux estimates from the experimental 
data.
S6- O1 | PET imaging and in vivo bio- 
distribution of small extracellular vesicles
Arnab Banerjee1; Tiago Rondão1; José Sereno2; Vítor Alves2; 
Miguel Lino1; Andreia Ribeiro1; Antero Abrunhosa2; Lino 
Ferreira
1CNC- Center for Neurosciences and Cell Biology, University of Coimbra, 
Coimbra, Portugal;  2ICNAS – Institute for Nuclear Sciences Applied to 
Health; University of Coimbra, Coimbra, Portugal
Small extracellular vesicles (SEVs) are biological nanopar-
ticles, with sizes between 30 to 200 nm and are secreted by 
most cells. SEVs contain mRNA, miRNA, protein and lipid 
which correspond to source cells. There is an increasing 
interest in using these SEVs for diagnostic purposes and 
also for regenerative medicine applications. Most common 
method for in vivo bio- distribution of SEV is fluorescence 
or luminescence imaging, but it has low sensitivity. Do Won 
Hwang el al radiolabeled SEVs by encapsulating 99mTc- 
HMPAO in the core and used it for SPECT/CT imaging. 
PET imaging has many advantages over SPECT imaging 
even for PET/MR or SPECT/MR images. Here we used 
SEVs from the mononuclear cells of umbilical cord blood 
and radio- labelled it by introducing a metal chelator with 
64Cu2 + on the surface. Our modification did not affect 
the morphology, surface protein and internal RNA content 
of those SEVs. Our modified SEVs were stable ~ 94% sta-
bility in plasma and had no toxic effect on its bio- activity 
which we tested in HUVECs survival assay. Finally, we 
successfully imaged SEVs in C57BL/6J mice after inject-
ing our radio labeled SEVs intravenously and measure the 
bio- distribution of it in different organs. The highest accu-
mulation of these SEVs was observed in the liver (25- 30%) 
and the lowest in the brain (~0.4- 0.5%). Our strategy will 
be very useful in the biomedical research to understand the 
role of SEV. This strategy can easily translate into the clin-
ical research for developing new diagnostic and therapeutic 
tools for cancer, myocardial infarction and stroke etc. The 
authors would like to thank the financial support of Project 
TRoMBONE grant number 748583 under the Horizon 
2020 program of European commission, “StrokeTherapy” 
co- promoted by Stemlab, Rovisco Pais and Universidade 
de Coimbra, POCI- 01 - 0247- FEDER- 003386) and EC pro-
ject ERAatUC (Ref:669088). 
S6- O2 | CRISPR interference- mediated 
silencing of mutant ATXN3 decreases motor 
impairments of an in vivo Machado- Joseph disease 
model
Carlos Matos1,2; Frederico Pena1; André Conceição1; Sara 
Lopes1,3; Sónia Duarte1; Catarina Miranda; Luís Pereira de 
Almeida1,4
1Center for Neuroscience and Cell Biology - CNC, Coimbra, Portugal;  
2Centre for Biomedical Research - CBMR, Faro, Portugal;  3Institute for 
Interdisciplinary Research, University of Coimbra, Coimbra, Portugal;  
4Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal
Background: Machado- Joseph disease (MJD) is a hereditary 
neurodegenerative disorder caused by an abnormal expan-
sion of CAG trinucleotides in the codifying a region of the 
ATXN3 gene. When expanded, the gene product - ataxin-
 3 (atxn3) - aggregates and causes cell demise in the nerv-
ous system. MJD remains an incurable disease, but silencing 
ATXN3 is recognized as a promising therapeutic approach, 
considering that previous studies employing RNA interfer-
ence were able to counter disease- related phenotypes in 
animal models of MJD. Reports have however highlighted 
that mRNA transcripts of mutant ATXN3 are toxic as well, 
prompting investigation into pre- transcriptional silencing 
methods. CRISPR systems of gene editing employ nucleases 
– usually the bacterial Cas9 – guided by RNA molecules to 
produce modifications in precise regions of the DNA, but 
CRISPR- Cas9 can also be modified to target other proteins 
to particular genetic loci, including transcriptional inhibitors 
such as the Krüppel- associated box domain (KRAB).
Material and methods: The aim of the current study was 
to develop a silencing strategy that targeted a fusion protein 
composed by inactive Cas9 and KRAB (dCas9- KRAB) to the 
human ATXN3 gene, in order to repress mutant ATXN3 gene 
expression and thereby produce phenotypic amelioration.
Results and conclusion: Results demonstrate that the si-
lencing system selectively reduces the expression of mutant 
ATXN3 in cell cultures. Importantly, in a transgenic MJD 
mouse model, lentiviral delivery of these molecular tools to 
the cerebellum decreases motor incoordination. Our results 
support the potential of CRISPR- based pre- transcriptional 
silencing as a putative approach to MJD treatment.
Funding sources: This work was supported by funds 
FEDER and the Competitive Factors Operational Program 
– COMPETE and by national funds through FCT (PTDC/
NEU- NMC/0084/2014, E- Rare4/0003/2012 and EU Joint 
Programme - Neurodegenerative Disease Research (JPND) 
projects SynSpread, ESMI and ModelPolyQ); by the Richard 
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Chin and Lily Lock MJD Research Fund; and the National 
Ataxia Foundation.
S6- O3 | Orchestrating the release of small 
extracellular vesicles with a light- triggerable 
hydrogel
Helena Henriques-Antunes1; Renato Cardoso1; Alessandra 
Zonari1; Joana Correia1; Ermelindo Leal1; Adrián Jimenez-Balsa1; 
Miguel Lino1; Ana Barradas1; Ivana Kostic1; Célia Gomes2; 
Eugénia Carvalho1; Lino Ferreira1
1Cnc, Coimbra, Portugal;  2Faculdade de Medicina da Universidade de 
Coimbra, Coimbra, Portugal
Wound healing is a complex process that requires the in-
tervention of multiple molecules in an orchestrated man-
ner. The majority of the formulations is designed for the 
controlled release of few molecules (not more than two), 
usually growth factors. In this work, we used small extra-
cellular vesicles (SEVs) that contain a cocktail of biomol-
ecules, namely proteins, mRNAs and microRNAs which are 
powerful modulators of cell activity and play an essential 
role in cell/tissue communication and tissue regeneration. 
We developed a light- responsive hydrogel to control the de-
livery of SEVs isolated from human umbilical cord blood 
mononuclear cells. The hydrogel was prepared by using 
a photocleavable linker to crosslink hyaluronic acid with 
SEVs. The bioactivity of the hydrogel loaded with SEVs 
was tested in vitro and in vivo in a diabetic wound healing 
mouse model. The hydrogel was able to maintain the integ-
rity of SEVs and sustain their topical release at the wound 
bed and consequently improve the wound healing kinetics, 
performing better than topical applications of SEVs (2x/
day) without the hydrogel. Immunofluorescence analysis 
indicate that the regenerative process was characterized 
by enhanced re- epithelization due to the proliferation of 
epidermal keratinocytes expressing keratin 14, and by an 
increase of neovascularization. At the molecular level, the 
wound regeneration was characterized by an alteration in 
the expression of 7 miRNAs in the skin. In particular, miR- 
150- 5p, one of the most abundant in these SEVs, was found 
to mediate the wound healing properties of the vesicles by 
modulating the expression of the MYB gene.
Funding sources: FCT (SFRH/BDE/103512/2014; SFRH/
BPD/112883/2015; SFRH/BPD/97286/2013; MITP- TB/
ECE/0013/2013; EXCL/DTP- PIC/0069/2012; UID/
NEU/04539/2013). EFSD/JDRF/Novo Nordisk European 
Programme in Type 1 Diabetes Research; QREN- 
COMPETE funding (FCOMP- 01- 0202- FEDER- 038631; 
Project “ExoCord” promoted by Stemlab, SA and Biocant), 
Portugal 2020- COMPETE funding (Project “Stem cell based 
platforms for Regenerative and Therapeutic Medicine”, 
Centro- 07- ST24- FEDER- 002008; Project “StrokeTherapy”, 
POCI- 01- 0247- FEDER- 003386) and EC project ERAatUC 
(Ref:669088).
S6- O4 | Intersection of autophagy and exosome 
secretion on alpha- synuclein spreading pattern in in 
vitro models of Parkinson's disease
Rita Perfeito1,2; Vanessa Anjos1; Rui Jorge Nobre1,2; Manuel 
Garrido1,3; Jens Schwamborn4; Luís Pereira de Almeida1,5
1CNC- Center For Neuroscience And Cell Biology, University of 
Coimbra; 3004- 504 Coimbra, Coimbra, Portugal;  2Instituto de 
Investigação Interdisciplinar, University of Coimbra; 3030- 789 Coimbra, 
Coimbra, Portugal;  3Genibet Biopharmaceuticals; 2780- 157 Oeiras, 
Oeiras, Portugal;  4LCSB- Luxembourg Centre for Systems Biomedicine, 
University of Luxembourg, Luxembourg, Luxembourg, 5Faculty of 
Pharmacy, University of Coimbra; 3000- 548 Coimbra, Coimbra, 
Portugal
Background: Parkinson's disease (PD) is characterized 
by the accumulation of aggregated α- synuclein (α- syn). α- 
Syn has been described to be transmitted between neurons 
through different mechanisms, including exosomes, propa-
gating aggregate pathology and contributing to PD progres-
sion. α- Syn accumulation in neurons has also been linked to 
an ineffective clearance of this protein by autophagy. The 
main goal of this work was to clarify a possible role for the 
interaction between α- syn exosome secretion and autophagy 
in PD and to investigate whether pharmacological activation 
of autophagy would prevent secretion of α- syn in exosomes.
Methods: Two in vitro PD cell models were used mouse 
neuroblastoma (N2a) cells expressing human WT α- syn and 
human neuroepithelial stem cells (hNESCs) derived from fi-
broblasts of PD patients.
Results: Upon incubation of exosomes isolated from 
N2a cells expressing human α- syn with non- transfected 
N2a cells, α- syn was detected in the latter, suggesting 
that it was transferred from cell- to- cell via exosomes. 
Pharmacological activation of autophagy in N2a cells 
transduced with human WT α- syn, effectively reduced the 
levels of this protein. Importantly, we found that in ex-
osomes isolated from transfected N2a cells treated with an 
autophagy activator during 12 h, α- syn levels were signifi-
cantly decreased. Preliminary data with hNESCs showed 
a reduced autophagic flux in PD cells compared to con-
trols. Furthermore, an increased concentration of exosomes 
was detected in PD cells comparing to control hNESCs. 
Nevertheless, α- syn mRNA was found to be decreased in 
exosomes from PD hNESCs.
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Conclusions: We demonstrated that autophagy plays a role 
in the clearance of α- syn levels in N2a cells and provided 
information on a possible interaction between the autophagic 
process and the spreading of α- syn via exosomes. We pro-
pose that inhibiting α- syn release in exosomes and inducing 
degradation of α- syn species by autophagy may constitute a 
novel pharmacological approach for treatment of synucle-
inopathies such as PD.
S6- O5 | Histone acetylation and apoptosis in 
penumbra after photothrombotic stroke in the rat 
cerebral cortex
Anatoly Uzdensky; Svetlana Demyanenko; Valentina Dzreyan
Southern Federal University, Rostov- on- don, Russia
In ischemic stroke, vessel occlusion rapidly induces oxygen 
and glucose deficiency, and tissue infarction. For next hours 
damage propagates and forms the potentially salvageable 
transition zone (penumbra). Using immunoblotting and im-
munofluorescence microscopy, we studied epigenetic pro-
cesses that regulate gene expression and protein synthesis 
in penumbra 4 or 24 h after photothrombotic stroke (PTS). 
PTS was induced by laser irradiation of the rat cerebral cor-
tex after injection of Bengal Rose, which does not penetrate 
cells and remains in vessels. Light exposure induced Ø3 mm 
infarct core surrounded by 1.2- 1.5 mm width penumbra. 
Controls contralateral cortex of the same rats or ipsilateral 
cortex of sham- operated animals. Histone H3 acetylated 
on Lys9 (H3K9Ac) localized in neuronal nuclei. PTS de-
creased H3K9Ac level and its colocalization with neuronal 
marker NSE in penumbra. Colocalization of H3K9Ac with 
apoptotic nuclei (TUNEL) was not observed. Therefore, ap-
optosis of penumbra cells was not associated with H3K9Ac 
downregulation. Histone deacetylase HDAC1 localized both 
in the neuronal nuclei and cytoplasm. HDAC1 expression 
increased in nuclear and especially in cytoplasmic fractions 
of penumbra at 4- 24 h after PTS. Co- localization of HDAC1 
with nuclear marker Hoechst 33342 decreased twice at this 
time. Therefore, HDAC1 redistributed from the nucleus into 
the cytoplasm. Localization of HDAC1 in astrocytes did not 
change. HDAC2 localized exclusively in neuronal nuclei. Its 
nuclear expression in penumbra significantly increased 4 and 
24 h after PTS. Colocalization of HDAC2 with NSE and as-
trocyte marker GFAP increased more than twofold at 24 h. 
HDAC2 did not redistribute to cytoplasm. TUNEL- labeled 
apoptotic nuclei were co- localized with HDAC2, but not 
HDAC1. HDAC2 expression in neuronal nuclei increased 
after PTS along with apoptosis development. Therefore, 
regulation of neuronal apoptosis in PTS- induced penumbra 
was associated with HDAC2 but not HDAC1. Supported by 
Russian Science Foundation; #18- 15- 00110. A.B. Uzdensky 
also supported by Minobrnauki RF (Research Organization, 
#6.4951.2017/6.7).
S6- O6 | A miRNA- based gene therapy 
approach to knock- down mutant ATXN3: 
Alleviation of Machado- Joseph disease phenotype 
in two mouse models upon two routes of 
administration 
Rui Jorge Nobre1,2,3; Joana Saraiva1; Clelia Fusco1; Susana 
Paixao1; Magda Santana1,2; Catarina Miranda1,2; Lorena Petrella4; 
Jose Sereno4; Joao Castelhano4; Miguel Castelo-Branco4; Miguel 
Sena-Esteves5; Luis Almeida1,3,6
1Center for Neuroscience and Cell Biology, Coimbra, Portugal;  
2Institute for Interdisciplinary Research IIIUC, Coimbra, Portugal;  
3ViraVector - Viral Vectors for Gene Transfer Core Facility, Coimbra, 
Portugal;  4ICNAS - Institute of Nuclear Sciences Applied to Health, 
Coimbra, Portugal;  5University of Massachusetts Medical School, 
Worcester, USA;  6Faculty of Pharmacy, University of Coimbra, 
Coimbra, Portugal
Background: Machado- Joseph disease (MJD) is the most 
common dominantly- inherited ataxia. Although there is 
no cure, our group and others have been shown that RNA 
interference holds great promise for its treatment. With 
the aim of translation to clinics, we developed an adeno- 
associated viral vector serotype 9 (AAV9)- based system 
that enables an allele- specific silencing of mutant ataxin- 3 
and alleviation of MJD upon intracranial (ic) and intrave-
nous (iv) injection.
Methods: Specific gene silencing RNAs, whose anti- sense 
sequences are complementary to SNPs that are in linkage 
disequilibrium with the disease- causing expansion, were 
firstly designed and tested in modified neuronal cell lines. An 
AAV9 vector encoding the most effective artificial micro-
RNA (AAV9- mirATAX3) was then generated and validated 
in a lentiviral- based model of MJD upon ic injection. Finally, 
severely- impaired transgenic mice were iv- injected at post-
natal day one (PN1), were submitted to behavioral tests at 
three different time points, underwent Magnetic resonance 
imaging/spectroscopy (MRI/MRS) at PN75 and sacrificed at 
PN95.
Results: The silencing potential of the mirATX3 sequence 
demonstrated superior specificity in vitro compared to 
the allele- specific silencing sequence previously reported. 
AAV9- mirATAX3's treatment reduced the number of pro-
tein aggregates and cerebellar neuropathology in both 
animal models and led to significant improvements in be-
havioral tests. Moreover, MRI/MRS data indicated that 
mirATXN3 treatment ameliorates the levels of a specific 
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set of neurometabolites, which can be used as therapeutic 
biomarkers.
Conclusion: This study provides compelling evidence that 
AAV9- mirATAX3 is able to silence mutant ataxin- 3 in dif-
ferent disease models, through different routes of administra-
tion. This may have a significant impact on the treatment of 
MJD, as well as other Polyglutamine diseases.
Funding: Regional Operational Program Center 2020, 
COMPETE 2020 and FCT (projects CENTRO- 01- 0145- 
FEDER- 000008, CENTRO- 01- 0145- FEDER- 022095, POCI- 
01- 0145- FEDER- 029716, POCI- 01- 0145- FEDER- 007440, 
EXPL/NMC/0331/2012 and SFRH/BPD/66705/2009); by 
NAF and by the AFM- Téléthon no. 21163.
S6- O7 | A cross- sectional and longitudinal 
study on plasma derived miRNAs revealed novel 
dysregulated signatures in Duchenne muscular 
dystrophy patients 
Francesco Catapano1; Dominic Scaglioni1; Kate Maresh1; Joana 
Domingos1; Pierpaolo Ala1; Valeria Ricotti1; Lauren Phillips2; 
Laurent Servais3; Imelda  de Groot4; E.H. Niks5; J.J.G.M. 
Verschuuren5; Volker Straub2,6; Thomas Voit7; Jennifer Morgan1; 
Francesco Muntoni1
1The Dubowitz Neuromuscular Centre, UCL Great Ormond Street 
Institute of Child Health, London, UK;  2John Walton Muscular 
Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle 
University, Newcastle upon Tyne, UK;  3Service of Clinical Research 
and Databases, Institute of Myology, Paris, France;  4UMC St. 
Radboud, Nijmegen, The Netherlands;  5Department of Neurology, 
Leiden University Medical Center, Leiden, The Netherlands;  
6Northern Genetics Service, Newcastle upon Tyne Hospitals NHS 
Foundation Trust, Institute of Human Genetics, International Centre 
for Life, Newcastle upon Tyne, UK;  7NIHR Great Ormond Street 
Hospital Biomedical Research Centre, UCL Great Ormond Street 
Institute of Child Health, London, UK
Background: Duchenne muscular dystrophy (DMD) is an 
X- linked recessive neuromuscular disorder affecting 1 in 
5000 newborn males, mainly caused by out- of- frame dele-
tions or, more rarely, duplications, nonsense or other small 
mutations affecting DMD gene and therefore dystrophin 
protein production. MicroRNAs are short (~20- 23 nucleo-
tides) non- coding RNAs that regulate gene expression; their 
dysregulation in serum and urine has been associated with 
many paediatric neuromuscular conditions including DMD. 
MiRNAs are present in biofluids as free circulating mol-
ecules or included in exosomes. Here we investigated the 
potential of plasma derived exosomal miRNAs as novel non- 
invasive biomarkers in DMD. Moreover, we assessed if there 
was any association between miRNA levels in plasma and 
corticosteroid treatment.
Materials and methods: The patients included in this study 
are part of a cohort of DMD boys in a multicentre natural 
history study registered in clinicaltrials.gov (NCT02780492). 
Samples from patients recruited in London, Paris, Newcastle 
and Leiden were analysed. qPCR microRNA profiling was 
performed using Serum/Plasma Focus microRNA PCR 
SYBR green- based panels (Exiqon), while validations were 
carried out by a qPCR TaqMan small RNA Assay (Life 
Technology).
Results and conclusion: We detected novel miRNAs (both 
free- circulating and exosomal) dysregulated in plasma from 
DMD patients and validated those with the strongest abnor-
mal expression.
We also detected a set of longitudinally dysregulated miR-
NAs between different time points (∆T1- T2 = 24 months) 
in DMD patients. Our findings indicate that a set of free- 
circulating miRNAs is longitudinally dysregulated in plasma 
from DMD patients. Moreover, we detected novel dysregu-
lated miRNAs in plasma from DMD patients.
Funding source: Association Française contre les 
Myopathies (AFM).
S6- O8 | Quiet! They may be at rest: Metabolic 
regulation of paused- pluripotency by manipulating 
culture conditions
Bibiana Silva1; Ana Sofia Rodrigues1; Maria Inês Sousa1,2; João 
Ramalho-Santos1,2
1Biology of Reproduction & Stem Cells Group, Center for Neuroscience 
and Cell Biology, University of Coimbra, Coimbra, Portugal;  
2Department of Life Sciences, University of Coimbra, Coimbra, Portugal
Background: Embryonic Diapause (ED) is a mechanism in 
which embryo development is temporarily arrested to ensure 
proper conditions are available for embryonic development. 
Recently, the mTOR pathway was found to regulate ED, since 
its pharmacological inhibition, induces a diapause- like state 
in embryos. This reversible inhibition was extended to mouse 
embryonic stem cells (mESCs), inducing a novel pluripotent- 
paused state. The mTOR pathway is a major integrative path-
way that coordinates several cellular processes in response to 
a variety of environmental cues, including amino acid avail-
ability. Therefore, the main goal of this study was to induce 
this paused- state by withdrawing specific amino acids from 
the medium, avoiding pharmacological approaches.
Materials and methods: Naive mESCs were cultured in 
the presence/absence of different conditions of amino acid 
availability. As a positive control, cells were incubated with 
mTOR inhibitor INK128. Cell proliferation, pluripotency sta-
tus and glycolytic and oxidative metabolism were assessed.
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Results: Absence of specific amino acids was more effec-
tive than INK128 in reducing cell proliferation, affecting 
cell cycle progression, which was reflected by an increase 
of cells in the G1 phase. The effects included a reduction 
in glycolytic and oxidative metabolism, further evidenced by 
decreased lactate production and differential nutrient uptake. 
Additionally, privation of these amino acids reduced mTOR 
activity- related phosphorylation without affecting pluripo-
tency and the observed effects of amino acid withdrawal 
were reversible.
Conclusions: Metabolic modulation of culture conditions in 
mESCs, by amino acid withdrawal were shown to be potent 
inducers of the paused- state.
Funding: Fundação para a Ciência e Tecnologia(FCT) 
Portugal, funded M.I.S.(SFRH/BD/86260/2012) and 
A.S.R.(SFRH/BPD/119367/2016) scholarships. Funding was 
provided by the STEM@REST Project(CENTRO- 01- 0145- 
FEDER- 028871) and by the European Regional Development 
Fund(ERDF), through the Centro2020 Regional Operational 
Programme project CENTRO- 01- 0145- FEDER- 000012- 
HealthyAging2020, the COMPETE2020- Operational 
Programme for Competitiveness and Internationalisation, and 
the Portuguese national funds via FCT–Fundação para a Ciência 
e a Tecnologia, I.P.:projectPOCI- 01- 0145- FEDER- 007440.
S6- O9 | Efficient non- coding RNA delivery in 
wound healing by photo- triggerable nanoparticles
Vitor Francisco1,2; Josephine Blersch1; Catarina Rebelo1,2; Adrian 
Jimenez1; Helena Antunes1,2; Carlo Gonzato3; Sandra Pinto1; 
Susana Simões1; Klaus Liedl4; Karsten Haupt2; Lino Ferreira1,2
1Center for Neuroscience and Cell Biology - University of Coimbra, 
Coimbra, Portugal;  2Faculty of Medicine - University of Coimbra, 
Coimbra, Portugal;  3Campiegne University of Technology, CNRS 
Institute Enzyme and Cell Engineering, Compiègne Cedex, France;  
4Faculty of Chemistry and Pharmacy - University Innsbruck, Leopold- 
Franzens, Austria
Background: Wound healing and its medical complications 
remain one of the most prevalent and economically burden-
some healthcare issues in the world. RNA- based therapies 
have emerged recently as promising drugs for skin regen-
eration [1], with distinct advantages over conventional drug 
therapies. However, several obstacles need to be addressed 
before the clinical translation of RNA- based therapeutics. In 
particular, the design of formulations that enable their deliv-
ery to a target cell in the skin reducing potential off- target 
effects and simultaneously increase their efficacy in the intra-
cellular delivery. The hypothesis of the current work was that 
biocompatible light- activatable nanoparticles (NPs) allowing 
precise control of the timing and spatial release of the RNA 
molecules could accelerate the translation of these therapies.
Materials and methods: The polymers was prepared by the 
addition of monomers in dimethyl sulfoxide (DMSO), for 
5 days, at 60 ºC. The monomers were then precipitated in 
water to form NPs.
Results: Herein, we synthesized a nanoparticle library 
composed by 160 formulations, with a variety of physico- 
chemical properties and responsiveness to UV light. We 
have performed high- throughput screenings in reporter 
cells to identify formulations that were rapidly taken up by 
cells and deliver efficiently siRNA (more effectively than 
Lipofectamine RNAiMAX). We have identified candidates 
that were further characterized in secondary tests regarding 
their specificity to skin cells (some NPs were more internal-
ized by a specific type of cell than other), endolysosomal es-
cape and functional studies before and after light activation. 
Moreover, we have confirmed the advantages of one of the 
candidate formulations in a wound healing animal model, for 
the delivery of a skin regenerative miRNA identified recently 
by us.
Conclusion: Light- activatable NPs offer a new strategy to 
deliver topically non- coding RNAs.
Funding sources: ERA Chair project ERA@UC ref:669088, 
POCI- 01- 0145- FEDER- 016390:CANCEL STEM, 
POCI- 01- 0145- FEDER- 029414:LIghtBRARY.
Reference: [1] Randeria, P.S., et al., PNAS, 2015, 112, 5573
S6- O10 | Paracrine effect of bone marrow and 
adipose tissue mesenchymal stem cell derived 
extracellular vesicles on Glioblastoma
Gulcin Tezcan1; Zarema Gillazieva1; Svetlana Arkhipova1; 
Valeriya Solovyeva1; Albert Rizvanov1; Svetlana Khaiboullina1,2
1Kazan Federal University, Academic and Research Centre of the 
Institute of Fundamental Medicine and Biology, Kazan, Russia; 
2Department of Microbiology and Immunology, University of Nevada, 
Reno, USA
Background: Glioblastoma multiform (GBM) is the most 
commonly diagnosed brain tumor. There is no cure and mor-
tality rate remains high. Mesenchymal stem cells (MSCs) 
were shown to have therapeutic potential due to migration 
towards the sites of inflammation, which are commonly 
found in GBM. It is believed that MSCs therapeutic effect 
is associated with production of microvesicles (MVs). We 
investigated the activation capacity of MVs derived from 
adipose tissue MSCs (AD- MSCs) and bone marrow MSCs 
(BMMSCs) on peripheral blood mononuclear cells (PBMCs). 
Also, the effect of AD- MSCs - MVs and BM- MSCs- MVs 
on GBM derived tumor cells was analyzed.
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Material and methods: MVs were derived from rat 
BMMSCs and AD- MSCs. Rat PBMCs were loaded with 
BMMSCs- MVs or AD- MSCs- MVs and then co- cultured 
with C6 cells, a GBM derived cell line, using transwell sys-
tem. After 24 hours, C6 cells were used for RNA extraction 
and RT- qPCR analysis of CASP3 and PTEN tumor suppres-
sor genes. Data was statistically analyzed using independent 
samples t test, SPSS 20. All experiments were carried out in 
compliance with the procedure protocols approved by KFU 
local ethics committee (protocol #5, date 27.05.2014) ac-
cording to the rules of KFU and Russia Laws.
Results: In the presence of BM- MSCs- MVs, expression 
of CASP3 and PTEN in PBMCs was increased 3.63 fold 
(P = 0.067) and 8.06 fold (P = 0.075) respectively, as com-
pared to PBMCs cultured without MVs. When PBMC were 
co- cultured with AD- MSCs- MVs, transcription of CASP3 
and PTEN in C6 cells was significantly increased (6.96 fold 
(P < 0.001) and 10.56 fold (P < 0.001), respectively) as 
compared to PBMCs cultured without MVs.
Conclusion: We have demonstrated that AD- MSCs- MVs 
have higher capacity to increase CASP3 and PTEN mRNA 
expression as compared to BM- MSCs- MVs. We suggested 
that AD- MSCs have a potential as a therapeutic for GBM 
therapy.
Funding sources: This study was supported by RFBR grant 
18- 74- 10044.
S6- O11 | Tackling the controversia: Decoding 
human cardiac progenitor cells regenerative 
potential in acute myocardial infarction 
Maria João Sebastião1,2; Ivo Reis1,2; Itziar Palacios3; Margarida 
Serra1,2; Patrícia Gomes-Alves1,2; Paula M. Alves1,2
1iBET- Instituto de Biologia Experimental e Tecnológica, Oeiras, 
Portugal;  2ITQB- NOVA- Instituto de Tecnologia Química e Biológica 
António Xavier, Oeiras, Portugal;  3Coretherapix, S.L.U. Tigenix Group, 
Takeda, Tres Cantos, Spain
Background: Upon Acute Myocardial Infarction (AMI) and 
inherent Ischemia/Reperfusion (I/R) injury, endogenous car-
diac progenitor cells (CPCs) are activated, contributing to my-
ocardial repair through an auto/paracrine crosstalk between 
CPCs and cardiomyocytes (CMs) in stress. Transplantation 
of CPCs is being tested in clinical trials, and although im-
provements have been reported, the mechanisms of action of 
these cells are still mostly unknown and controversial.
Material and methods: Our work combines the develop-
ment of I/R in vitro human cell models with advanced mass 
spectrometry proteomic tools to further characterize hCPC 
and unveil associated regenerative mechanisms. hCPCs em-
ployed in the clinical trial CARE- MI (NCT02439398) were 
used. Different strategies were explored to recapitulate I/R, 
including use of human adult/mature cells, 3D culture and 
bioreactor technology. Firstly, we developed a transwell co- 
culture I/R model, with hCPCs and human induced pluri-
potent stem cell derived CMs(hiPSC- CMs). Following this 
work aiming at further improving the in vitro I/R relevance, 
3D hiPSC CM cultures and bioreactors were combined.
Results: Important features of I/R injury were successfully 
captured, including hiPSC- CM death, cell ultra- structure 
disruption, as well as increased release of inflammatory 
cytokines. hCPCs response to I/R was probed using whole 
proteome analysis (including quantitative SWATH- MS), 
allowing to propose new pathways in the hCPCs- mediated 
regenerative process along I/R injury. Our data shows that 
our AMI- setup up- regulates hCPC proteins associated with 
migratory, proliferation and stress response- related path-
ways. Moreover, our results reinforce the idea that paracrine- 
mediated mechanisms are central for hCPC activation, with 
the enrichment of several paracrine signaling pathways.
Conclusions: The systems established allowed to better char-
acterize hCPC mechanisms of action in response to AMI con-
texts. The knowledge generated has the potential to be used 
in the development of novel strategies excelling endogenous 
and transplanted hCPCs regenerative potential.
Funding sources: This work was supported by the project 
NETDIAMOND (SAICTPAC/0047/2015), FCT/POCI- 
01- 0145- FEDER- 016385; and iNOVA4Health - UID/
Multi/04462/2013.
S7- O1 | Increased plasmatic NETs by- products 
in patients in severe obesity
Marco D'Abbondanza1; Eva Edvige Martorelli1; Maria Anastasia 
Ricci1; Stefano De Vuono1; Elisa Nulli Migliola1; Donatella Siepi1; 
Maria Teresa Paganelli1; Norma Maugeri2; Graziana Lupattelli1
1University of Perugia, Perugia, Italy;  2Autoimmunity and vascular 
inflammation Unit. San Raffaele Scientific Institute and Vita- Salute 
University, Milano, Milano, Italy
Objective: Neutrophil extracellular traps (NETs) are DNAs 
products involved in immune process. Obesity through a 
low- grade chronic inflammation determines neutrophil acti-
vation, but it is still unclear its role in NETs formation. The 
aim of our study was to investigate NETs levels in healthy 
and morbid obese, their association with anthropometric and 
glyco- metabolic parameters and their changes after bariatric 
surgery.
Methods: We enrolled 73 patients with morbid obesity (BMI 
40 kg/m2 or 35 kg/m2 + comorbidity) eligible to sleeve gas-
trectomy and a control group of 32 healthy subjects. We eval-
uated anthropometric parameters, peripheral blood pressure 
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(BP), biochemical and serum analysis at the enrollment and 
at twelve months after surgery. Plasmatic levels of MPO- 
DNA complexes were assessed by ELISA.
Results: NETs levels were higher in obese than in control 
group (P < 0.001) and correlated with the main anthropo-
metric variable (BMI, waist, hip), glyco- metabolic vari-
ables and systolic BP. NETs trend after intervention was 
uneven. The reduction of NETs correlated with the entity 
of reduction of BMI (ρ=0.416, P < 0.05), VFA (ρ=0.351, 
P < 0.05), and glycaemia (ρ=0.495, P < 0.01). In medical 
history of patients in whom NETs increased, we observed 
a higher number of thromboembolic and atherosclerotic 
events.
Conclusion: Severe obesity is associated with increased 
generation of NETs, which in turn could influence the 
patients’ systemic inflammatory state. Weight loss and 
in particular loss of adipose tissue after bariatric surgery 
does not in itself correct NET's dysregulated production. 
Finally, patients in whom NETs accumulation persists after 
surgery are probably those at the highest risk of cardiovas-
cular events.
S7- O2 | The effects of thiol- containing amino 
acids on the neuronal activity in the hippocampus 
of newborn rats
Elina Gataulina; Viktoriya Shakhmatova; Elizaveta Ermakova; 
Evgeniya Kurmashova; Guzel Sitdikova; Aleksey Yakovlev
Kazan Federal University, Kazan, Russia
Background: Homocysteine is related to the large group 
of endogenous thiols compounds that provide the redox 
balance of the cells. An elevated levels of L- homocysteine 
induce excitotoxicity during prenatal and postnatal devel-
opment resulted in impairments of maternal metabolism 
and inborn deficiency of enzyme activity. The neonatal hip-
pocampus is characterized by periodical synchronous net-
work driven giant depolarizing potentials (GDPs), playing 
an important role in synaptogenesis. The aim of our study 
was to investigate the effects of homocysteine, its oxidized 
form- L- homocysteine and L- homocysteine- thiolactone on 
spontaneous and population activity of hippocampal neu-
rons of newborn rat.
Materials and methods: In present study we used extracel-
lular field potential recording of the spontaneous network 
activity from rat newborn hippocampus during first week of 
postnatal development.
Results: Application of L- homocysteine and its metabo-
lites has dose- depend effects on the spontaneous network 
activity and multiunit activity (MUA) of rat hippocampus. 
L- homocysteine and his forms at concentration 0.1- 0.5 mM 
increase of frequency as actions potentials, as GDPs dur-
ing the postnatal development of brain. The GDPs- local 
field potential amplitude and duration were unchanged. It 
is known that L- homocysteine directly stimulates different 
types of glutamate receptors, especially NMDA receptors 
playing an important role in brain maturation. Inhibition 
of glutamate receptors completely prevented the effects of 
homocysteine- thiolactone and homocysteine on the spon-
taneous network and multiunit activity of hippocampus 
neurons. At the same time, the effects of homocysteine 
were partially preserved.
Conclusions: Our results demonstrated that the acute ap-
plication of homocysteine and its derivatives causes an 
increase in the spontaneous network activity of the hip-
pocampal neurons during the postnatal development of brain 
by glutamate- depending mechanisms. It was concluded that 
an abnormality of the thiols metabolism could implicate in 
the hyperexcitability of immature hippocampus and may un-
derlie the risk of seizures development during postnatal pe-
riod. This work was supported by RFBR № 18- 015- 00423.
S7- O4 | Functionality of neurovascular and 
neurometabolic coupling in the hippocampus of a 
rodent model of aging: Impact on cognition
Cátia F. Lourenço1,2; Ana Ledo1,2; Rui M. Barbosa1,2; João 
Laranjinha1,2
1Center for Neuroscience and Cell Biology, University of Coimbra, 
Coimbra, PT, Portugal;  2Faculty of Pharmacy, University of Coimbra, 
Coimbra, PT, Portugal
Evidence support the prominent role of altered nitric 
oxide (•NO) signaling, cerebral blood flow (CBF) and 
brain metabolism in the dysfunctional cascade leading 
to pathological brain aging. Yet, the putative connec-
tion between these processes and the temporal pattern 
among them are not clear. Notably, •NO is a key mes-
senger both in neurovascular coupling, by signaling from 
neurons to blood vessels, and in neurometabolic cou-
pling, by modulating O2 utilization by mitochondria. In 
this study, we aimed to investigate the functionality of 
neurovascular and neurometabolic coupling in associa-
tion to cognitive performance along aging and whether 
local redox alteration would contribute to a dysfunctional 
neurovascular- neurometabolic axis. For this, we evaluated 
the cognitive performance of F344 rats along aging and 
performed in vivo simultaneous measurements of •NO, 
O2 and CBF in response to glutamatergic activation. The 
local administration of a redox- active quinone was used 
to assess the putative contribution of redox alterations in 
•NO- mediated neurovascular process. We observed that, 
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although the glutamate- induced •NO dynamics were not 
significantly affected along aging, the neurovascular cou-
pling was progressively impaired accompanying a decline 
in memory performance. Noteworthy, in spite of a reduced 
CBF response coupled to glutamatergic activation, the 
ΔpO2 associated to the hemodynamic response was higher 
in older animals, strongly suggesting a decrease in global 
metabolic rate of O2. Furthermore, the age- dependent im-
pairment in the neurovascular coupling was mimicked in 
young rats by promoting an unbalance in redox status to-
ward oxidation via intracellular generation of superoxide 
radical by using the redox- active quinone. This observa-
tion strengthens the idea that oxidative stress may have 
a critical role in the neurovascular uncoupling underly-
ing brain aging and dysfunction. Overall, data supports a 
connection of impairment of neurovascular response with 
cognition decline.
Funding: Work funded by FEDER through 
COMPETE and FCT - POCI- 01- 0145- 
FEDER- 007440/POCI- 01- 0145- FEDER- 029099 and 
by the Centro 2020 Regional Operational Program 
- CENTRO- 01- 0145- FEDER- 000012- HealthyAging2020.
S7- O5 | An active lifestyle decreases the severity 
of prostate cancer lesions in male Wistar rats
Paula Oliveira1; Elisabete Nascimento-Gonçalves1; Bruno 
Colaço1; Rita Ferreira2; Margarida Fardilha3; Ana Faustino-
Rocha4; Maria Neuparth5; José Duarte5; Fernanda Seixas6; Daniel 
Moreira-Gonçalves5
1CITAB, UTAD, Vila Real, Portugal;  2Organic Chemistry, Natural 
Products and Foodstuffs QOPNA, Mass Spectrometry Center, 
Department of Chemistry, University of Aveiro UA , Aveiro, Portugal;  
3Institute for Biomedicine iBiMED, Department of Medical Sciences, 
UA , Aveiro, Portugal;  4Faculty of Veterinary Medicine, Lusophone 
University of Humanities and Technologies, Lisbon, Portugal;  
5CIAFEL, Faculty of Sports, University of Porto, Porto, Portugal;  
6Animal and Veterinary Research Center CECAV, UTAD , Vila Real, 
Portugal
Background: Prostate cancer (PC) hormonal dependence is 
well known, as well as the effect of exercise on androgen 
levels. This work aims to evaluate the influence of an ac-
tive lifestyle on dorsolateral prostate lesions in a rat model of 
chemically- induced PC.
Materials and methods: Fifty- five male Wistar Unilever 
rats were divided into four groups group I (sedentary), group 
II (sedentary- PC), group III (exercised), group IV (exer-
cised- PC). Animals began the physical exercise in a tread-
mill at eight weeks of age and were trained at an intensity 
corresponding to 50% of the maximum speed determined in 
the maximum effort test performed monthly, 5 days/week, 
during 53 weeks. At 12 weeks of age PC was induced by flu-
tamide testosterone propionate, N- methyl- N- nitrosourea and 
crystalline testosterone implants. Animals were sacrificed at 
61 weeks of age. Experiments were approved by DGAV.
Results and conclusions: At the end of the experiment, 
group I showed higher mean body weight than group III 
(P = 0.04); group II showed higher body weight compared 
to group IV (P < 0.001). The prostate average weights were 
higher in PC- induced groups (P < 0.001). The mean values 
of cholesterol were higher in groups I and II (P < 0.05). 
The creatine kinase concentration was higher in group IV 
than in group II (P = 0.003). Testosterone serum concen-
trations were 128.42 ± 25.53 pg/mL, 1921.55 ± 255.57 pg/
mL, 256.99 ± 31.44 pg/mL and 2715.70 ± 315.18 pg/mL in 
groups I, II, III, and IV, respectively. Animals from group II 
showed 85.7% of dysplasia, 64.3% of PIN and 64.3% of mi-
croinvasive carcinomas of the dorsolateral prostate. Animals 
from group IV showed a slight decrease in the number of ob-
served lesions (70% of dysplasia, 58.8 % of PIN and 58.8% 
of invasive carcinomas). Our results suggest that exercise 
may have the potential to delay PC progression.
Funding sources: This work was supported by FEDER/
COMPETE/POCI; POCI- 01- 0145- FEDER- 016728 and 
FCT; PTDC/DTP- DES/6077/2014.
S7- O6 | The neuroprotective effect of N- 
acetylcysteine in the rat model of the endothelin- 1- 
induced focal cerebral ischemia
Gulshat Burkhanova1; Kseniya Chernova1; Julia Lebedeva1; 
Andrey Zakharov1; Rustem Khazipov1,2
1Kazan Federal University, Kazan, Russia;  2INMED, Aix- Marseille 
University, Marseille, France
The increased production of reactive oxygen species (ROS) 
is a crucial factor aggravating cerebral ischemia. Here, we 
explored neuroprotective effects of the ROS scavenger N- 
acetylcysteine in a model of focal ischemia induced by one 
hour long epipial application of 10- 20 μM endothelin- 1 on 
somatosensory rat barrel cortex. The level of suppression 
of sensory- evoked and spontaneous activity following three 
hours of endothelin- 1 washout was used to estimate the level 
of ischemia- induced functional impairment. N- acetylcysteine 
(20 μM) was epipially applied throughout one hour before and 
one hour during endothelin- 1 application. We found that the 
frequency of spontaneous action potentials (AP) in the ani-
mals pretreated with N- acetylcysteine recovered to 67 ± 32% 
of control level three hours after endothelin- 1 application 
(n = 12 rats), while in control animals, the AP frequency 
recovered only to 5 ± 2% of control (n = 7 rats, P < 0.05). 
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Also, the level of recovery of the principal whisker- evoked 
cortical sensory potential initial slope and amplitude was 
fivefold in animals pretreated with N- acetylcysteine com-
pared to control group. Thus, N- acetylcysteine significantly 
improves the recovery of neuronal activity in rat barrel cortex 
in a model of the endothelin- 1 induced focal ischemia.
Funding: This work was supported by RSF (17- 15- 01271, 
electrophysiological experiments) and the subsidy allocated 
to Kazan Federal University for the state assignment in the 
sphere of scientific activities (6.5520.2017/9.10, eviewer 
development).
S8- O1 | Connecting the dots between a High- 
Fat/Cholesterol Diet and Sporadic Alzheimer's 
Disease
Ana Ledo1,2; Gianni Mancini3; Cândida Dias1,2; Cátia F. 
Lourenço1,2; João Laranjinha1,2; Andreza de Bem4
1Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal;  
2Center for Neuroscience and Cell Biology, Coimbra, Portugal;  
3Department of Biochemistry, Universidade Federal de Santa Catarina, 
Florianopolis, Brazil;  4Department of Physiological Sciences, Institute 
of Biological Sciences, University of Brasília, Brasilia, Brazil
Ample evidence from epi- clinical and pre- clinical stud-
ies suggests mid- life hypercholesterolemia is a risk factor 
for developing Alzheimer's disease (AD) at a later age. 
However, the mechanistic link between the two is poorly 
understood. In the present work we performed a compara-
tive study between a transgenic model of AD (3xTgAD) 
and age- matched NTg mice fed a high- fat/cholesterol diet 
(HFCD) for an 8- week period, evaluating cognitive func-
tion, hippocampal synaptic plasticity and nitrergic trans-
mission as well as oxidative metabolism. We observed that 
the HFCD produced a modest 10% increase in serum cho-
lesterol levels in NTg mice. Despite this, behavioral tasks 
(novel object recognition and Y- maze) revealed that the 
HFCD induced in NTg mice cognitive deficits similar to 
those observed in age- matched 3xTgAD mice. Similarly, 
evaluation of synaptic plasticity revealed compromised 
LTP in the CA1 subregion of hippocampal slices in HFCD- 
fed NTg mice similar to that observed in the genetic model 
of AD. Considering our previous observation of age- and 
genotype- dependent change in nitric oxide (NO) bioac-
tivity in the hippocampus of NTg and 3xTgAD mice, we 
determined NMDAr- linked NO production in the CA1 of 
hippocampal slices. We found that the HFCD decreased 
NO production resulting from receptor activation, reca-
pitulating the effect of age. Similarly, evaluation of mi-
tochondrial respiration in intact hippocampal slices using 
high- resolution respirometry showed decreased respiratory 
capacity resulting from HFCD, similar to that observed 
previously as a result of aging and not the 3xTg genotype. 
These observations suggest that NTg mice fed a HFCD 
develop an AD- like after that recapitulates some aspects 
observed in a genetic model of AD. Furthermore, a HFCD 
induces changes in NMDAr- linked NO dynamics as well 
as mitochondrial sparing capacity that we have found to be 
poorly expressed in the 3xTgAD model, although we have 
shown them to be a result of aging.
S8- O2 | Characterization and follow- up of 
the Coimbra cohort of Machado- Joseph disease 
patients 
Magda M. Santana1; Patrick Silva1; Joana Ribeiro2; Inês Cunha2; 
Laetitia Gaspar1; Cristina Januário2; Luís Pereira de Almeida1,3,4; 
ESMI consortium
1CNC - Center For Neuroscience And Cell Biology, University of 
Coimbra, Coimbra, Portugal;  2CHUC - Coimbra Hospital and 
University Centre , Coimbra, Portugal;  3CIBB – Center for Innovative 
Biomedicine and Biotechnology, Coimbra, Portugal;  4FFUC - Faculty of 
Pharmacy, University of Coimbra, Coimbra, Portugal
Background: Machado–Joseph disease (MJD) is the most 
common of the dominantly- inherited ataxias worldwide. To 
date, there is no therapy to stop or slow disease progression, 
but potential candidates are ready for clinical studies and 
therefore the availability of a large cohort of patients is criti-
cal. The European Spinocerebellar ataxia type 3/Machado- 
Joseph disease Initiative (ESMI) is, in this context, intended 
to set up an international MJD cohort ready for interven-
tional trials. Here, we characterized the Coimbra's cohort of 
MJD patients that integrates the ESMI project.
Methods: This study was approved by Ethics Committee 
of Faculty of Medicine, University of Coimbra. Patients 
were enrolled upon signing informed consent and charac-
terized using clinical and functional tests at baseline and 
after 1 year.
Results: 39 patients were enrolled. Mean age of disease onset 
was 40.4 ± 11.9 years old, disease duration was 10.1 ± 6.1 years 
and number of CAG repeats on expanded allele was 71.7 ± 4.6. 
At baseline, mean SARA (Scale for the Assessment and Rating 
of Ataxia) score was 13.8 ± 10.1, whereas mean INAS count 
was 5.6 ± 2.3. All patients exhibited at least one non- ataxic 
symptom. ADL score was 9.4 ± 9. For CCFS scale, obtained 
mean scores were 2.513 ± 0.2. Follow- up data revealed no 
variations from baseline in SARA and INAS. ADL scores, on 
the contrary, were significantly higher comparing with base-
line. No statistically significant changes were observed in 9- 
Hole Peg and PATA tests, but a decrease in the performance of 
8- meters walking test was observed.
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Conclusion: We characterized a cohort of MJD patients. 
Follow- up analysis showed that early stage disease patients 
worsen their ability to walk and to perform daily life activi-
ties. Recognizing parameters affecting these patients is rel-
evant to identify the needs for therapeutic interventions.
Funding: JPND and FCT (JPCOFUND/0001/2015, 
JPCOFUND/0005/2015), COMPETE 2020 and 
Regional Operational Program Center2020 (CENTRO- 
07- ST24- FEDER- 002006), BrainHealth2020 
(CENTRO- 01- 0145- FEDER- 000008), ViraVector 
(CENTRO- 01- 0145- FEDER- 022095), POCI- 01- 0145- 
FEDER- 007440, POCI- 01- 0145- FEDER- 029716, UID/
NEU/04539/2013, 01/BIM- ESMI/2016.
S8- O3 | WWOX1 and mitochondria crosstalk in 
diabetic conditions: The beginning of a cell death 
fait
Cristina Carvalho1,2; Paula I. Moreira1,3
1Center for Neuroscience and Cell Biology, University of Coimbra, 
Coimbra, Portugal;  2Institute for Interdisciplinary Research, University 
of Coimbra, Coimbra, Portugal;  3Laboratory of Physiology – Faculty of 
Medicine, University of Coimbra, Coimbra, Portugal
Background: Accumulating evidence demonstrates that 
type 2 diabetes (T2D) increases the risk of cognitive impair-
ment and dementia, particularly Alzheimer's disease (AD). 
To gain insights into the mechanisms underlying T2D- 
associated neurodegeneration, we propose to evaluate the 
contribution of the crosstalk between the putative tumor sup-
pressor WW domain- containing oxidoreductase (WWOX1) 
and mitochondria in T2D- like neurodegeneration.
Methods: For this purpose, we evaluated WWOX1 acti-
vation pattern in the brain cortex of 6- and 14- month- old 
Goto- Kakizaki (GK) rats, a non- obese, spontaneous model 
of T2D as well as in 3xTg- AD mice at different ages (3, 6, 
9 and 11- month- old), a model of AD. Moreover, studies in 
differentiated SH- SY5Y human neuroblastoma cells under 
hyperglycemic conditions were also performed to better un-
derstand the relationship between WWOX1 activation and 
mitochondrial dysfunction.
Results and conclusions: In GK rats, WWOX1 activation, 
evaluated through Tyr33 phosphorylation, occurs in younger 
animals while in older animals a significant decrease of 
WWOX1 activation was observed. Interestingly, a similar 
pattern of WWOX1 activation is observed in 3xTg- AD, 
suggesting the involvement of WWOX1 in AD and T2D- 
associated neurodegeneration. In differentiated SH- SY5Y 
cells under hyperglycemic conditions, WWOX1 activation 
occurs after 24 hours of incubation. Interestingly, WWOX1 
activation is associated with a loss of mitochondrial 
membrane potential and increased p53 levels. Moreover, an 
accumulation of protein particle complex (TPC6A) in mi-
tochondria seems to occur, suggesting its dissociation from 
WWOX1, with consequent increase in amyloid β (Aβ) pro-
duction. Curiously, an increase in amyloid precursor pro-
tein (APP), β- secretase (BACE) and phosphorylated tau 
protein levels was also observed. In sum, our results sug-
gest that WWOX1 activation can underlie T2D- associated 
neurodegeneration.
Funding sources: This work was funded by European 
funds from FEDER, through the Programa Operacional 
Factores de Competitividade – COMPETE 2020 
(HealthyAging2020 CENTRO- 01- 0145- FEDER- 000012) 
and Fundação para a Ciência e a Tecnologia (PEst- C/
SAU/LA0001/2013- 2014 and fellowship SFRH/
BPD/107741/2015 to C. Carvalho)
S8- O4 | Levels of nitric oxide production in the 
rats of different age
Vyatcheslav Andrianov1,2; Farit Sitdikov1; Railya Zaripova1; 
Gusel Yafarova1,2; Ludmila Muranova1; Svetlana Yurtaeva2; 
Vassily Iyudin2; Nafisa Ziiatdinova1; Timur Zefirov1; Khalil 
Gainutdinov1,2
1Institute of Fundamental Medicine and Biology, Kazan Federal 
University, Kazan, Russia;  2Zavoisky Physical- Technical Institute of the 
Russian Academy of Sciences, Kazan, Russia
Recently, during analyzing the functions of the cardiovas-
cular system, attention is drawn to nitric oxide (NO), which 
is a free radical with a short life time. In the cardiovas-
cular system, NO controls vascular tone, blood pressure, 
proliferation of endothelial and smooth muscle cells of the 
vascular wall. Detailed analysis shows that the different ef-
fects of NO donors and NOS blockers may be depended 
from differences in the experimental conditions. Since 
in many experiments there are used juvenile animals, the 
study NO level in heart tissues during ontogenesis is of 
great interest. Therefore, the aim of investigation was to 
study the dynamics of NO- containing iron complexes in rat 
heart tissues during ontogenesis by EPR spectroscopy using 
the method of spin traps. Rats 14, 21, 70 and 100 days of 
age were used in the experiment. The records were carried 
out on EPR spectrometer X- band “Bruker” ER 200E SRC. 
Three types of paramagnetic complexes of iron ions with 
NO were recorded in all measured EPR spectra. It is a spin 
trap based complex of Fe2 + with diethyldithiocarbamate 
(DETC)2- Fe2 + - NO and two types of iron complexes R- 
and T- conformers of Hb- NO. It was found that the sum-
mer concentration of NO (all three components) produced 
in rat heart tissues proved to considerably decrease during 
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ontogeny. However, in 14- day- old rats, the signal from 
the T- conformer is much greater than in 100- day- old rats. 
Thus, it can be assumed that the NO system plays an im-
portant role in the early stages of postnatal ontogenesis.
Funding: Supported by RFBR (grant 18- 515- 00003).
S8- O5 | Cofilin inhibitor T56- LIMKi protects 
mouse brain from photothrombotic stroke
Anatoly Uzdensky; Svetlana Demyanenko
Southern Federal University, Rostov- on- don, Russia
After ischemic stroke injurious factors spread from in-
farction core and form transition zone, penumbra, which 
is potentially salvageable. However, neuroprotectors 
for rescuing cerebral tissue are absent. Recently, we 
demonstrated upregulation of tryptophan hydroxylase 
(TH), phosphotyrosine- regulated dual specificity kinase 
(DYRK1A), and cofilin in penumbra after photothrombotic 
stroke (PTS) in the rat cerebral cortex. Here, we studied ef-
fects of inhibitors of these proteins 4- chlorophenylalanine 
(PCPA), harmine, and T56- LIMKi, respectively, on PTS- 
induced infarct volume and tissue morphology in the mouse 
brain. PTS was induced by laser irradiation after adminis-
tration of Bengal Rose, which doesn't penetrate cells and re-
mains in blood vessels. Following photoirradiation induces 
local thrombosis, and tissue infarct. Mean infarct volume 
(V) in control groups (PTS without inhibitors) was 13 ± 2% 
of the cerebral hemisphere volume on day 7 after PTS and 
8 ± 1% on day 14. PCPA or harmine did not change V after 
these intervals. However, T56- LIMKi reduced V by 2.1 
and 3.4 times at 7th and 14th days, respectively. On 3rd 
day many small necrotic cells and peri- cellular edema were 
observed in the infarction core. Percents of normochromic, 
hypochromic, hyperchromic and pyknotic cells did not dif-
fer significantly from that in other control and experimental 
groups. On day 7, percents of altered cells did not change 
from that at day 3. On 14th day, accumulated glial cells 
formed scar in infarction core and along its borders in all 
experimental groups. However, T56- LIMKi reduced den-
sity of glial scar and stimulated formation of new capillar-
ies on its periphery. This inhibitor also increased percent 
of normochromic neurocytes and decreased percent of cells 
with altered morphology (pyknotic, hypo- and hyperchro-
mic). Thus, cofilin inhibitor T56- LIMKi protected mouse 
brain from negative consequences of photothrombotic 
stroke. Supported by Russian Science Foundation (#18- 15- 
00110). A.B. Uzdensky was supported by Russian Ministry 
of Education and Science (#6.4951.2017/6.7).
S8- O6 | Type 2 diabetes attenuates brain 
glycolytic and oxidative glucose metabolism in 
middle- aged female rats
Inês Alves1,2; Débora Mena1,2; Raquel Seiça3; Catarina R. 
Oliveira1,4; Paula I. Moreira1,3; Ana I. Duarte1,5
1CNC - Center for Neuroscience and Cell Biology, University 
of Coimbra, Coimbra, Portugal;  2Department of Life Sciences, 
University of Coimbra, Coimbra, Portugal;  3Laboratory of 
Physiology, Faculty of Medicine, University of Coimbra, Coimbra, 
Portugal;  4Laboratory of Biochemistry, Faculty of Medicine, 
University of Coimbra, Coimbra, Portugal;  5Institute for 
Interdisciplinary Research IIIUC, University of Coimbra, Coimbra, 
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Background: Type 2 diabetes (T2D) is a risk factor for 
Alzheimer's disease (AD) and their common pathophysiolog-
ical mechanisms may be further affected by female gender 
(especially during perimenopause and menopause). We hy-
pothesized that sex differently affects brain metabolic func-
tion and the susceptibility to AD in T2D at midlife.
Materials and methods: We aimed to analyze the role of 
sex on brain cortical mitochondrial energy metabolism in 
middle- aged T2D rats. We used brain cortical lysates from 
middle- aged (8- month- old) male and female Wistar and 
non- obese T2D Goto- Kakizaki (GK) rats to analyze mito-
chondrial energy metabolism (like mitochondrial respira-
tory chain complexes’ activities and adenine nucleotides), by 
HPLC and colorimetry.
Results: T2D female rats showed increased glycemia, but 
their brain glucose levels were similar to the respective GK 
males, which similarly to Wistar females showed a massive 
decrement in brain glucose. This suggests an impairment in 
brain glucose transport and/or its immediate metabolism. 
Brain pyruvate levels and citrate synthase activity were 
slightly decreased in both control and T2D females, point-
ing towards an attenuation of their brain glycolysis and early 
stages of Krebs cycle. Middle- aged T2D females also had an 
overall inhibition of brain cortical mitochondrial complexes 
I- IV, suggesting a slowdown in their mitochondrial chain 
function that, nonetheless, did not affect their ATP levels.
Conclusions: Attenuation of brain cortical glycolytic and 
oxidative metabolism in middle- aged T2D females may ac-
count for their lower accumulation of AD hallmarks. Further 
studies are needed to uncover their precise crosslinking 
mechanisms.
Funding sources: Portuguese funds from FCT (PTDC/SAU- 
TOX/117481/2010), Fundo Europeu de Desenvolvimento 
Estratégico Regional (FEDER), through the “Projectos de 
Desenvolvimento e Implementação de Infraestruturas de 
Investigação inseridas no RNIE”, “Programa Operacional 
Competitividade e Internacionalização - POCI”, and 
by “Programa Operacional COMPETE2020” (SFRH/
BPD/84473/2012 to A.I. Duarte).
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S8- O7 | Loss of HUMMR in Alzheimer's disease 
acts as a “red traffic light” on the mitochondrial 
movement
Sónia Correia1; Xionguei Zhu2; George Perry3; Paula I. Moreira1,4
1Center for Neuroscience and Cell Biology, University of Coimbra, 
Coimbra, Portugal;  2Case Western Reserve University, Cleveland, USA;  
3University of Texas at San Antonio, San Antonio, USA;  4Faculty of 
Medicine, University of Coimbra, Coimbra, Portugal
Background: Alterations in axonal transport of mitochondria 
play a critical role in Alzheimer's disease (AD) neuropathol-
ogy; however, the molecular mechanisms involved remain 
unexplored. This study was conducted to unveil the role of 
the hypoxia up- regulated mitochondrial movement regulator 
(HUMMR - a protein that favors the anterograde movement 
of mitochondria in a hypoxia- inducible factor 1 (HIF- 1α)- 
dependent process) on defective mitochondrial trafficking 
during the course of AD pathology.
Material and methods: Using human post- mortem brain 
cortex and hippocampus from AD subjects and AD rodent 
models and differentiated SH- SY5Y cells (resemble mature 
neurons) exposed to amyloid- β1- 42 (Aβ1- 42), we evaluated 
HIF- 1α and HUMMR protein levels and mRNA by Western 
blotting and RT- PCR, respectively, and mitochondrial func-
tion and dynamics by fluorimetry and confocal microscopy.
Results: A progressive reduction in HIF- 1α and HUMMR pro-
tein levels and mRNA was observed with increasing AD Braak 
stage. Consistently, AD rodent models also presented a decrease 
in HUMMR protein levels in the brain cortex. Interestingly, 
low levels of the amyloidogenic peptide Aβ1- 42 increased both 
HIF- 1α and HUMMR protein levels in mature neurons without 
affecting mitochondrial function and transport and synaptic in-
tegrity. Meanwhile, mature neurons treated with high levels of 
Aβ1- 42 exhibit a marked reduction in HUMMR protein levels, 
reduced number of mitochondria presented in the axons with 
the concomitant accumulation of these organelles in the perinu-
clear region, neuritic retraction and loss of synaptic integrity as 
evidenced by diminished SNAP- 25 protein levels.
Conclusion: These results suggest that during the initial 
phases of AD pathology, HUMMR sustains the anterograde 
movement of mitochondria in order to cope with the ener-
getic demands within the synapses, acting as a cell quality 
control mechanism. However, with the progression of the 
disease this mechanism fails contributing to an energy crisis 
and, consequently to synaptic and neuronal loss.
Funding: Sónia C. Correia has a post- doctoral fellowship 
(SFRH/BPD/109822/2015) from FCT.
S8- O8 | The gut hypothesis for alzheimer s´ 
disease: Bacterial metabolites cause bioenergetic 
failure and activation of innate immunity in cortical 
neurons
Diana F. Silva1; Emanuel Candeias1; Ana Raquel Esteves1; João 
Duarte Magalhães1; Ildete Luísa Ferreira1; Ana Cristina Rego1; 
Nuno Empadinhas1; Sandra Morais Cardoso2
1Center for Neuroscience And Cell Biology, University Of Coimbra, 
Coimbra, Portugal, 2Institute of Cellular and Molecular Biology, Faculty 
of Medicine; University of Coimbra, Coimbra, Portugal
Alzheimer's disease (AD) is associated with neuronal loss, 
progressive synaptic and mitochondrial dysfunction, accom-
panied by the deposition of Abeta peptides and abnormal tau 
protein. Supporting evidence showing that the gut microbiota 
influences the brain was observed in a germ- free AD genetic 
mice model colonized with the microbiota of conventionally- 
raised AD mice that dramatically increased Abeta plaques. 
Here we seek to demonstrate that gut bacterial metabolites 
(PAMPs) target brain cortical mitochondria triggering a se-
quence of events that lead to the activation of innate immu-
nity with the production of antimicrobial peptides, such as 
Abeta, mimicking AD pathology. After exposure to PAMPs, 
mitochondrial function was evaluated in isolated mitochon-
dria and primary cortical neurons using Seahorse apparatus. 
Also regarding mitochondrial metabolism, reactive oxygen 
species (ROS), mitochondrial network status and cardiolipin 
exposure were evaluated. Neuronal innate immunity activa-
tion was accessed namely by TLR protein levels, IL- 1β, cas-
pase- 1 activation and cytokine production, such as IL- 6 and 
TNF- α. PAMPs caused a decrease in mitochondrial respira-
tion both in cortical neurons and isolated mitochondria. This 
was accompanied by an increased in mitochondrial ROS pro-
duction, decreased ability to store calcium and fragmented 
mitochondrial network with exposure of cardiolipin. These 
alterations activated mitophagy but also induced neuronal in-
nate immunity activation, with an increase in Abeta oligom-
ers. Our data show that bacterial PAMPs are able to trigger 
cellular pathways that underlie AD pathology, highlighting 
the importance of gut dysbiosis for AD development.
Funding: Work supported by Fundação para a Ciência e a 
Tecnologia (FCT) and by EU- FEDER funding through the 
Operational Competitiveness Program—COMPETE grant 
UID/NEU/04539/2013, by the European Regional Development 
Fund, Centro 2020 Regional Operational Program (CENTRO- 
01- 0145- FEDER- 000012- HealthyAging2020), by Prémio 
Santa Casa Neurociências Mantero Belard MB- 40- 2016. DF 
Silva and AR Esteves hold contracts of DL57. E Candeias is 
supported by a MB- 40- 2016 fellowship. JM Magalhães is sup-
ported by HealthyAging2020 fellowship.
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S8- O9 | Obstructive sleep apnea as an aging 
trigger
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in Biomedicine and Biotechnology, University of Coimbra CIBB, 
Coimbra, Portugal;  4Faculty of Pharmacy, University of Coimbra, 
Coimbra, Portugal;  5Sleep Medicine Centre, Coimbra Hospital and 
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Background: Obstructive Sleep Apnea (OSA) is one of the 
most common sleep disorders worldwide. Still, 80- 90% of the 
OSA cases are estimated to be undiagnosed. And untreated, 
OSA decreases functional activity and increases susceptibil-
ity to aging- related diseases and mortality. We propose that 
OSA might anticipate/aggravate aging by inducing cellular 
and molecular age- related impairments. Understanding how 
OSA might putatively accelerate/aggravate aging and aging- 
related diseases may guide into new strategies to improve 
OSA diagnosis.
Aims: To evaluate cellular and molecular age- related impair-
ments in OSA patients, before and after treatment.
Methods: In collaboration with CHUC, a cohort of 25 
Portuguese male patients [age: 55 ± 2 years; BMI: 31 ± 1] di-
agnosed with severe OSA (47.8 ± 5.4 obstructions/hour) was 
integrated in this study, with the approval of the ethical com-
mittee. Cellular and molecular age- related impairments were 
assessed before (T0) and after short (4 months, T1) and long- 
term treatment (2 years, T2) with continuous positive airway 
pressure (CPAP). For that, the axillary temperature was meas-
ured and blood was collected at four time points along the day.
Results: At T0 and T1, an overall dampening was observed 
in circadian profiles as evaluated by axillary temperature and 
expression levels of several genes in blood. By opposite, at 
T2, the profile of the same markers showed significant ame-
liorations, resembling healthy subjects, and overall increased 
expression levels. Some of the assessed markers significantly 
correlated with parameters commonly assessed for OSA di-
agnosis, such as sleepiness, number of obstruction episodes 
and arousals frequency.
Conclusion: The obtained preliminary data suggests that 
OSA has potential to accelerate/aggravate aging and pin-
points potential biomarkers with application in OSA diagno-
sis. Further studies are ongoing to validate these results.
Funding: This project was funded by ERDF through 
COMPETE2020 and Portuguese national funds via 
FCT, under POCI- 01- 0145- FEDER- 029002, POCI- 
01- 0145- FEDER- 007440, UID/NEU/04539/2013 
and PD/BD/135497/2018, and InovC, under 
CENTRO- 01- 0246- FEDER- 000017.
S8- O10 | Hydrogen sulfide prevented pro- 
nociceptive effects of ATP in the trigeminovascular 
system of rats
Kseniia Koroleva1,2; Raisa Giniatullina2; Yan Konshev1; Guzel 
Sitdikova1
1Kazan Federal University, Kazan, Russia;  2A.I. Virtanen Institute for 
Molecular Sciences at University of Eastern, Kuopio, Finland
Background: ATP is one of the most prominent algogens, 
increasing the firing of the trigeminal nerve, underlying the 
migraine pain. H2S is a member of gasotransmitters family, 
induces both pro- and anti- nociceptive action in different tis-
sues. The aim of our work was to study the effects of H2S on 
the ATP- induced firing of the trigeminal nerve and extracel-
lular level of ATP in dura mater of P35- 45 rats.
Materials and methods: The firing of trigeminal nerve was 
recorded using extracellular suction electrode in rat hemiskull 
preparation (DAM80, WPI, USA). ATP release from the rat 
hemiskulls was measured with the ATPlite Luminescence 
Assay System (PerkinElmer, USA). The assay was performed 
following the ATPlite Assay Kit protocol instructions using 
white polystyrene 96- well Costar plates (Corning, USA). 
Luminescence was measured with a POLARstar Optima mi-
croplate reader (BMG Labtech GmbH, Germany).
Results: Application of ATP (100 µM) on the afferent endings 
induced the robust increase of firing of the trigeminal nerve. 
Preliminary application of NaHS (100 µM) resulted in short- 
term rise of action potential frequency however prevented the 
pro- nociceptive effects of ATP. Extracellular ATP level was 
found to increase in migraine patients. The effects of NaHS 
on the extracellular level of ATP in rat meningeal tissues were 
measured. In the control group ATP level was 1.12 ± 0.13 nM 
and did not change significantly after 20 min of incubation in sa-
line (1,04 ± 0.24 nM; n = 8). In treatment group the initial level 
of ATP was 0.99 ± 0.17 nM and decreased to 0.23 ± 0.05 nM; 
n = 8; P˂0.05) after 20 min incubation in NaHS.
Conclusion: Our data suggest the novel inhibitory effect of 
H2S donor the pro- nociceptive action of ATP in the trigemi-
novascular system.
Funding: This study was supported by Program of 
Competitive Growth of KFU and RFBR №18- 315- 00256.
S8- O11 | Cu(II) mediated dityrosine cross- 
linking in the AD brain
George Perry; Andrea Kelley; Stephan Bach
University of Texas at San Antonio, San Antonio, USA
Background: A primary theory surrounding aging and age- 
related diseases, such as Alzheimer's disease (AD), is that 
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oxidative stress plays a crucial role in the post- translations 
modification (PTMs) of proteins in the brain and causes dys-
homeostasis resulting in neuronal death and decay. Cu(II) is 
thought to mediate dityrosine cross- linking of toxic amyloid- 
beta peptides that leads to their eventual aggregation in those 
with AD.
Materials and methods: Our goal is to utilize various mass 
spectrometric techniques, as well as classic microscopy, 
to shine light on the abundance and localization of metal- 
mediated PTMs in AD tissue compared to control tissue. This 
is accomplished by first creating the modifications in vitro. 
Synthetic amyloid- beta(1- 42) (Aβ42) is cross- linked by me-
diation of Cu(II) under oxidative conditions. Site of binding 
and site of cross- linking are investigated by modification of 
the protein at various residues and analysis is accomplished 
through matrix- assisted laser desorption/ionization mass 
spectrometry (MALDI MS). Experimentation and results are 
then translated to intact human brain tissue analysis by imag-
ing MALDI MS.
Results and conclusion: We have previously demonstrated 
the tendency of Cu(II) to bind to synthetic Aβ42. Dityrosine 
cross- linking, with and without the addition of Cu(II), have 
been characterized by mass spectrometry and spectroscopy. 
We have begun to transfer these results to the imaging of 
intact human brain tissue from AD and control brains. This 
allows us to compare the activity of the dityrosine in- vitro 
and in- vivo. Additionally, this allows for the localization and 
relative abundance quantitation within actual human sam-
ples. Future work will involve extending these results to the 
analysis of senile plaques from AD patients.
Funding sources: National Institute on Minority Health 
and Health Disparities (G12MD007591), National Science 
Foundation (CHE- 1126708), Semmes Foundation
S8- O12 | Brain activity of white wine 
polyphenols in the Alzheimer's disease context: 
Effects on cell redox state and amyloid- beta 
peptides levels
Daniela Mendes1; Maria Manuel Oliveira2; Paula Moreira3; David 
Pereira1; Patrícia Valentão1; Paula Andrade1; Romeu António 
Videira1
1REQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of 
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Viterbo Ferreira, nº 228, Porto 4050- 313, Portugal., Porto, Portugal;  
2Chemistry Center – Vila Real CQ- VR, Chemistry Department, School 
of Life and Environmental Sciences, University of Trás- os- Montes e Alto 
Douro, UTAD, P.O. Box 1013; 5001- 801 Vila Real, Portugal., Vila Real, 
Portugal;  3CNC – Center for Neuroscience and Cell Biology, University 
of Coimbra and Laboratory of Physiology, Faculty of Medicine, 
University of Coimbra, 3000- 548 Coimbra, Portugal., Coimbra, Portugal
The development of effective medicines to break or delay the 
progressive brain degeneration underlying Alzheimer's dis-
ease (AD) is one greatest challenge of our time. In the present 
work, a selected pool of white wine polyphenols, designed as 
PVPP- white wine extract, was characterized and used to pre-
pare a polyphenols- enriched diet, supplementing the drink-
ing water with 100 mg/L (as Gallic acid equivalents) of wine 
polyphenolic extract. The impact of daily consumption of 
water supplemented with polyphenols (25 mg/kg/d) for two 
months on brain of 10- month- old 3xTg- AD and NonTg mice 
was rationalized, considering (i) brain the levels of polyphe-
nols; (ii) the capacity to modulate the redox status of brain 
cells, assessing enzymatic and non- enzymatic antioxidant pa-
rameters in whole brain homogenates, mitochondria- enriched 
and mitochondria- free cytosolic fractions; (iii) brain levels of 
amyloid- β peptides. HPLC- DAD analysis revealed that the 
PVPP- with wine extract (880.38 ± 58.68 µg phenols/mg of 
freeze- dried extract) is a complex mixture with 20 phenolic 
compounds, dominated by proanthocyanidin (as oligomers 
of catechin), trans- caftaric and gallic acids, which together 
represent more than 80% of the total phenolic content. The 
polyphenols- enriched diet promotes the brain accumulation 
of six phenolic compounds, being the catechin- derivative the 
most abundant (1.951 ± 0.070 ng/mg of 3xTg- AD brain pro-
tein). Additionally, the functional diet decreases the 3xTg-
 AD brain levels of both amyloid- β peptides, Aβ1- 40 and 
Aβ1- 42. The results show that this diet modulates the redox 
state of brain cells of 3xTg- AD mice, restoring the GSH/
GSSG ratio, improving the catalase activity and reducing 
the oxidation of membrane lipids, as detected in whole brain 
homogenates and mitochondria- enriched fraction. Therefore, 
the polyphenolic- enriched diets promote a significant benefit 
in AD by modulating multiple disease- modifying mecha-
nisms, showing the importance in the development of poly-
phenolic compounds for AD therapy and/or prevention.
Acknowledgments: FCT/MEC (UID/QUI/50006/2013, UID/
QUI/00616/2013) FEDER (Partnership Agreement PT2020), 
NORTE2020, PORTUGAL2020, ERDF (NORTE- 01- 0145- 
FEDER- 000024), POCTEP (0377_IBERPHENOL_6_E). D. 
Mendes (SFRH/BD/138206/2018) thank FCT/MEC.
S8- O13 | Involvement of mitochondria in 
obesity- related myocardial fibrosis
Ching-Yi Chen1; Sin-Jin Li1
1National Taiwan University, Taipei, Taiwan
The worldwide prevalence of obesity increases 3- folds be-
tween 1975 and 2016. WHO reports that 39% of adult popu-
lation are overweight and 13% are obese in 2016. Obesity 
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has been regarded as an independent risk factor and a direct 
cause of cardiovascular diseases. However, the underlying 
mechanisms involved in obesity- related heart dysfunctions 
is still unknown. Heart is a high energy demand organ, and 
95% of energy is contributed by the mitochondrial network. 
Any disruption in mitochondrial homeostasis causes cardio-
myocyte death and heart failure. Our recent studies investi-
gate the link between obesity and cardiac damage regarding 
to mitochondrial functions. We use dietary- induced obese 
(DIO) minipig to mimic human obesity. After 6- month of 
high- fat diet (HFD) feeding, Lee- Sung minipigs are obese, 
hypertension, hyperlipidemia, hyperglycemia, and hyperin-
sulinemia. Energy deficit, mitochondrial dysfunctions and 
fibrosis are noticed in left ventricle of these DIO minipigs. 
We further explore the direct and indirect effect of HFD on 
mitochondrial functions in left ventricle. Our animal and in 
vitro studies show that HFD induces lipotoxicity (direct) and 
alters the characters of pericardial adipose tissue (indirect), 
both changes impair mitochondrial functions and eventually 
lead to cardiomyocyte apoptosis. To conclude, our finding 
provide evidences that HFD impairs mitochondrial functions 
directly and indirectly, thus causing myocardial fibrosis.
